10-K 1 f10k2012_attitudedrink.htm ANNUAL REPORT f10k2012_attitudedrink.htm


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 10-K

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended March 31, 2012
Commission File Number 000-52904

ATTITUDE DRINKS INCORPORATED
(Exact name of registrant as specified in its charter)

Delaware
 
65-0109088
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
 
Identification No.)

10415 Riverside Drive, Suite # 101, Palm Beach Gardens, Florida 33410 USA
(Address of principal executive offices)          (Zip Code)
Telephone number:          (561) 227-2727

Securities registered under Section 12(b) of the Exchange Act:
None
   
Securities registered under Section 12(g) of the Exchange Act
Common Stock, $.001 par value (Title of class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No o
  
Indicate by check mark whether the registrant has submitted electronically  and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x No o
 
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-X (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one)

Large accelerated filer
o
Accelerated filer
o
Non-accelerated filer
o
Smaller reporting company
x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x
 
The issuer's gross revenues for its most recent fiscal year were $406,315.
 
The aggregate market value of the voting stock held by non-affiliates of the issuer on June 29, 2012, based upon the $.001 per share close price of such stock on that date, was $1,127,500 based upon 1,127,500,234 shares held by non-affiliates of the issuer.  The total number of issuer's shares of common stock outstanding held by affiliates and non-affiliates as of July 13, 2012 was 1,132,789,196 shares. 

Transitional Small Business Disclosure Format (check one): Yeso No x
 
 
 
 
 
 
TABLE OF CONTENTS
 
   
Page
PART I
     
ITEM 1
3
ITEM 2
6
ITEM 3
7
ITEM 4
7
 
PART II

 
PART III


PART IV

ITEM 15
41

DOCUMENTS INCORPORATED BY REFERENCE:  See Exhibits

 
 

 

FORWARD-LOOKING STATEMENTS

Statements that are not historical facts, including statements about our prospects and strategies and our expectations about growth contained in this report, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These forward-looking statements represent our present expectations or beliefs concerning future events.  We caution that such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among other things, the uncertainty as to our future profitability; the accuracy of our performance projections and our ability to obtain financing on acceptable terms to finance our operations until profitability.

PART I


The Company
Attitude Drinks Incorporated (“Attitude,” “We” or “Our”) was formed in Delaware on May 10, 1988 under the name International Sportfest, Inc. In January 1994, we acquired 100% of the issued and outstanding common stock of Pride Management Services Plc ("PMS"). PMS was a holding company of six subsidiaries in the United Kingdom engaged in the leasing of motor vehicles throughout the United Kingdom. Simultaneously with the acquisition of PMS, we changed our name to Pride, Inc. From January 1994 through October 1999, we engaged in the leasing of motor vehicles throughout the United Kingdom. On October 1, 1999, we acquired all of the issued and outstanding stock of Mason Hill & Co. and changed our name to Mason Hill Holdings, Inc. During the quarter ended June 30, 2001, our operating subsidiary, Mason Hill & Co., was liquidated by the Securities Investors Protection Corporation. As a result, we became a shell corporation whose principal business was to locate and consummate a merger with an ongoing business.

On September 19, 2007, we acquired Attitude Drink Company, Inc., a Delaware corporation (“ADCI”), under an Agreement and Plan of Merger among Mason Hill Holdings, Inc., MH 09122007, Inc. and ADCI.  Pursuant to the Merger Agreement, each share of ADCI common stock was converted into 40 shares of Company common stock, resulting in the issuance of 4,000,000 shares of our common stock.  The acquisition was accounted for as a reverse merger (recapitalization) with ADCI deemed to be the accounting acquirer, and Attitude deemed to be the legal acquirer.  Accordingly, the financial information presented in the financial statements is that of ADCI as adjusted to give effect to any difference in the par value of the issuer’s and the accounting acquirer’s stock with an offset to capital in excess of par value.  The basis of the assets, liabilities and retained earnings of ADCI, the accounting acquirer, has been carried over in the recapitalization.  On September 30, 2007, we changed our name to Attitude Drinks Incorporated. Our wholly owned subsidiary, ADCI, was incorporated in Delaware on June 18, 2007. Our principal executive offices are located at 10415 Riverside Drive, Suite 101, Palm Beach Gardens, Florida 33410. The telephone number is 561-227-2727.  Our company’s common stock shares (OTCBB: ATTD) began trading in June 2008.  Our fiscal year ends on March 31.
 
Nature of Business
Currently, our plan of operation during the next 12 months is to focus on the non-alcoholic single serving beverage business, developing and marketing milk based products in two fast growing segments: sports recovery and functional dairy. We do not directly manufacture our products but instead outsource the manufacturing process to a third party contract packer.

The Business
From 2001 to 2007, we were a shell corporation, whose principal business was to locate and consummate a merger with an ongoing business which occurred on September 19, 2007.  Once the merger was completed, we developed our first product which was a “healthful” energy drink called VisViva™. This particular product was formulated as a juice blend with our proprietary IQZOL™ energy formula in 12 ounce “slim” cans.  This additive blend provided a unique energy boost with low calories, carbohydrates and caffeine levels, thereby revolutionizing the energy experience derived from energy drinks.  Production began in January 2008 with the first generated sales in late March 2008. Our initial co-packer for the VisViva ™ product was Carolina Beer & Beverage LLC in Mooresville, North Carolina. We stopped the production and sale of the VisViva™ product during 2010 and will consider reintroducing this product as a “focus drink” in late 2012 or 2013.    Our second product which is branded as “Phase III® Recovery” is a milk-based protein drink. Our co-packer for our dairy based product is O-AT-KA Milk Products Cooperative, Inc. in Batavia, New York.  As our company grows and matures, a disruption or delay in production of any of such products could significantly affect our revenues.

Our ability to estimate demand for our products is imprecise and may be less precise during periods of rapid growth, particularly in new markets.  If we materially underestimate demand for our products or are unable to secure sufficient ingredients or raw materials, we might not be able to satisfy demand on a short-term basis.
 
 
3

 
 
We completed development on our second product “Phase III® Recovery” in 2010 which was introduced to address the growing need for sophisticated, exercise recovery solutions while offering a natural protein/carbohydrate ratio optimal for fitness recovery. This product contains 35 grams of protein that are naturally inherent in ultra filtered milk.  The product is packaged as retort processed shelf stable dairy-based 100% milk based sports recovery drink, currently in both chocolate and vanilla flavors, in new state of the art, eco-friendly convenient re-sealable 14.5 oz aluminum bottles. We began distribution of this product in early 2010. Storage, distribution and sale of this product can be done at room temperature while our current retail presence is predominantly in coolers.

Other products to be considered in the future will be Blenders™ ‘Meal on the Move’ which will be a lactose free milk based meal replacement in various flavors.  This product is expected to be developed and marketed in late 2012, depending on available capital.

In House Intellectual Property
We have a trademark for Phase III® from the United States Patent and Trademark Office that was registered December 28, 2010.

While working on trademark and brand development for the dairy platform of functional drinks and protein delivery, we were approached by the owners of the entire intellectual property portfolio once developed and commercialized at Bravo Brands, Inc. On August 8, 2008, we entered into an Asset Purchase Agreement with RFC BB Holdings, LLC (seller) with a $507,500 secured convertible promissory note to purchase the right, title, trademarks and interest to this intellectual property portfolio, notably “Slammers” and “Blenders”.  As these particular brands have been marketed and sold in the past, it is anticipated that these products can be reintroduced into the market much quicker and less expensive than developing a brand new product.

Production Contracts/Administration
Our operations are only in the United States and are run directly by our subsidiary, Attitude Drink Company, Inc.  On December 16, 2008, the company signed a manufacturing co-packing agreement with O-AT-KA Milk Products Cooperative, Inc. for the production of our latest product, Phase III® Recovery, and future new dairy-based products.  The manufacturer shall manufacture, package and ship such products.  All products shall be purchased F.O.B., the facility by the company.  

Industry Trends
We are an innovative beverage brand-development company that was formed to exploit the accelerating shift in beverage consumption patterns of Americans. Consumers are embracing two distinct trends which have redefined the ever-growing single serve beverage industry. First, consumers representing all demographics are purchasing fewer “empty-calorie”, sugar sweetened, carbonated beverages, a trend that has continued for the last ten years. Second, and according to the CSP 2012 Category Management Handbook, “we’ll definitely see more and more functional beverages offering nutrient, vitamins and probiotics”.  In our opinion, consumers are demanding drinks with functionality, delivering either nutritional or experiential impact. During recent years, our experience has indicated beverage consumers have demonstrated growing enthusiasm to pay significant premiums for these functional beverages while exhibiting passionate brand loyalty to the brands.

Management has extensive experience innovating functional products and pioneered the milk-based platform of this beverage “revolution” previously at Bravo! Brands Inc. During that time, management worked with Coca-Cola Enterprises to launch branded milk beverages nationwide. We enjoy strategic relationships, know-how, creativity and perspective in this space. We believe that the two platforms that we will address, sports recovery and functional dairy, represent the fastest growing, most innovative and highest priced drinks ever seen in the beverage industry.

Market Analysis
While there may be more current information, the most recent data that we have analyzed is informative.  According to preliminary data from New York City based Beverage Marketing Corporation which is a leading research, consulting and financial service firm dedicated to the global beverage industry, the U.S. liquid refreshment beverage market grew by 0.9% in 2011.  This marked a second year of growth after two consecutive declines, but it also represented a slowdown from 2010.  The weakened economy hindered beverages’ performance in 2008 and 2009, and improving conditions contributed to their upticks in 2010 and 2011.  Even so, higher prices did almost certainly contribute to 2011’s deceleration as lower-income consumers continued to struggle.  Even so, total liquid refreshment beverage volume exceeded 29.5 billion gallons in 2011. Premium beverages such as ready-to-drink (RTD) tea and coffee, sports beverages and energy drinks advanced particularly forcefully during 2011.  Larger more established segments such as carbonated soft drinks and fruit beverages failed to grow once again.  Energy drinks moved forward faster than all other segments with a 14.4% volume increase in 2011.  Despite this advance, the segment accounted for a relatively small share of total liquid refreshment beverage volume.  Indeed, the only liquid refreshment beverage type with a smaller share of volume was RTD coffee, which charted the second fastest surge, growing by 9.4%. Not surprisingly, no energy drink or RTD coffee brand ranked among the leading trademarks by volume.  Sports beverages, in contrast, had Gatorade (including all brand variations) as the fifth largest beverage trademark during the year, and the category it led showed exceptional vigor.  The brand topped 1 billion gallons for the first time in 2011.  Carbonated soft drinks still stood by far the biggest liquid refreshment beverage category, but they continued to lose both volume and market share.  Volume slipped by 1.7% from 13.8 billion gallons in 2010 to 13.6 billion gallons in 2011 which lowered their market shares from 47% to 46%.  Four companies accounted for all of the leading refreshment beverage trademarks. Pepsi-Cola had four brands including the only fruit beverage brand to make the list, Tropicana.  Coca-Cola had three while Nestle Waters North American had two and Dr. Pepper Snapple Group, Inc. had one.  Beverages continued growth in 2011 proved their essential vitality, and the strong showing by high-end and functional products shows that consumers, at least the more affluent ones are not concerned exclusively with economic considerations when making their beverage selections.
 
4

 
 
The CSP (convenience store/petroleum) recently released their “2012 Category Management Handbook.” In their release and according to the Nielsen Co. and Dr. Pepper Snapple Group, Inc., the Sports Drinks category represented 9.2% of the nonalcoholic beverages sector for the 52 weeks ended January 28, 2012.  In addition and according to the Symphony/IRI Group, the Sports Drinks category reflected increases in unit sales in 2011 as follows:  food – 9.6%; drug -10.4%; and convenience stores – 12.9%.  In fact the pace of sports-drink sales increases held steady in 2011, with dollars up nearly 10% and units up almost 13%.  In the last quarter of the year, the pace actually accelerated.

Further, findings from the Sports and Performance Nutrition 2011 Conference as published by Multi-Sport Research Ltd. on May 26, 2011 indicated the following:

-  Combined enrollment at Ironman, IM 70.3 and ITU (World Cup & World Championship) events grew more than 20%  on year in 2009 as this growth came amidst global recession.

-  An online and TV push, notably by ITU in 2010, presents strong broadcast and revenue opportunities – particularly leading to 2012 and beyond.

-  Sales are largely via specialty retail rather than ‘big box’ retail.

-  Price segmentation fits within standard premium/mainstream/value pricing brands with some ‘super-premium’ pricing across product sectors.

-  Interviews on sports nutrition usage indicated that 16% of athletes and coaches use the products daily, 24% use the products 4+ times a week and 23% use the products 2-3 times a week.

- Feedback indicated the top four factors that influence choice of sports nutrition:  availability near training facilities; results published in peer review articles; research evidence and blind tests; and taste and consistency.

Market Segment Strategy
As we have operated for nearly five years, our future strategy will be to develop our products in the two fast growing segments: sports recovery and functional milk. We produced our first product, VisViva™ which is an energy drink; however, that product has been tabled for now. Phase III® Recovery is our second product which is a protein sports recovery drink. We expect to develop two to three new products in the next two fiscal years, depending on available capital.

We know from experience that the largest retailers of milk products are demanding new and more diverse refreshment drinks, thus our response to consumer interest and demand with our latest dairy based product, “Phase III® Recovery” that was introduced in early 2010.

Competition
The beverage industry is highly competitive. The principal areas of competition are pricing, packaging, development of new products and flavors and marketing campaigns. Our products will compete with a wide range of drinks produced by a relatively large number of manufacturers, any of which have substantially greater financial, marketing and distribution resources than we do.

Important factors affecting our ability to compete successfully include taste and flavor of products, trade and consumer promotions, rapid and effective development of new, unique cutting edge products, attractive and different packaging, branded product advertising and pricing. We will also compete for distributors who will concentrate on marketing our products over those of our competitors, provide stable and reliable distribution and secure adequate shelf space in retail outlets. Competitive pressures in the sports beverage market could cause our products to be unable to gain market share, or we could experience price erosion, which could have a material adverse effect on our business and results. According to The Beverage Industry magazine for May 2011, the domestic sports drink category is now estimated at approximately $3.8 billion annual sales.

We compete not only for customer acceptance but for maximum marketing efforts by multi-brand licensed bottlers, brokers and distributors, many of which have a principal affiliation with competing companies and brands. Certain large companies such as The Coca-Cola Company and Pepsico Inc. market and/or distribute products in that market segment such as Muscle Milk® and other protein beverages.

 
5

 
 
Marketing
Management believes that the impact of the internet and the enhanced communication systems that it has enabled have dramatically changed the way we live our lives today. There is vastly improved access to information, and the public is bombarded with messages that have diminished the value and impact of traditional media advertising. There have been increases in interest in protein RTD “ready to drink” beverages.

Strong emphasis will be placed on public relations initiatives in an effort to capture and maintain consumer awareness. Validation of the advanced science behind each introduced brand will provide clear and reliable messaging behind each functional line. Carefully developed and executed focus groups will also be conducted, designed to raise awareness about the true functionality and lifestyle enhancement offered with each innovative line.  We plan to focus on gorilla and grass roots marketing programs, investing in sponsorships and spokespeople in venues of competitive sports activities.  This strategy allows promoters to develop brand essence, communicate directly with spectators and participants and promote trial with consumers directly. This marketing approach, best executed by the Red Bull energy drink brand, escapes the filters that consumers use to reduce messaging. When executed properly, as Red Bull has, this technique defines the brand image while consumers embrace the branding as trend setting entertainment. In addition, we intend to continue participating in nationwide events and programs supporting the unique causes.

Government Regulation
The production, distribution and sale in the United States of many of our products are subject to the Federal Food, Drug and Cosmetic Act; the Dietary Supplement Health and Education Act of 1994; the Occupational Safety and Health Act; various environmental statutes; and various other federal, state and local statutes and regulations applicable to the production, transportation, sale, safety, advertising, labeling and ingredients of such products.

Measures have been enacted in various localities and states that require that a deposit be charged for certain non-refillable beverage containers. The precise requirements imposed by these measures vary. Other deposit, recycling or product stewardship proposals have been introduced in certain states and localities and in Congress, and we anticipate that similar legislation and regulations may be proposed in the future at the local, state and federal levels, both in the United States and elsewhere.

We do not expect that compliance with these provisions will have a material adverse effect upon our capital expenditures, net income or competitive position.

Employees
We currently have eleven total employees, all of which are full time.  Most of these individuals are employed at the corporate office with one sales representative in New York and one sale representative in central Florida.

Increase of Authorized Shares
The Company established a record date on March 20, 2012 for the purpose to notify shareholders of a special meeting on April 27, 2012 at the Company’s corporate offices for the purposes to increase the authorized common shares from one billion (1,000,000,000) to five billion (5,000,000,000).  On April 27, 2012, the shareholders approved the amendment to the Company’s Certificate of Incorporation to increase its authorized common shares from one billion (1,000,000,000) to five billion (5,000,000,000). This amendment was effective with the state of Delaware on May 1, 2012.  The comparable financial statements for the year ended March 31, 2012 will still reflect the authorized shares of one billion (1,000,000,000).  The authorized shares for the Series A Preferred Stock remain the same at twenty million (20,000,000).

Research and Development

Over the last two years, the Company spent approximately $2,074 and $7,900, respectively, on research and development activities related to the development of its Phase III® Recovery products.  All costs were borne by the Company.


On June 1, 2008, we moved to our current office at 10415 Riverside Drive, Suite 101, Palm Beach Gardens, Florida 33410.   This five-year lease began on June 1, 2008 and will expire on May 31, 2013.  The minimum monthly base rent for March 2012 is $8,341 (excluding variable common area maintenance charges and taxes), and the lease provides for annual 4% increases throughout its term.  We plan to sign an amended lease agreement in late July, 2012 to decrease the size of the premises.

 
6

 
 

On May 18, 2009, F&M Merchant Group, LLC commenced a lawsuit in the state of Texas to recover the balance owed by us under a Sales Agent Agreement entered by the parties on November 1, 2008.  This agreement requires us to pay $5,000 per month and a 5% commission on all net sales. On September 3, 2009, a final judgment by default was approved by the district court in Denton County, Texas for a total sum of $22,347.  This claim has been recorded on the Company’s records.   Due to the lack of adequate capital financing, we have not been able to make any payments.  We expect to resolve this matter as soon as practical.

On June 5, 2009, Tuttle Motor Sports, Inc. commenced a lawsuit in the state of Florida to recover the balance owed by us under a Letter of Agreement to sponsor a Top Fuel Dragster for the 2008 NHRA racing season in the amount of $803,750. Out of this total amount, only $300,000 is required to be paid in cash with the remainder to be paid in shares of common stock. This amount had already been recorded in our records.  During May, 2010, Tuttle Motor Sports, Inc. dismissed the lawsuit without prejudice.  Prior to that time, the parties went through mediation but were unable to settle.  The likelihood of an unfavorable outcome cannot be evaluated as another lawsuit possibly could be filed against the Company.

On August 21, 2009, CH Fulfillment Services, LLC commenced a lawsuit in the state of Alabama to recover past due amounts owed by us under a contract to provide shipping and fulfillment services.  The claim is for $2,106 plus interest and legal costs.  This amount was already recorded on our records as well as projected interest costs of $682 and estimated court costs of $307 for a total of $3,095. A process of garnishment by the district court in Mobile County, Alabama was approved on September 25, 2009 for the total amount of $3,095.  On October 26, 2009, the same court authorized a garnishment process to pay $657 which was done as part payment of the total due amount. Current outstanding balance due is $2,438.  No other payments have been made.

On April 20, 2012, Arena Advertising and Sports Marketing Inc commenced a lawsuit in the state of Florida to recover past due amounts owed by us in the amount of $15,000 plus interest since January 16, 2012.  The $15,000 was already recorded in our records.  We expect to resolve this matter as soon as practical.


PART II
 

Common stock market price
The Company’s common stock began trading on the OTC Electronic Bulletin Board (ticker symbol ATTD.OB) on June 19, 2008. The approximate number of record holders of the Company’s common stock at March 31, 2012 was 4,599.

The following quarterly quotations for common stock transactions on the OTC Bulletin Board reflect inter-dealer prices, without retail mark-up, markdown or commissions and may not represent actual transactions. Source is NASDAQ.COM.

QUARTER
 
HIGH BID PRICE
   
LOW BID PRICE
 
             
Fiscal year – 2010/2011
           
             
First Quarter
  $ 1.10     $ 0.05  
Second Quarter
  $ 0.15     $ 0.01  
Third Quarter
  $ 0.045     $ 0.015  
Fourth Quarter
  $ 0.067     $ 0.017  
                 
Fiscal year – 2011/2012
               
                 
First Quarter
  $ 0.022     $ 0.008  
Second Quarter
  $ 0.015     $ 0.001  
Third Quarter
  $ 0.0046     $ 0.0008  
Fourth Quarter
  $ 0.0093     $ 0.001  

Dividends

The holders of common stock are entitled to receive, pro rata, such dividends and other distributions as and when declared by our board of directors out of the assets and funds legally available therefore.  We have not paid dividends on our common stock and do not anticipate paying dividends to holders of our common stock in the foreseeable future.  Management intends to retain future earnings, if any, to finance working capital and to expand our operations.

 
7

 
 
Securities Authorized for Issuance under Equity Compensation Plans
 
                Number of securitiesremaining available for futureissuance under equitycompensation plans, excluding securities
reflected in column
 
    Number of securitiesissued upon exercise ofoutstanding options, warrants and rights            
        Weighted average exerciseprice of outstanding options, warrants and rights      
             
Plan Category
           
               
(a)
 
   
(a)
   
(b)
   
(c)
 
Equity compensation plans
                 
approved by stockholders
    -       -       -  
Equity compensation plans
                       
not approved by stockholders
    1,838,765 (1)(2)     0.06 (3)     1,961,235  
    Total
    1,838,765     $ 0.06       1,961,235  
 
                   
(c) Available to issue in future
 
(1) 2007 Stock Compensation and Incentive Plan for a total of
      50,000       124  
(Filed on April 11, 2008 as an exhibit to Form S-1/A and filed on May 16, 2008 as an exhibit to Form S-8)
                 
(2) 2010 Stock Compensation and Incentive Plan for a total of
      3,750,000       1,961,111  
(Filed on May 25, 2010 as an exhibit to Form S-8)
                 
 
            3,800,000       1,961,235  
(3) Based on 28,129,077 outstanding stock options.
                 
 
Sale of Unregistered Securities
Quarter Ended March 31, 2012

On February 22, 2012, the Company entered into a subscription agreement with institutional and accredited investors for a convertible debt financing in the principal amount of $1,000,000 (J&N Invest LLC - $200,000, Alpha Capital Anstalt - $175,000,  Schlomo & Rochel Rifkind - $100,000, Ramshead Holding Ltd. - $100,000, Naomie Klissman - $100,000, Whalehaven Capital Fund, Ltd. - $50,000, Seth Farbman - $50,000, Louis Goldberg - $50,000, David Lamplough - $50,000, Joseph & Sue Maya - $50,000, Emmy Cutler - $25,000, Jan Veryke - $25,000, and PSM Holdings for $25,000) with an interest rate of 10%. The due date for the notes is August 22, 2013, and the notes are convertible into common stock at a conversion price equal to seventy-five percent (75%) of the average of the three lowest closing bid prices for the Common Stock as reported by Bloomberg L.P. for the principal market for the ten trading days preceding a conversion date but in no event greater than $.02. Subscribers in the offering included some holders of the Company’s senior secured notes and warrants. Associated finance fees of $160,000 includes a 10% finder’s fee of $100,000 which was deducted from the gross proceeds along with payments of October 7, 2011 and a December 1, 2011 short term promissory note and accrued interest totaling $103,451 plus the exchange of three previous short term promissory notes ($75,000 dated October 7, 2011, $25,000 dated December 20, 2011 and $75,000 dated December 28, 2011 for a total of $175,000) for 10% convertible notes led to a net received amount of $561,549.  In addition, the placement agent (Perrin Holden & Davenport Capital Corp (“PHD”) received a total of 5,000,000 restricted shares of the Company’s common stock which was equal to ten percent (10%) of the Class A warrants sold. One Class A Common Stock Purchase Warrant was issued for every share (total of 50,000,000 warrants) which would be issued on the closing date assuming the complete conversion of the notes on the closing date at the conversion price. The exercise price to acquire a Warrant Share upon exercise of a Class A Warrant is equal to $.02, subject to reduction as described in the Class A Warrant.  The Class A Warrants are exercisable until five years (February 21, 2017) after the issue date of the Class A Warrants.    In addition and as part of the February 2012 financing, the Company entered into an amendment and consent agreement with all institutional and accredited investors holding all convertible notes payable  with a due date of March 31, 2012 to extend the maturity date to March 31, 2014. Further, each undersigned subscriber to the Subscription Agreements waives the ratchet/reset benefit that such subscriber is entitled to as a result of any subscriber’s conversion of a note or exercise of a warrant to the extent such conversion or exercise would result in a conversion price or exercise price less than $0.02, provided however all subscribers will get the ratchet/reset benefit to the $0.02 floor as a result of any such conversion of exercise.   In addition, the undersigned subscribers waived the Company’s reservation obligation to the extent such requirement is in excess of 100% required reservation of shares for conversion of principal and interest of the notes until such time as the Company either increases its authorized shares or effectuates a reverse split of its common stock but in any event no later than June 1, 2012. For purposes of clarification commencing June 2, 2012, the Company is required to have a number of shares of common stock equal to 150% of the amount of common stock to all Subscribers to be able to convert all of the notes (including interest that would accrue therein) through the Maturity Date and 100% of the amount of warrant shares issuable upon exercise of the warrants.
 
 
8

 
 
On March 31, 2012, the Company entered into an extension agreement with certain noteholders for their notes that had a maturity date of March 31, 2012 to extend such notes to March 31, 2014.  In consideration for this extension, the Company issued to each applicable noteholder a convertible note in the principal amount representing ten percent (10%) of the principal amount owed to each noteholder (Alpha Capital Anstalt - $162,085, Whalehaven Capital Fund Limited - $7,841, Smivel LLC - $400 and CMS Capital, Inc for $1,885 for a grand total of $172,211).  The conversion price shall be equal to seventy-five percent (75%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal market for the ten trading days preceding a conversion date but in no event greater than $0.02, subject to further reductions as described in the notes.  These notes have an interest rate of 12% and are due March 31, 2014.  There are no warrants associated with these notes.
 
These securities were issued in reliance upon an exemption from registration under Section 4(2) and/or Regulation D of the Securities Act of 1933, as amended. All of the investors were accredited investors and/or had preexisting relationships with the Company, there was no general solicitation or advertising in connection with the offer or sale of securities and the securities were issued with a restrictive legend.
 
During the three months ended March 31, 2012, the Company issued a total of 661,046,325 shares of common stock for the conversions of $1,151,717 of principal of convertible notes payable and $196,939 of related accrued interest to note holders of the Company pursuant to the terms of the note instruments.  No additional consideration was given for these conversions by the note holders.  The shares of common stock issued upon conversion of these notes were issued pursuant to an exemption from the registration requirements of the Securities Act provided by Section 3(a)(9) thereof as the conversions were an exchange of securities with existing holders exclusively, and no commission or other remuneration  was paid or given in connection with the exchange.
 
 
Not applicable.


EXECUTIVE LEVEL OVERVIEW

Our Business Model
 
Our plan of operation during the next 12 months is to focus on the non-alcoholic single serving beverage business, developing and marketing milk based products in two fast growing segments; sports recovery and functional dairy,  We do not directly manufacture our products but instead outsource the manufacturing process to a third party contract packer.  Our efforts were focused in our first full year operations primarily on developing our first energy drink which is called VisViva™  which sales began in late March 2008. We have since tabled that product.

Milk, while the second highest beverage consumed in America in terms of overall volume, is still under-represented in the American single serve ready-to-drink beverage industry.  While known for generations by nutritionists and more recently identified by sports, hydration, metabolism and protein professionals and scientists as “mother nature’s most perfect food”, milk has yet to be successfully branded and commercialized.

We completed research and development work in developing our latest dairy based product which is called “Phase III® Recovery” and is designed for the third phase of exercise, the “after phase” of before, during and after. This product is the first milk based protein drink ever to be produced in America and is shelf-stable with a twelve (12) months long shelf life. We started to sell this new product in February 2010. Our co-pack partner, O-AT-KA Milk Products, is the largest retort milk processor in America, located in Batavia, New York and has the most advanced retort processor and know-how to produce this product with state-of-the-art milk filtration systems as well as the packaging of this product in new Ball Container aluminum eco-friendly re-sealable bottles.    The primary target for Phase III Recovery® is active sports minded males and females from ages 15 to 35, but we will target active sports and exercise consumers at all levels.  Gyms, sports teams, body builders and even high-endurance athletes are all beginning to focus on sports recovery drinks which we consider the “next generation” sports drink. We anticipate the development of other dairy based drink products in late 2012 or early 2013, depending upon available capital.

 
9

 
 
We organized a Scientific Advisory Board of three well known experts that have extensive experience in sports nutrition.  This board is helpful in communicating the scientific benefits of our sports recovery drink as well as new functional milk drinks.  Their contacts in the world of sports will be very important in our sales efforts, especially in the early days.

We plan to initially focus on the largest markets for beverages in the eastern United States.  We intend to develop key working partnerships with regional direct store delivery (DSD) beverage distributors in these markets and will support them with field representatives to assure sufficient shelf compliance.  Regional distributors have lost four major beverage lines in the last couple of years including Monster Energy (moved to Anheuser Bush), Fuze (purchased by Coca-Cola), Vitamin Water (purchased by Coca-Cola, and the V-8 brands (now distributed by Coca-Cola).  We will develop regionally exclusive DSD agreements that are desperately needed by the distributors to replace these losses as well as shipping direct to our customers via our own warehouse system.

We will pre-sell in four sales channels; grocery, convenience, drug and sports and gym specialty.  Certain accounts like chained convenience stores, grocery and drug stores will require warehouse distribution.  The shelf-stable and long shelf life attributes of our products will accommodate any and all distribution and warehouse systems. To accommodate this business, we will employ beverage brokers and work with the “tobacco & candy” and food service warehouse distributors like McLane Company and Sysco Foods.
 
The pricing and gross profit margin for the products will vary. Each product delivers different functionality and utilizes different types of packaging and package sizes.  Without exception, these products will command premium pricing due to the functionality and value-added formulation and will therefore be priced according to the nearest competitive brands in their respective spaces.  The functional milk drinks are also expected to command approximately the same percentage margin due to the premium pricing commanded by the experiential functionality.  Singles will obtain higher margin than multi-packs.

Plan of Operations

We are continuing to seek other sources of financing to develop our business plan, implement our sales and marketing plan and to meet other operational expense requirements.  Historically, we have had to rely on convertible debt financings to cover operating costs. Based on the available cash, we have no assurance that we will be able to obtain additional funding to sustain our limited operations.  If we do not obtain additional funding, we may need to cease operations until we do so and, in that event, may consider a sale of the rights to our product line(s) and intangible assets such as our trademarks or a joint venture partner that will provide funding to the enterprise.  However, certain of our debt obligations totaling $5,005,539 are secured by our assets.  Failure to fulfill our obligations under these notes and related agreements could lead to the loss of these assets, which would be detrimental to our operations.

Our future operations are totally dependent upon obtaining additional funding.  Past fundings have been subject to defaults by the company’s inability to meet due dates for certain notes payable, thereby triggering anti-dilution rights which created the need to issue additional shares of common stock and/or additional warrants to purchase additional shares of common stock in order to extend the applicable due dates for  certain notes payable.  There can be no assurance that these defaults will not happen again in the future, thereby creating the potential need for additional issuances of shares of common stock and/or warrants, assuming the holders agree to further extensions.

We will consider equity and/or convertible debt financings, either or both of a private sale or a registered public offering of our common stock; however, at this time and with the current economy, it seems unlikely that we can obtain an underwriter.

We anticipate that, depending on market conditions and our plan of operations, we may incur operating losses in the future based mainly on the fact that we may not be able to generate enough gross profits from our sales to cover our operating expenses and to increase our sales and marketing efforts.  Our most recently developed “Phase III® Recovery” drink product was introduced in early 2010 and based on historical spending, we anticipate a need of funding in the range of $1,500,000 to $2,100,000 for the next twelve months to meet our business plan and operating needs only.  This figure does not include any new product research and development activities.

This discussion and analysis of our consolidated financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles that are generally accepted in the United States of America.  Our fiscal year end is March 31.

 
10

 
 
Critical Accounting Policies

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most critical estimates included in our financial statements are the following:
 
Financial Instrument Valuation

In estimating the fair value of our hybrid financial instruments that are required to be carried as liabilities at fair value pursuant to the FASB Accounting Standards Codification for the period ended March 31, 2012, we use all available information and appropriate techniques including outside consultants to develop our estimates. However, actual results could differ from our estimates.

Derivative Financial Instruments

We generally do not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks.  However, we have and will frequently enter into certain other financial instruments and contracts, such as debt financing arrangements and freestanding warrants with features that are either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts or (iii) may be net-cash settled by the counterparty to a financing transaction.  As required by the FASB Accounting Standards Codification, these instruments are required to be carried as derivative liabilities, at fair value, in our financial statements.  However, we are allowed to elect fair value measurement of the hybrid financial instruments, on a case-by-case basis, rather than bifurcate the derivative.  We believe that fair value measurement of the hybrid convertible promissory notes arising from our various financing arrangements provides a more meaningful presentation of that financial instrument.

We estimate fair values of derivative financial instruments using various techniques (and combinations thereof) that are considered to be consistent with the objective measuring of fair values.  In selecting the appropriate technique(s), we consider, among other factors, the nature of the instrument, the market risks that such instruments embody and the expected means of settlement.  For less complex derivative instruments, such as free-standing warrants, we generally use the Black-Scholes-Merton option valuation technique, since it embodies all of the requisite assumptions (including trading volatility, estimated terms and risk free rates) necessary to fair value these instruments.  For complex hybrid instruments, such as convertible promissory notes that include embedded conversion options, puts and redemption features embedded in them, we generally use techniques that embody all of the requisite assumptions (including credit risk, interest-rate risk, dilution   and exercise/conversion behaviors) that are necessary to fair value these more complex instruments.  For forward contracts that contingently require net-cash settlement as the principal means of settlement, we project and discount future cash flows applying probability-weightage to multiple possible outcomes.

Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors.  In addition, option-based techniques are highly volatile and sensitive to changes in the trading market price of our common stock, which has a high-historical volatility.  Since derivative financial instruments are initially and subsequently carried at fair values, our income will reflect the volatility in these estimate and assumption changes.

Impairment of Long-Lived Assets

Our long-lived assets consist principally of intangible assets, and to a much lesser extent, furniture and equipment.  We evaluate the carrying value and recoverability of our long-lived assets when circumstances warrant such evaluation by applying the provisions of the FASB Accounting Standards Codification which requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected to result from the use and eventual disposition of the assets.  Whenever any such impairment exists, an impairment loss will be recognized for the amount by which the carrying value exceeds the fair value.

Recent accounting pronouncements

In December 2011, the Financial Accounting Standards Board issued an Accounting Standards Update (“ASU”) that provides amendments for disclosures about offsetting assets and liabilities.  The amendments require an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. Entities are required to disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. This scope would include derivatives, sale and repurchase agreements and reverse sale and repurchase agreements, and securities borrowing and securities lending arrangements.  The amendments are effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. Disclosures required by the amendments should be provided retrospectively for all comparative periods presented. For the Company, the amendment is effective for fiscal year 2014. The Company is currently evaluating the impact these amendments may have on its disclosures.

 
11

 
 
In June 2011, the Financial Accounting Standards Board issued an ASU that provides amendments on the presentation of comprehensive income. The amendments require that all nonowner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In the two-statement approach, the first statement should present total net income and its components followed consecutively by a second statement that should present total other comprehensive income, the components of other comprehensive income and the total of comprehensive income. The amendments do not change the items that must be reported in other comprehensive income or when an item of other comprehensive income must be reclassified to net income. The amendments do not change the option for an entity to present components of other comprehensive income either net of related tax effects or before related tax effects, with one amount shown for the aggregate income tax expense or benefit related to the total of other comprehensive income items. In both cases, the tax effect for each component must be disclosed in the notes to the financial statements or presented in the statement in which other comprehensive income is presented. The amendments do not affect how earnings per share is calculated or presented. The amendments are effective for fiscal years and interim periods within those years, beginning after December 15, 2011 and should be applied retrospectively. For the Company, the amendment is effective for fiscal 2013. The effect of adoption will have minimum impact on the Company as the Company’s current presentation of comprehensive income follows the two-statement approach.

RESULTS OF OPERATIONS

Revenues

As we recently started to recognize  revenue, there is no meaningful comparison with prior periods. 
 
Consolidated Revenues
                       
   
For The Years Ended March 31,
             
   
2012
   
2011
   
$ Change
   
% Change
 
Revenues
  $ 406,315     $ 61,327     $ 344,988       562.5 %
Less slotting expense
    -       -       -       -  
Less discounts
    (29,878 )     (10,967 )     (18,911 )     172.4 %
Net Revenues
  $ 376,437     $ 50,360     $ 326,077       647.5 %
 
All revenues were generated in the United States. The increase in our revenues for the year ended March 31, 2012 as compared to the prior year ended March 31, 2011 is the result of increased customer accounts mainly in the fourth quarter for our Phase III® Recovery product.

Slotting fees are common in the large store channels and represent cash payments made for rights to place our products on customer retail shelves for a stipulated period of time.  A component of our growth plan includes increasing penetration in the large store channel which may be subject to future slotting fees.  There were no recorded slotting fees for the years ended March 31, 2012 and March 31, 2011. 

We plan to increase our revenues during the next twelve months by implementing marketing and sales promotion programs to introduce our new “Phase III® Recovery” drink to new markets in the 2012 calendar year, increasing our internal sales force, securing additional national distributors, expanding our products offering, increasing our volume per outlet and implementing new grass roots marketing and sample programs.

 
12

 
 
Consolidated Product and Shipping Costs
 
For The Years Ended March 31
             
   
2012
   
2011
   
$ Change
   
% Change
 
Product costs
  $ 278,300     $ 42,613     $ 235,687       553.1 %
Shipping costs
    38,300       9,346       28,954       309.8 %
Inventory Obsolescence
    2,137       -       2,137       N/A  
  Total costs
  $ 318,737     $ 51,959     $ 266,778       513.4 %
 
The computation of the percentage of expenses to revenues is not meaningful at this time and is not representative of expected future operations.

Product and shipping costs for the year ended March 31, 2012 were higher over the year ended March 31, 2011 mainly due to the increased customers for the sales of the Phase III® Recovery product.
 
Operating Expenses
 
For The Years Ended March 31
             
   
2012
   
2011
   
$ Change
   
% Change
 
Salaries, taxes and employee benefit costs
  $ 535,690     $ 311,471     $ 224,219       72.0 %
Marketing and promotion
    461,272       265,358       195,914       73,8 %
Consulting fees
    82,645       40,329       42,316       104.9 %
Professional and legal fees
    228,799       260,951       (32,152 )     -12.3 %
Travel and entertainment
    47,308       (427 )     47,735       -11179.2 %
Product development costs
    2,074       7,900       (5,826 )     -73.7 %
Stock compensation expense
    165,068       195,000       (29,932 )     -15.3 %
Other overhead expenses
    374,902       468,441       (93,539 )     -20.0 %
   Total operating expenses
  $ 1,897,758     $ 1,549,023     $ 348,735       22.5 %

Salaries, taxes and employee benefit costs
For the year ended March 31, 2012, total expenses of $535,690 were higher by $224,219 over last year’s comparable figures of $311,471, partly due to the Company’s policy to record non cash payments for past due salaries in  stock compensation expense instead of salary expense. From the $224,219 increase, an amount of $195,000 was recorded in stock compensation expense for the year ended March 31, 2011 for issued common stock to Roy Warren and Tommy Kee and none in 2012, (see the Stock compensation expense section below) which contributed to most of the increase. The table below reflects a net increase of $29,219 in which this amount was caused by the increase of employees during the year ended March 31, 2012.

   
3/31/2012
   
3/31/2011
   
Variance
 
                   
Salaries
  $ 535,690     $ 311,471     $ 224,219  
Stock compensation expense for employees
    -       195,000       (195,000 )
Net variance   $ 535,690     $ 506,471     $ 29,219  
 
Marketing and promotion
For the year ended March 31, 2012, we incurred total marketing and promotion costs of $461,272 as compared to $265,358 for the year ended March 31, 2011 for an increase of $195,914 or 73.8%.  This increase was due primarily to increased broker commissions costs of $69,234, Walgreen's advertising expense for $65,000, increased sample costs of $18,379 and increase in various marketing programs including costs associated with the use of athlete endorsements for our Phase III® Recovery drink.

Consulting fees
Consulting fees of $82,645 for the year ended March 31, 2012 were $42,316 or 104.9% higher than last year’s figures mainly due to the use of more outside sales consultants and merchandisers in selling our Phase III® Recovery product in 2012.

Professional and legal fees
These costs related to the use of outside legal, accounting and auditing firms. Total costs for the year ended March 31, 2012 of $228,799 were $32,152 lower than the previous year’s comparable costs of $260,951, mainly due to a decrease use of legal services.

 
13

 
 
Travel and entertainment

These costs increased over the prior year ending March 31, 2011 by $47,735 mainly due to increased travel activities for promoting our Phase III® Recovery product in new markets primarily in the northeastern United States.

Product development costs
These costs decreased over the prior year ending March 31, 2011 mainly due to the fact that most development costs for our new product, Phase III® Recovery, were incurred in the previous year.  Due to limited capital, we have delayed the development of other potential new products.

Stock compensation expense
For the year ended March 31, 2012, we recorded stock compensation expense of $165,068 mainly for services rendered to outside vendors as well as the costs of issued stock options to employees.  For the year ended March 31, 2011, these costs for a total of $195,000 related to the recording of costs associated with the conversions of past due salaries for the company’s CEO, Roy Warren, for $125,000 and for the company’s CFO, Tommy Kee, for $70,000 as we record all issuances of common stock to employees in this account instead of salary expense for non-cash identification purposes.

Other operating expenses
The total costs decreased by $93,539 or 20% over the prior year mainly due to decreased investor relations costs of $79,720.   The other main components of this category represent Board of Directors’ fees and rent expense.

Other Income (Expense)

Derivative income/(expense)
Derivative income/(expense) arises from changes in the fair value of our derivative financial instruments and, in rare instances, day-one losses when the fair value of embedded and freestanding derivative financial instruments issued or included in financing transactions exceed the proceeds or other basis.  In addition, the fair value of our financial instruments that are recorded at fair value will change in future periods based upon changes in our trading market price and changes in other assumptions and market indicators used in the valuation techniques.  Future changes in these underlying internal and external market conditions will have a continuing effect on derivative income/expense associated with our derivative financial instruments.

The following table summarizes the effects on our income (expense) associated with changes in the fair values of our financial instruments that are carried at fair value from inception through March 31, 2012:
 
       
Inception
 
       
through
 
       
March 31, 2012
 
Our financing arrangements giving rise to derivative
     
instruments and the income effects:
     
Day-on derivative losses:
     
 $      600,000
 
Original Face Value Convertible Note Financing
  $ (2,534,178 )
 $      500,000
 
Original Face Value Convertible Note Financing
    (899,305 )
 $      100,000
 
Original Face Value Convertible Note Financing
    (1,285,570 )
 $        55,000
 
Original Face Value Short Term Bridge Loan Financing
    (12,700 )
 $      120,000
 
Original Face Value Convertible Note Financing
    (72,251 )
 $        60,000
 
Original Face Value Convertible Note Financing
    (38,542 )
 $      200,000
 
Original Face Value Convertible Note Financing
    (119,136 )
 $        27,778
 
Original Face Value Convertible Note Financing
    (6,378 )
 $      161,111
 
Original Face Value Convertible Note Financing
    (45,846 )
 $      111,112
 
Original Face Value Convertible Note Financing
    (185,657 )
 $        50,000
 
Original Face Value Convertible Note Financing
    (182,843 )
 $        55,000
 
Original Face Value Convertible Note Financing
    (80,135 )
 $      137,500
 
Original Face Value Convertible Note Financing
    (1,023,463 )
 $        55,000
 
Original Face Value Convertible Note Financing
    (55,641 )
 $      400,000
 
Original Face Value Convertible Note Financing
    (730,079 )
 $      600,000
 
Original Face Value Convertible Note Financing
    (1,420,653 )
 $      221,937
 
Original Face Value Convertible Note Financing
    (295,144 )
 $      500,000
 
Original Face Value Convertible Note Financing
    (288,718 )
 $   1,000,000
 
Original Face Value Convertible Note Financing
    (1,215,164 )
Total day-one derivative losses
  $ (10,491,403 )
 
 
14

 
 
       
Inception
 
       
through
 
       
March 31, 2012
 
           
Derivative income (expense):
     
 $      600,000
 
Original Face Value Convertible Note Financing
  $ 3,311,574  
 $      500,000
 
Original Face Value Convertible Note Financing
    1,658,448  
 $      100,000
 
Original Face Value Convertible Note Financing
    1,163,487  
 $      120,000
 
Original Face Value Short Term Bridge Loan Financing
    213,769  
 $      120,000
 
Original Face Value Short Term Bridge Loan Financing
    213,769  
 $        60,000
 
Original Face Value Short Term Bridge Loan Financing
    106,885  
 $        33,000
 
Original Face Value Short Term Bridge Loan Financing
    58,786  
 $        55,000
 
Original Face Value Short Term Bridge Loan Financing
    63,162  
 $      243,333
 
Original Face Value Convertible Note Financing
    134,424  
 $        60,833
 
Original Face Value Convertible Note Financing
    6,602  
 $      120,000
 
Original Face Value Convertible Note Financing
    41,039  
 $        60,000
 
Original Face Value Convertible Note Financing
    27,358  
 $      200,000
 
Original Face Value Convertible Note Financing
    111,662  
 $      161,111
 
Original Face Value Convertible Note Financing
    147,820  
 $        50,000
 
Original Face Value Convertible Note Financing
    45,208  
 $        55,000
 
Original Face Value Convertible Note Financing
    48,749  
 $      137,500
 
Original Face Value Convertible Note Financing
    303,644  
 $        55,000
 
Original Face Value Convertible Note Financing
    2,302  
 $      900,000
 
Original Face Value Convertible Note Financing
    (48,610 )
 $      400,000
 
Original Face Value Convertible Note Financing
    286,413  
 $      600,000
 
Original Face Value Convertible Note Financing
    713,055  
 $      221,937
 
Original Face Value Convertible Note Financing
    77,766  
 $      500,000
 
Original Face Value Convertible Note Financing
    64,723  
 $   1,000,000
 
Original Face Value Convertible Note Financing
    36,230  
Total income arising from fair value adjustments
  $ 8,788,265  
Total derivative expense from inception
  $ (1,703,138 )
 
 
15

 

       
Inception
 
       
through
 
       
March 31, 2012
 
           
Interest income (expense) from instruments recorded at fair value:
     
 $      600,000
 
Original Face Value Convertible Note Financing
  $ (832,752 )
 $      500,000
 
Original Face Value Convertible Note Financing
    (617,167 )
 $      100,000
 
Original Face Value Convertible Note Financing
    (145,046 )
 $      312,000
 
Original Face Value Convertible Note Financing
    (1,033,786 )
 $      120,000
 
Original Face Value Convertible Note Financing
    (189,861 )
 $          5,000
 
Original Face Value Convertible Note Financing
    (5,667 )
 $          5,000
 
Original Face Value Convertible Note Financing
    (3,190 )
 $        60,000
 
Original Face Value Convertible Note Financing
    (17,292 )
 $        70,834
 
Original Face Value Convertible Note Financing
    (20,479 )
 $      200,000
 
Original Face Value Convertible Note Financing
    (50,480 )
 $        27,778
 
Original Face Value Convertible Note Financing
    10,262  
 $      161,111
 
Original Face Value Convertible Note Financing
    (65,305 )
 $      111,112
 
Original Face Value Convertible Note Financing
    (57,979 )
 $      507,500
 
Original Face Value Convertible Note Financing
    (590,078 )
 $        50,000
 
Original Face Value Convertible Note Financing
    67,143  
 $        55,000
 
Original Face Value Convertible Note Financing
    (236,231 )
 $      137,500
 
Original Face Value Convertible Note Financing
    167,298  
 $      100,000
 
Original Face Value Convertible Note Financing
    (8,212 )
 $        55,000
 
Original Face Value Convertible Note Financing
    (214,299 )
 $      400,000
 
Original Face Value Convertible Note Financing
    (392,075 )
 $      600,000
 
Original Face Value Convertible Note Financing
    (786,208 )
 $      221,937
 
Original Face Value Convertible Note Financing
    (997,913 )
 $      500,000
 
Original Face Value Convertible Note Financing
    (154,481 )
 $   1,000,000
 
Original Face Value Convertible Note Financing
    375,103  
 $      172,211
 
Original Face Value Convertible Note Financing
    (300,961 )
Total expense arising from fair value adjustments
  $ (6,099,656 )

 
16

 
 
The following tables summarize the effects on our income (expense) associated with changes in the fair values of our financial instruments that are carried at fair value from the twelve months ended March 31, 2012 and the twelve months ended March 31, 2011.

       
Twelve Months
   
Twelve Months
 
Our financing arrangements giving rise to
 
Ended
   
Ended
 
  derivated financial instruments and the income effects:
 
March 31, 2012
   
March 31, 2011
 
Derivative income (expense):
           
 $          600,000
 
Original Face Value Convertible Note Financing
  $ 18,337     $ 1,809,873  
 $          500,000
 
Original Face Value Convertible Note Financing
    13,891       1,371,024  
 $          100,000
 
Original Face Value Convertible Note Financing
    2,779       274,272  
 $          120,000
 
Original Face Value Short Term Bridge Loan Financing
    101       36,521  
 $          120,000
 
Original Face Value Short Term Bridge Loan Financing
    101       36,521  
 $            60,000
 
Original Face Value Short Term Bridge Loan Financing
    50       18,260  
 $            33,000
 
Original Face Value Short Term Bridge Loan Financing
    28       10,043  
 $            55,000
 
Original Face Value Short Term Bridge Loan Financing
    6       17,991  
 $          120,000
 
Original Face Value Convertible Note Financing
    1,186       102,972  
 $            60,000
 
Original Face Value Convertible Note Financing
    593       51,486  
 $          200,000
 
Original Face Value Convertible Note Financing
    4,119       357,544  
 $          161,111
 
Original Face Value Convertible Note Financing
    3,318       288,022  
 $            50,000
 
Original Face Value Convertible Note Financing
    1,030       89,386  
 $            55,000
 
Original Face Value Convertible Note Financing
    1,030       89,386  
 $          137,500
 
Original Face Value Convertible Note Financing
    2,832       245,812  
 $            55,000
 
Original Face Value Convertible Note Financing
    1,133       1,169  
 $          900,000
 
Original Face Value Convertible Note Financing
    560,148       (608,758 )
 $          400,000
 
Original Face Value Convertible Note Financing
    157,071       129,342  
 $          600,000
 
Original Face Value Convertible Note Financing
    456,044       257,011  
 $          221,937
 
Original Face Value Convertible Note Financing
    77,766       -  
 $          500,000
 
Original Face Value Convertible Note Financing
    64,723       -  
 $       1,000,000
 
Original Face Value Convertible Note Financing
    36,229       -  
Total derivative income (expense) arising from fair value adjustments
    1,402,515       4,577,877  
Day-one derivative losses
    (1,799,027 )     (2,206,373 )
   Total derivative income (expense)
  $ (396,512 )   $ 2,371,504  
 
 
17

 

       
Twelve Months
   
Twelve Months
 
       
Ended
   
Ended
 
       
March 31, 2012
   
March 31, 2011
 
Interest income (expense) from instruments recorded at fair value:
           
 $          600,000
 
Original Face Value Convertible Note Financing
  $ (334,764 )   $ 1,492,317  
 $          500,000
 
Original Face Value Convertible Note Financing
    22,502       2,032,631  
 $          100,000
 
Original Face Value Convertible Note Financing
    -       169,943  
 $          312,000
 
Original Face Value Convertible Note Financing
    (75,181 )     796,457  
 $          120,000
 
Original Face Value Short Term Bridge Loan Financing
    (90,383 )     553,390  
 $              5,000
 
Original Face Value Short Term Bridge Loan Financing
    700       20,652  
 $              5,000
 
Original Face Value Short Term Bridge Loan Financing
    955       23,057  
 $            60,000
 
Original Face Value Convertible Note Financing
    32,393       276,694  
 $            70,834
 
Original Face Value Convertible Note Financing
    38,242       326,655  
 $            27,778
 
Original Face Value Convertible Note Financing
    22,357       136,487  
 $          200,000
 
Original Face Value Convertible Note Financing
    116,037       911,251  
 $          111,112
 
Original Face Value Convertible Note Financing
    (24,656 )     502,756  
 $          161,111
 
Original Face Value Convertible Note Financing
    284,241       514,534  
 $          507,500
 
Original Face Value Convertible Note Financing
    (391,426 )     2,188,319  
 $            50,000
 
Original Face Value Convertible Note Financing
    100,922       112,763  
 $            55,000
 
Original Face Value Convertible Note Financing
    (84,077 )     118,033  
 $          137,500
 
Original Face Value Convertible Note Financing
    (80,516 )     295,083  
 $          100,000
 
Original Face Value Convertible Note Financing
    (11,041 )     495,787  
 $            55,000
 
Original Face Value Convertible Note Financing
    (84,076 )     (135,222 )
 $          900,000
 
Original Face Value Convertible Note Financing
    -       (20,921 )
 $          400,000
 
Original Face Value Convertible Note Financing
    (476,520 )     67,052  
 $          600,000
 
Original Face Value Convertible Note Financing
    (1,056,806 )     264,798  
 $          221,937
 
Original Face Value Convertible Note Financing
    (997,913 )     -  
 $          500,000
 
Original Face Value Convertible Note Financing
    (154,481 )     -  
 $       1,000,000
 
Original Face Value Convertible Note Financing
    375,103       -  
 $          172,211
 
Original Face Value Convertible Note Financing
    (300,962 )     -  
 Total interst income (expense) arising from fair value adjustments
    (3,169,350 )     11,142,516  
     Other interest expense
    (729,078 )     (576,502 )
       Interest income (expense) and other financing costs
  $ (3,898,428 )   $ 10,566,014  
 
 
18

 

The following tables summarize the effects on our income (expense) associated with changes in the fair values of our financial instruments that are carried at fair value for the three months ended March 31, 2012 and the three months ended March 31, 2011.
 
       
Three Months
   
Three Months
 
Our financing arrangements giving rise to
 
Ended
   
Ended
 
  derivated financial instrumentsand the income effects:
 
March 31, 2012
   
March 31, 2011
 
Derivative income (expense):
           
 $          600,000
 
Original Face Value Convertible Note Financing
  $ (2,654 )   $ (15,227 )
 $          500,000
 
Original Face Value Convertible Note Financing
    (2,010 )     (11,535 )
 $          100,000
 
Original Face Value Convertible Note Financing
    (402 )     (2,308 )
 $          120,000
 
Original Face Value Short Term Bridge Loan Financing
    (8 )     18  
 $          120,000
 
Original Face Value Short Term Bridge Loan Financing
    (8 )     -  
 $            60,000
 
Original Face Value Short Term Bridge Loan Financing
    (4 )     -  
 $            33,000
 
Original Face Value Short Term Bridge Loan Financing
    (3 )     -  
 $            55,000
 
Original Face Value Short Term Bridge Loan Financing
     -       (5 )
 $          120,000
 
Original Face Value Convertible Note Financing
    (159 )     (845 )
 $            60,000
 
Original Face Value Convertible Note Financing
    (80 )     (423 )
 $          200,000
 
Original Face Value Convertible Note Financing
    (554 )     (2,936 )
 $          161,111
 
Original Face Value Convertible Note Financing
    (446 )     (2,365 )
 $            50,000
 
Original Face Value Convertible Note Financing
    (138 )     (734 )
 $            55,000
 
Original Face Value Convertible Note Financing
    (138 )     (734 )
 $          137,500
 
Original Face Value Convertible Note Financing
    (380 )     (2,019 )
 $            55,000
 
Original Face Value Convertible Note Financing
    (152 )     (808 )
 $          900,000
 
Original Face Value Convertible Note Financing
    (75,283 )     (460,459 )
 $          400,000
 
Original Face Value Convertible Note Financing
    (20,340 )     129,342  
 $          600,000
 
Original Face Value Convertible Note Financing
    (58,471 )     257,011  
 $          221,937
 
Original Face Value Convertible Note Financing
    (28,859 )     -  
 $          500,000
 
Original Face Value Convertible Note Financing
    (37,896 )     -  
 $       1,000,000
 
Original Face Value Convertible Note Financing
    36,230       -  
Total derivative income (expense) arising from fair value adjustments
    (191,755 )     (114,027 )
  Day-one derivative loss
    (1,215,165 )     (2,150,631 )
        $ (1,406,920 )   $ (2,264,658 )
 
 
19

 

       
Three Months
   
Three Months
 
       
Ended
   
Ended
 
       
March 31, 2012
   
March 31,2011
 
Interest income (expense) from instruments recorded at fair value:
           
 $          600,000
 
Original Face Value Convertible Note Financing
  $ (363,579 )   $ (121,500 )
 $          500,000
 
Original Face Value Convertible Note Financing
    (66,882 )     (89,976 )
 $          100,000
 
Original Face Value Convertible Note Financing
    -       (55,707 )
 $          312,000
 
Original Face Value Convertible Note Financing
    (79,070 )     (245,062 )
 $          120,000
 
Original Face Value Short Term Bridge Loan Financing
    (155,902 )     11,322  
 $              5,000
 
Original Face Value Convertible Note Financing
    (2,030 )     (1,446 )
 $              5,000
 
Original Face Value Convertible Note Financing
    (1,775 )     471  
 $            60,000
 
Original Face Value Short Term Bridge Loan Financing
    (368 )     5,661  
 $            70,834
 
Original Face Value Convertible Note Financing
    (433 )     6,683  
 $            27,778
 
Original Face Value Convertible Note Financing
    13,529       10,196  
 $          200,000
 
Original Face Value Convertible Note Financing
    48,704       1,960  
 $          111,112
 
Original Face Value Convertible Note Financing
    (49,778 )     6,706  
 $          161,111
 
Original Face Value Convertible Note Financing
    39,235       (215,199 )
 $          507,500
 
Original Face Value Convertible Note Financing
    (474,593 )     80,378  
 $            50,000
 
Original Face Value Convertible Note Financing
    6,924       (112,664 )
 $            55,000
 
Original Face Value Convertible Note Financing
    (212,084 )     (130,464 )
 $          137,500
 
Original Face Value Convertible Note Financing
    (275,786 )     (342,205 )
 $          100,000
 
Original Face Value Convertible Note Financing
    (35,230 )     33,928  
 $            55,000
 
Original Face Value Convertible Note Financing
    (212,084 )     (131,086 )
 $          900,000
 
Original Face Value Convertible Note Financing
    -       (20,921 )
 $          400,000
 
Original Face Value Convertible Note Financing
    (177,665 )     67,052  
 $          600,000
 
Original Face Value Convertible Note Financing
    (835,101 )     264,798  
 $          221,937
 
Original Face Value Convertible Note Financing
    (899,307 )     -  
 $          500,000
 
Original Face Value Convertible Note Financing
    30,038       -  
 $       1,000,000
 
Original Face Value Convertible Note Financing
    375,103       -  
 $          172,211
 
Original Face Value Convertible Note Financing
    (300,962 )     -  
Total derivative income (expense) arising from fair value adjustments
    (3,629,096 )     (977,075 )
   Other interest expense
    (540,464 )     (485,568 )
        $ (4,169,560 )   $ (1,462,643 )
 
 
20

 
 
Our derivative liabilities as of March 31, 2012, and our derivative income/ expense during the twelve months ended March 31, 2012 and from inception through March 31, 2012 are significant to our consolidated financial statements. The magnitude of derivative income (expense) reflects the following:

 
In connection with our accounting for the:
$600,000, $500,000, $100,000 face value convertible promissory notes and warrant financings for the October 23, 2007 financing arrangement,
the $55,000 face value short term bridge loan and warrant financing dated August 5, 2008,
the $120,000 face value convertible note and warrant financing dated January 27, 2009,
the $60,000 face value convertible note and warrant financing dated February 17, 2009,
the $200,000 face value convertible note and warrant financing dated March 30, 2009,
the $161,111 face value convertible note and warrant financing dated July 15, 2009,
the $27,778 face value convertible note and warrant financing dated October 1, 2009,
the  $111,112 face value convertible note issuance dated November 13, 2009,
the $50,000 face value convertible note issuance dated January 28, 2010,
the $50,000 face value convertible note and warrant financing dated January 28, 2010,
the $55,000 face value convertible note and warrant financing dated February 19, 2010,
the $137,500 face value convertible note and warrant financing dated March 26, 2010,
the $55,000 face value convertible note and warrant financing dated May 13, 2010,
the $900,000 face value convertible note and warrant financing dated July 15, 2010,
the $400,000 face value convertible note and warrant financing dated January 21, 2011,
the $600,000 face value convertible note and warrant financing  dated March 17, 2011,
the $500,000 face value convertible note and warrant financing dated July 15, 2011 and
the $1,000,000 face value convertible note and warrant financing dated February 22, 2012
 
We encountered the unusual circumstance of a day-one derivative loss related to the recognition of (i) the hybrid notes and (ii) the derivative instruments arising from the arrangement at fair values. That means that the fair value of the hybrid notes and warrants exceeded the proceeds that we received from the arrangement, and we were required to record a loss to record the derivative financial instruments at fair value.
  
 
In addition, our financial instruments that are recorded at fair value will change in future periods based upon changes in our trading market price and changes in other assumptions and market indicators used in the valuation techniques.

Generally, the FASB Accounting Standards Codification provides for the exclusion of registration payment arrangements, such as the liquidated damage provisions that are included in the financing contracts underlying the convertible debt financing arrangements, from the consideration of classification of financial instruments. Rather, such registration payments will require recognition when they are both probable and reasonably estimable. As of March 31, 2012, our management concluded that registration payments are not probable.

Loss on extinguishment of debt
We recorded a loss on extinguishment of debt for the fiscal year ended March 31, 2011 for $3,264 as these costs represent the changes caused to common stock equivalents from certain modifications of terms normally associated with extending the due dates of certain debts.  There was no loss on extinguishment of debt for the fiscal year ended March 31, 2012 due to no term modifications of existing debt instruments.

Interest and Other Financing Costs:
We recorded interest expense for the fiscal year ended March 31, 2012 for $3,898,428 and interest income for $10,566,014 for the year ended March 31, 2011 in connection with our debt obligations at interest rates from 10% to 15%.  The change of $14,464,442 over the prior fiscal year was attributed to the recording of debt instruments at fair value (debt discount expense) due to the changes in the stock price. We recorded the amortization of debt discounts for $365,127 for the year ended March 31, 2012 with the July 2010, January 2011, March 2011, June 2011 debt exchange into a convertible note financing, July 2011 and February 2012 convertible note financings as well as $84,078 with the July, 2010, January, 2011 and March, 2011 convertible note financings for the year ended March 31, 2011.

Net Loss
We reported a net loss for the year ended March 31, 2012 of $6,149,343 and a net profit of $11,383,632 for the year ended March 31, 2011.  The majority of the expenses for the year ended March 31, 2012 related to salary related costs, marketing and promotion costs for promotion of our Phase III® Recovery drink, professional and legal fees, investor relations costs included in other overhead expenses, recognition of derivative expense and interest expense reflecting the changes in the fair value of the convertible debts.  Most of the costs incurred in the prior year ended March 31, 2011 related to salary related costs, marketing and promotion costs for introduction and promotion of our Phase III® Recovery drink, professional and legal fees and investor relations costs included in other overhead expenses. The net profit for March 31, 2011 was due to the recognition of derivative income and interest income reflecting the changes in the fair value of the convertible debts. As a result, our current revenue volume was not sufficient to recover all of our operating expenses.  We expect that both our revenues and expenses will increase in the next fiscal year, new products will be developed and sold as well as the expectation of certain cost containment programs that will be based on incremental increased unit sales such as shipping of full truck loads of products, lower product production costs, etc.

 
21

 
 
Loss per Common Share Applicable to Common Stockholders
The Company’s basic and diluted loss per common share applicable to common stockholders for the period ended March 31, 2012 was $(0.03), and the basic and diluted earnings per common share for the period ended March 31, 2011 was $ 0.66 and $.0.03, respectively.  Because the Company experienced a net loss for the period ended March 31, 2012, all potential common share conversions existing in our financial instruments would have an anti-dilutive impact on earnings per share; therefore, diluted loss per common share equals basic loss per common share for this period.  The weighted average common shares outstanding for the period ended March 31, 2012 and 2011 were 225,250,685 and 17,302,251, respectively for the basic earnings/loss calculation and 225,250,685 and 355,511,621for the diluted earnings/loss calculation for the period ended March 31, 2012 and March 31, 2011, respectively.  Potential common stock conversions (non-weighted) excluded from the computation of diluted earnings per share amounted to 425,538,843 for March 31, 2011 as there is no consideration for these potential common stock conversions due to the loss for the period ended March 31, 2012.

LIQUIDITY AND CAPITAL RESOURCES

Being a company with less than five years of operations, we have yet to achieve any substantial revenues or profitability, and our ability to continue as a going concern will be dependent upon receiving additional third party financings to fund our business at least throughout the next twelve months in our new fiscal year.  Ultimately, our ability to continue is dependent upon the achievement of profitable operations.  We anticipate that, depending on market conditions and our plan of operations, we may incur operating losses in the future based mainly on the fact that we may not be able to generate enough gross profits from our sales to cover our operating expenses and to increase our sales and marketing efforts.  There is no assurance that further funding will be available at acceptable terms, if at all, or that we will be able to achieve profitability or receive adequate funding for new product research and development activities.  These conditions raise substantial doubt about our ability to continue as a going concern.  The accompanying financial statements do not reflect any adjustments that may result from the outcome of this uncertainty.

Working Capital Needs and Major Cash Expenditures
 
We currently have monthly working capital needs of approximately $150,000 to $175,000.  This amount is, however, expected to increase in the next fiscal year, primarily due to the following factors:
 
      Increased employees and related travel costs
      Required interest payments on our convertible promissory notes payable
      Increased product development costs for new products, packaging and marketing materials

External Sources of Liquidity-External Debt Financing and Use of Common Stock for the last two years:

External Debt Financing:

On April 9, 2010, the Company received $59,400 for one of the March, 2010 allonges that had been recorded as a stock subscription receivable in March 2010.
 
On May 13, 2010, the Company executed an allonge to the March, 2009 Secured Notes in the amount of $55,000, increasing the aggregate face values of these notes from $359,834 to $414,834. Associated finance fees of $5,000 were deducted from the gross proceeds for a net received amount of $50,000.  In addition, we issued 114,583 warrants with an exercise price of $0.16 as these warrants are exercisable up to July 15, 2015.
 
On June 17, 2010, the Company entered into a promissory note in the amount of $25,000.  This note is subject to an interest rate of 18% and is due the sooner of July 1, 2010 or upon the next financing.  This note was paid in August 2010.
 
On July 15, 2010, the Company entered into a subscription agreement for a convertible debt financing in the principal amount of $900,000 with an interest rate of 10%.   The due date is July 15, 2012.
 
On December 21, 2010, the Company entered into a promissory note in the amount of $100,000.  This note is subject to an interest rate of 10% and is due the sooner of (i) January 21, 2011 or (ii) from the proceeds of the next funding.  The note was paid in connection with a January 11, 2011 agreement to extend the due date to March 31, 2011 for a non-convertible short-term bridge loan with an accredited investor for $120,000, the Company issued on March 4, 2011 Class A Warrants to purchase 12,000 common shares at an exercise price of $.05 as well as issued 100,000 shares of restricted stock to the lender.
 
 
22

 
 
On January 21, 2011, the Company entered into a subscription agreement with institutional and accredited investors for a convertible debt financing in the principal amount of $400,000 with an interest rate of 10%. The due date for the notes is July 15, 2012, and the notes are convertible into common stock at a conversion price equal to seventy-five percent (75%) of the average of the three lowest closing bid prices for the Common Stock as reported by Bloomberg L.P. for the principal market for the ten trading days preceding a conversion date but in no event greater than $.08. Subscribers in the offering included some holders of the Company’s senior secured notes and warrants. Associated finance fees of $70,000 which includes a 10% finder’s fee of $40,000 were deducted from the gross proceeds along with payment of a December 21, 2010 short term promissory note and accrued interest of $102,500 for a net received amount of $227,500 ($128,500 received in first closing on January 21, 2011 and $99,000 received in second closing on February 1, 2011).  In addition, the placement agent received a total of 2,046,035 restricted shares of the Company’s common stock which was equal to ten percent (10%) of the Class A warrants sold. One Class A Common Stock Purchase Warrant was issued for every share (total of 20,460,357 warrants) which would be issued on the closing date assuming the complete conversion of the notes on the closing date at the conversion price. The exercise price to acquire a Warrant Share upon exercise of a Class A Warrant is equal to $.035, subject to reduction as described in the Class A Warrant.  The Class A Warrants are exercisable until five years after the issue date of the Class A Warrants.
 
On March 17, 2011, the Company entered into a subscription agreement with institutional and accredited investors for a convertible debt financing in the principal amount of $600,000 with an interest rate of 10%. The due date for the notes is September 17, 2012, and the notes are convertible into common stock at a conversion price equal to seventy-five percent (75%) of the average of the three lowest closing bid prices for the Common Stock as reported by Bloomberg L.P. for the principal market for the ten trading days preceding a conversion date but in no event greater than $.02. Subscribers in the offering included some holders of the Company’s senior secured notes and warrants. Associated finance fees of $90,000 which includes a 10% cash finder’s fee of $60,000 were deducted from the gross proceeds for a net received amount of $510.000.  In addition, the placement agent received 3,973,510 warrants to purchase common shares which was equal to ten percent (10%) of the Class A warrants sold as well as a convertible note payable (same terms as the March 17, 2011 convertible notes payable) for a three percent (3%) non accountable expense allowance of $18,000. One Class A Common Stock Purchase Warrant was issued for every share (total of 39,735,100 warrants) which would be issued on the closing date assuming the complete conversion of the notes on the closing date at the conversion price. The exercise price to acquire a Warrant Share upon exercise of a Class A Warrant is equal to $.02, subject to reduction as described in the Class A Warrant.  The Class A Warrants are exercisable until five years after the issue date of the Class A Warrants.
 
On March 17, 2011 and as part of the above March 2011 financing, the Company entered into amendment and consent agreements with all institutional and accredited investors holding all convertible notes payable to extend the maturity date of these applicable notes to March 31, 2012 except for the July 2010 and January 2011 convertible notes as they already have a due date of July 15, 2012. These agreements also allowed the conversion price of all convertible notes payable prior to the above March, 2011 financing to equal the conversion criteria of the above March 17, 2011 financing as follows:  seventy-five percent (75%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal market for the ten trading days preceding a conversion date, but in no event greater than $.02.  In addition, all warrants issued from convertible note financings prior to the March, 2011 financing had the exercise price reduced to $.02.
 
On June 3, 2011, the Company entered into a promissory note in the amount of $100,000 with the Centaurian Fund LP, an accredited investor.  This note is subject to an interest rate of 10% and is due the sooner of July 3, 2011 or from the proceeds of the next funding by the Company.  This note was paid in July 2011from the $500,000 gross proceeds financing of the July 2011 financing.
 
On June 30, 2011, the Company entered into a promissory note in the amount of $25,000 with the Centaurian Fund LP, an accredited investor.  This note is subject to an interest rate of 10% and is due the sooner of July 30, 2011 or from the proceeds of the next funding by the Company.  This note was paid in July 2011from the $500,000 gross proceeds of the July 2011 financing.
 
On July 15, 2011, the Company entered into a Subscription Agreement for convertible debt financing up to $1,000,000 with an interest rate of 10% in which we received $500,000 gross proceeds. The notes are due January 15, 2013. One Class A Common Stock Purchase Warrant (total warrants to purchase 25,000,000 shares of common stock) was issued for every share which would be issued on the closing date assuming the complete conversion of the notes on the closing date at a conversion price of $0.02.   The exercise price to acquire a Warrant Share upon exercise of a Class A Warrant is $0.02, subject to reduction as described in the Class A Warrant.  The Class A Warrants are exercisable until five years after the issue date of the Warrants. Subscribers in the offering included holders of the Company’s senior secured notes and warrants. In addition, an additional warrant to purchase 2,500,000 shares of common stock and a convertible note for $15,000 was issued to the placement agent for finder’s fees.
 
On October 7, 2011, the Company entered into two non-convertible notes payables with two current accredited investors in the total amount of $150,000 (one note for $75,000 with Alpha Capital Anstalt and the other note for $75,000 with Centaurian Fund LP).  These notes are subject to an interest rate of 10% and are due the sooner of (i) January 30, 2012 or (ii) from the proceeds of the next funding by the Company.  The $75,000 note held by Centaurian was paid through proceeds from the February 2012 financing (part of the overall total payment of $100,000 plus interest of $3,451 for a grand total payment of $103,451), and the other $75,000 note held by Alpha was transferred as part of a new note totaling $175,000 of the overall $1,000,000 February, 2012 financing.
 
 
23

 
 
On November 3, 2011, the Company entered into a promissory note with conversion rights with outside legal counsel (Weed & Co. LLP) in the amount of $59,359.  This note is subject to an interest rate of 5% and is payable on or before May 5, 2012.    This note at the option of the holder at the due date may convert the unpaid interest and principal into newly issued shares of common stock.  The conversion shall be at a price equal to (1) the closing price on the day prior to the conversion date or (2) the lowest conversion price for other convertible debt.  The conversion price will be such as not to trigger any reset or anti-dilution rights in existing convertible notes on the due date. Weed & Co. LLP converted $50,000 on May 29, 2012 into 46,728,972 shares of common stock.
 
On December 1, 2011, the Company entered into two promissory notes with current accredited investors in the total amount of $50,000 (one note for $25,000 with Centaurian Fund and the other note for $25,000 with Alpha Capital Anstalt).  We received payment from Centaurian on December 1, 2011 and received the payment from Alpha on December 20, 2011.  Both notes are subject to an interest rate of 10% and are due the sooner of (i) January 30, 2012 or (ii) from the proceeds of the next funding by the Company.  The $25,000 note held by Centaurian was paid through proceeds from the February 2012 financing (part of the overall total payment of $100,000 notes plus interest of $3,451 for a grand total of $103,451), and the other $25,000 held by Alpha was transferred as part of a new note totaling $175,000 of the overall $1,000,000 February 2012 financing.
 
On December 28, 2011, the Company entered into a two years discount non-convertible note with a current accredited investor, Alpha Capital Anstalt, in the amount of $75,000.  This is a discount note in which the purchase price was $75,000, and the principal amount to be paid on December 28, 2013 will be $100,000.  This note is guaranteed by the Company’s CEO, Roy Warren.  This Alpha note was transferred as part of a new note totaling $175,000 of the overall $1,000,000 February 2012 financing.  The personal guarantee was eliminated.
 
All of the net proceeds from the above new financings were used for research and development activities as well as working capital purposes.

The foregoing securities were issued in reliance upon an exemption from registration under Section 4(2) and/or Regulation D of the Securities Act of 1933, as amended.  All of the investors were accredited investors and/or had preexisting relationships with the Company, there was no general solicitation or advertising in connection with the offer or sale of securities and the securities were issued with a restrictive legend.

Commitments for Common Stock for the last two years:

On June 2, 2010, the Board of Directors approved the issuance of 138,889 (valued at $25,000) and 150,000 (valued at $30,000) for a total of 288,889 shares for payment of past due services.  These shares were issued from the Company’s 2010 Stock Compensation Plan which was registered on a Form S-8 registration statement filed and declared effective on May 25, 2010.
 
On June 30, 2010, we issued 12,000 shares of common stock for the extension of the due date for certain April, 2008 short term notes payable to December 31, 2010.  These shares were valued at $624 or $.052 per share.
 
On July 21, 2010, we issued 8,333,333 shares of common stock to Roy Warren, CEO, for payment of past due salary for $125,000 at a conversion price of $.015 per share.
 
On January 21, 2011, we issued 2,046,035 restricted shares of common stock to the private placement agent for a finder’s fee for the January, 2011 $400,000 financing.
 
On February 25, 2011, the Company issued 4,156,566 shares of its restricted common stock and 1,500,000 shares from its stock plan to Tommy E. Kee, its chief financial officer, in exchange for conversion of $70,000 in accrued salary.  In addition, the Company issued 1,500,000 shares from its stock plan to two outside legal counsel members for past due services.

On May 5, 2011, certain employees converted a total $327,248 of past due salaries into 22,261,770 shares of common stock at a conversion price of $.0147 per share.
 
On May 5, 2011, we issued 2,000,000 shares of common stock to an investor relations firm for services rendered at a conversion price of $.0157 valued at $31,400.
 
 
24

 
 
On May 6, 2011, we issued 6,000,000 shares of common stock for the conversion of the original April 9, 2008 short-term bridge loan with principal balance of $120,000 at a conversion price of $.02.
 
On August 31, 2011, we issued 3,000,000 shares of restricted common stock to outside legal counsel for past due services at a conversion price of $.002 with a recorded value of $6,000.
 
On December 30, 2011, company employees returned 27,918,336 shares of common stock previously granted to them earlier in the year for past due services in exchange for a similar number of employee stock options at an exercise price of $.02 per share. These shares were cancelled and reduced the total outstanding number of common shares.
 
On February 22, 2012, we issued 5,000,000 shares of common stock as a finder’s fee for the February, 2012 financing. This amount represents 10% of the total 50,000,000 warrants that were issued in connection with this financing. We recorded a cost of $13,177 as financing fee expense for these shares.
 
Information about our cash flows

   
For The Year Ended
 
   
March 31,
   
March 31,
 
   
2012
   
2011
 
Cash provided by (used in):
           
             
Operating activities
  $ (1,585,215 )   $ (1,732,422 )
                 
Investing activities
  $ (16,002 )   $ (4,102 )
                 
Financing activities
  $ 1,500,000     $ 1,931,250  

For the year ended March 31, 2012, we reported a net loss of $6,149,343 which was offset by recording the fair value adjustment of the convertible notes for $3,169,350, derivative expense of $396,512, recording of $165,068 for compensatory stock and changes in accounts payable and accrued expenses for $642,836. Cash flows generated from our operating activities were inadequate to cover our cash disbursement needs as we had to rely on new convertible debt financings and bridge loans to cover operating costs.  Cash used by investing activities were attributed mainly to the purchase of a company vehicle.  Cash provided by financing activities increased due to the proceeds from the issuance of additional convertible debt financings for proceeds of $1,325,000.

For the year ended March 31, 2011, we reported a net profit of $11,383,632 which was offset by recording the fair value adjustment of the convertible notes for $11,142,516, derivative income for $2,371,504 and recording of $195,000 for compensatory stock.  Cash flows generated from our operating activities were inadequate to cover our cash disbursement needs as we had to rely on new convertible debt financings to cover operating costs. Cash provided by investing activities increased due to the proceeds from the issuance of additional convertible debt financings for proceeds of $1,955,000.

Defaults for Short-Term Non-Convertible Loans for the Year Ended March 31, 2012:

At March 31, 2012, two short-term bridge notes for a total of $115,000 were past due.

 
25

 
 
The following table sets forth various details of all convertible notes and short-term bridge loans including applicable interest and default rates for the period ended March 31, 2012:

  RECAP ANALYSIS OF ALL CONVERTIBLE NOTES PAYABLE
   AND SHORT-TERM BRIDGE NON-CONVERTIBLE LOANS
       FOR THE TWELVE MONTHS ENDED MARCH 31, 2012
 
           
 
                   
 
 
Original Note
 
Issue
     
Default
 
$ Amount
   
Interest
   
Default
Interest
   
Accrued
Default
 
Amount
 
Date
 
Due Date
 
Yes/No
 
Past Due
   
Rate
   
Rate
   
Interest
 
                                     
CONVERTIBLE NOTES
                               
                                     
 $     600,000
 
October, 2007
 
3/31/2014
 
No
    -       10 %     15 %     -  
 $     312,000
 
January, 2008
 
3/31/2014
 
No
    -    
None-discount note
      15 %     -  
 $     500,000
 
February, 2008
 
3/31/2014
 
No
    -       10 %     15 %     -  
 $     100,000
 
June, 2008
 
3/31/2014
 
No
    -       10 %     15 %     -  
 $     263,333
 
September, 2008
 
3/31/2014
 
No
    -    
None-discount note
      15 %     -  
 $       60,833
 
December, 2008
 
3/31/2014
 
No
    -    
None-discount note
      15 %     -  
 $     200,834
 
January, 2009
 
3/31/2014
 
No
    -       15 %     15 %     -  
 $       60,000
 
February, 2009
 
3/31/2014
 
No
    -       15 %     15 %     -  
 $     361,112
 
March, 2009
 
3/31/2014
 
No
    -       12 %     20 %     -  
 $       27,778
 
October, 2009
 
3/31/2014
 
No
    -       12 %     20 %     -  
 $     618,612
 
November, 2009
 
3/31/2014
 
No
    -       12 %     20 %     -  
 $     150,000
 
January, 2010
 
3/31/2014
 
No
    -       12 %     20 %     -  
 $     192,500
 
March, 2010
 
3/31/2014
 
No
    -       12 %     20 %     -  
 $       55,000
 
May, 2010
 
3/31/2014
 
No
    -       10 %     20 %     -  
 $     900,000
 
July, 2011
 
7/15/2012
 
No
    -       10 %     20 %     -  
 $     400,000
 
January, 2011
 
7/15/2012
 
No
    -       10 %     20 %     -  
 $     600,000
 
March, 2011
 
9/17/2012
 
No
    -       10 %     20 %     -  
 $     221,937
 
June, 2011
 
9/17/2012
 
No
    -       10 %     20 %     -  
 $     500,000
 
July, 2011
 
1/15/2013
 
No
    -       10 %     20 %     -  
 $       59,359
 
November, 2011
 
5/5/2012
 
No
    -       5 %  
NONE
      -  
 $  1,000,000
 
February, 2012
 
8/22/2013
 
No
    -       10 %     20 %     -  
 $     172,211
 
March, 2012
 
3/31/2014
 
No
    -       12 %     20 %     -  
 $  7,355,509
                                           
                                             
SHORT-TERM BRIDGE LOANS
                                       
                                             
 $       60,000
 
April 14, 2008
 
Past due
 
Yes (a)
  $ 60,000               15 %   $ 25,883  
 $       55,000
 
August 5, 2008
 
Past due
 
Yes (a)
  $ 55,000               15 %   $ 40,349  
 $     115,000
 
Total amount past due
      $ 115,000                     $ 66,232  
 
(a) Notes indicated in default are in default because they are past due.
             
 
 
26

 
 
CERTAIN BUSINESS RISKS:

Investing in our securities involves a high degree of risk. You should carefully consider the risk factors discussed below, together with all the other information contained or incorporated by reference in this report and in our filings under the Securities Exchange Act of 1934, as amended, or the Exchange Act, before deciding whether to purchase any of our securities. Each of the risk factors could adversely affect our business, operating results and financial condition, as well as adversely affect the value of an investment in our securities, and the occurrence of any of these risks might cause you to lose all or part of your investment.
 
Risks Relating to Our Business

We have a limited history of operating losses. If we continue to incur operating losses, we eventually may have insufficient working capital to maintain or expand operations according to our business plan.
 
As of March 30, 2012, we had total shareholders’ deficit of $14,018,894 and a working capital deficit of $8,743,079, compared to a total shareholders’ deficit of $14,215,259 and a working capital deficit of $11,861,608 at March 31, 2011. Cash and cash equivalents were $132,120 as of March 31, 2012 as compared to $233,337 at March 31, 2011. The main contributing factor to the working capital deficit was primarily attributable to the changes in the fair value calculations for the valuation of our convertible notes payable as well as changes in the derivative liabilities.
 
Ability to continue as a going concern.

Our financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.
 
For the foreseeable future, we will have to fund all of our operations and capital expenditures from the net proceeds of equity or debt offerings we may have and cash on hand.  Although we plan to pursue additional financing, there can be no assurance that we will be able to secure financing when needed or obtain such financing on terms satisfactory to us, if at all, or that any additional funding we do obtain will be sufficient to meet our needs in the long term. Obtaining additional financing may be more difficult because of the uncertainty regarding our ability to continue as a going concern.  If we are unable to secure additional financing in the future on acceptable terms, or at all, we may be unable to complete planned development of certain products.

To date, we have generated no material product revenues. Our operating losses have negatively impacted our liquidity, and we are continuing our efforts to develop new products, while focusing on increasing net sales.  However, changes may occur that would consume our existing capital at a faster rate than projected, including, among others, the progress of our research and development efforts and hiring of additional key employees.  If we continue to suffer losses from operations, our working capital may be insufficient to support our ability to expand our business operations as rapidly as we would deem necessary at any time, unless we are able to obtain additional financing. There can be no assurance that we will be able to obtain such financing on acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to pursue our business objectives and would be required to reduce our level of operations, including reducing infrastructure, promotions, personnel and other operating expenses. These events could adversely affect our business, results of operations and financial condition. If adequate funds are not available or if they are not available on acceptable terms, our ability to fund the growth of our operations, take advantage of opportunities, develop products or services or otherwise respond to competitive pressures, could be curtailed or significantly limited.   Any additional sources of financing will likely involve the sale of our equity securities, which will have a dilutive effect on our stockholders.  If we are unable to achieve profitability, the market value of our common stock will decline, and there would be a material adverse effect on our financial condition.
 
At March 31, 2012, we were in default on certain of our short-term bridge notes and have other substantial outstanding debt obligations.
 
At March 31, 2012, we were in default on short term bridge notes totaling $115,000 in principal.  The remedy for default under the notes is acceleration of principal and interest due thereunder.  Further, we have secured convertible notes outstanding totaling $5,005,539 in principal face value at March 31, 2012. Although we were able to extend the maturity dates of the notes issued prior to the July, 2010 financing until March 31, 2014, there is no assurance that we will be able to continue to extend these obligations. Further, an event of default under our convertible notes includes failure to pay certain debts over $50,000-$100,000.  Penalties for default under our convertible notes include but are not limited to acceleration of principal and interest, redemption provisions which allow the holders the option to redeem the notes for 120% of the principal balances plus interest and default interest rates up to 20%.  As of March 31, 2012, we have a total of $1,057,150 in outstanding notes payable that have a maturity date of July 15, 2012.  There is no guarantee that we will be able to obtain an extension, leading to an event of default.
 
 
27

 
 
Defaults on these obligations could materially adversely affect our business operating results and financial condition to such extent that we may be forced to restructure, file for bankruptcy, sell assets or cease operation.  Further, certain of these obligations are secured by our assets.  Failure to fulfill our obligations under these notes and related agreements could lead to the loss of these assets, which would be detrimental to our operations.
 
We may not be able to develop successful new beverage products which are important to our growth.
 
An important part of our strategy is to increase our sales through the development of new beverage products. We cannot assure you that we will be able to continue to develop, market and distribute future beverage products that will have market acceptance. The failure to continue to develop new beverage products that gain market acceptance could have an adverse impact on our growth and materially adversely affect our financial condition. Further, we may have higher obsolescent product expense if new products fail to perform as expected due to the need to write off excess inventory of the new products.
 
Our results of operations may be impacted in various ways by the introduction of new products, even if they are successful, including the following:
 
  
sales of new products could adversely impact sales of existing products;
 
 
we may incur higher cost of goods sold and selling, general and administrative expenses in the periods when we introduce new products due to increased costs associated with the introduction and marketing of new products, most of which are expensed as incurred; and
 
 
when we introduce new platforms and bottle sizes, we may experience increased freight and logistics costs as our co-packers adjust their facilities for the new products.
 
The beverage business is highly competitive.
 
The premium and functional beverage drink industries are highly competitive. Many of our competitors have substantially greater financial, marketing, personnel and other resources than we do. Competitors in these industries include bottlers and distributors of nationally advertised and marketed products, as well as chain store and private label drinks. The principal methods of competition include brand recognition, price and price promotion, retail space management, service to the retail trade, new product introductions, packaging changes, distribution methods, and advertising. We also compete for distributors, shelf space and customers primarily with other premium beverage companies. As additional competitors enter the field, our market share may fail to increase or may decrease.
 
The growth of our revenues is dependent on acceptance of our products by mainstream consumers.
 
We have limited resources to introduce our products to the mainstream consumer. As such, we will need to increase our sales force and execute agreements with distributors who, in turn, distribute to mainstream consumers at grocery stores, club stores and other retailers. If our products are not accepted by the mainstream consumer, our business could suffer.
 
Our failure to accurately estimate demand for our products could adversely affect our business and financial results.
 
We may not correctly estimate demand for our products. Our ability to estimate demand for our products is imprecise, particularly with new products, and may be less precise during periods of rapid growth, particularly in new markets. If we materially underestimate demand for our products or are unable to secure sufficient ingredients or raw materials including, but not limited to, containers, labels, flavors or packing arrangements, we might not be able to satisfy demand on a short-term basis. Moreover, industry-wide shortages of certain ingredients have been and could, from time to time in the future, be experienced, which could interfere with and/or delay production of certain of our products and could have a material adverse effect on our business and financial results. We do not use hedging agreements or alternative instruments to manage this risk.
 
The loss of our third-party distributors could impair our operations and substantially reduce our financial results.
 
We continually seek to expand distribution of our products by entering into distribution arrangements with regional bottlers or other direct store delivery distributors having established sales, marketing and distribution organizations. Many distributors are affiliated with and manufacture and/or distribute other beverage products. In many cases, such products compete directly with our products.
 
 
28

 
 
The marketing efforts of our distributors are important for our success. If our brands prove to be less attractive to our existing distributors and/or if we fail to attract additional distributors and/or our distributors do not market and promote our products above the products of our competitors, our business, financial condition and results of operations could be adversely affected.
 
Inability to secure co-packers for our products could impair our operations and substantially reduce our financial results.
 
We rely on third parties, called co-packers in our industry, to produce our products.  We currently have only one co-packing agreement for our products and at this time have only one milk-based product commercially available (Phase III® Recovery). Our co-packing agreement with our principal co-packer was signed on December 16, 2008 and had an initial term of three (3) years which has now expired. This agreement shall automatically renew for consecutive one (1) year periods (next renewal date of December 16, 2012) unless either party provides notice of cancellation at least one hundred twenty (120) calendar days prior to the end of the initial term or subsequent extension period.  Our dependence on one co-packer puts us at substantial risk in our operations.  If we lose this relationship and/or require new co-packing relationships for other products, we may be unable to establish such relationships on favorable terms, if at all.  Further, co-packing arrangements with potential new companies may be on a short term basis, and such co-packers may discontinue their relationship with us on short notice.  Our dependence on co-packing arrangements exposes us to various risks, including:
 
 
if any of those co-packers were to terminate our co-packing arrangement or have difficulties in producing beverages for us, our ability to produce our beverages would be adversely affected until we were able to make alternative arrangements; and
 
 
our business reputation would be adversely affected if any of the co-packers were to produce inferior quality products.
 
We compete in an industry that is brand-conscious, so brand name recognition and acceptance of our products are critical to our success.
 
Our business is substantially dependent upon awareness and market acceptance of our products and brands by our targeted consumers. In addition, our business depends on acceptance by our independent distributors of our brands as beverage brands that have the potential to provide incremental sales growth rather than reduce distributors’ existing beverage sales.  We believe that the success of our product name brands will also be substantially dependent upon acceptance of our product name brands. Accordingly, any failure of our brands to maintain or increase acceptance or market penetration would likely have a material adverse affect on our revenues and financial results.
 
We compete in an industry characterized by rapid changes in consumer preferences and public perception, so our ability to continue to market our existing products and develop new products to satisfy our consumers’ changing preferences will determine our long-term success.
 
Consumers are seeking greater variety in their beverages. Our future success will depend, in part, upon our continued ability to develop and introduce different and innovative beverages. In order to retain and expand our market share, we must continue to develop and introduce different and innovative beverages and be competitive in the areas of quality and health, although there can be no assurance of our ability to do so. There is no assurance that consumers will continue to purchase our products in the future. Additionally, many of our products are considered premium products and to maintain market share during recessionary periods, we may have to reduce profit margins, which would adversely affect our results of operations. Product lifecycles for some beverage brands and/or products and/or packages may be limited to a few years before consumers’ preferences change. The beverages we currently market are in their early lifecycles, and there can be no assurance that such beverages will become or remain profitable for us. The beverage industry is subject to changing consumer preferences, and shifts in consumer preferences may adversely affect us if we misjudge such preferences. We may be unable to achieve volume growth through product and packaging initiatives. We also may be unable to penetrate new markets. If our revenues decline, our business, financial condition and results of operations will be materially and adversely affected.
 
 
29

 
 
Our quarterly operating results may fluctuate significantly because of the seasonality of our business.
 
As our products are relatively new, there may be seasonality issues that could cause our financial performance to fluctuate. In addition, beverage sales can be adversely affected by sustained periods of bad weather.
 
Our business is subject to many regulations, and noncompliance is costly.
 
The production, marketing and sale of our unique beverages, including contents, labels, caps and containers, are subject to the rules and regulations of various federal, provincial, state and local health agencies. If a regulatory authority finds that a current or future product or production run is not in compliance with any of these regulations, we may be fined, or production may be stopped, thus adversely affecting our financial conditions and operations. Similarly, any adverse publicity associated with any noncompliance may damage our reputation and our ability to successfully market our products. Furthermore, the rules and regulations are subject to change from time to time and while we closely monitor developments in this area, we have no way of anticipating whether changes in these rules and regulations will impact our business adversely. Additional or revised regulatory requirements, whether labeling, environmental, tax or otherwise, could have a material adverse effect on our financial condition and results of operations.
 
We face risks associated with product liability claims and product recalls.
 
Other companies in the beverage industry have experienced product liability litigation and product recalls arising primarily from defectively manufactured products or packaging. Our co-packer maintains product liability insurance insuring our operations from any claims associated with product liability. This insurance may or may not be sufficient to protect us. We do not maintain product recall insurance. In the event we were to experience additional product liability or product recall claim, our business operations and financial condition could be materially and adversely affected.
 
Our intellectual property rights are critical to our success; the loss of such rights could materially, adversely affect our business.
 
We regard the protection of our trademarks, trade dress and trade secrets as critical to our future success. We have registered our trademarks in the United States that are very important to our business. We also own the copyright in and to portions of the content on the packaging of our products. We regard our trademarks, copyrights and similar intellectual property as critical to our success and attempt to protect such property with registered and common law trademarks and copyrights, restrictions on disclosure and other actions to prevent infringement. Product packages, mechanical designs and artwork are important to our success, and we would take action to protect against imitation of our packaging and trade dress and to protect our trademarks and copyrights, as necessary. We also rely on a combination of laws and contractual restrictions, such as confidentiality agreements, to establish and protect our proprietary rights, trade dress and trade secrets. However, laws and contractual restrictions may not be sufficient to protect the exclusivity of our intellectual property rights, trade dress or trade secrets. Furthermore, enforcing our rights to our intellectual property could involve the expenditure of significant management and financial resources. There can be no assurance that other third parties will not infringe or misappropriate our trademarks and similar proprietary rights. If we lose some or all of our intellectual property rights, our business may be materially and adversely affected.
 
If we are not able to retain the full time services of our management team, including Roy G. Warren, it will be more difficult for us to manage our operations and our operating performance could suffer.
 
Our business is dependent, to a large extent, upon the services of our management team, including Roy G. Warren, our founder and Chief Executive Officer and Chairman of the Board. We depend on our management team, but especially on Mr. Warren’s creativity and leadership in running or supervising virtually all aspects of our day-to-day operations. We do not have a written employment agreement with any member of our management team or Mr. Warren. In addition, we do not maintain key person life insurance on any of our management team or Mr. Warren. Therefore, in the event of the loss or unavailability of any member of the management team to us, there can be no assurance that we would be able to locate in a timely manner or employ qualified personnel to replace him. The loss of the services of any member of our management team or our failure to attract and retain other key personnel over time would jeopardize our ability to execute our business plan and could have a material adverse effect on our business, results of operations and financial condition.
 
 
30

 
 
We need to manage our growth and implement and maintain procedures and controls during a time of rapid expansion in our business.
 
If we are to expand our operations, such expansion would place a significant strain on our management, operational and financial resources.  Such expansion would also require improvements in our operational, accounting and information systems, procedures and controls.  If we fail to manage this anticipated expansion properly, it could divert our limited management, cash, personnel, and other resources from other responsibilities and could adversely affect our financial performance.
 
Our business may be negatively impacted by a slowing economy or by unfavorable economic conditions or developments in the United States and/or in other countries in which we may operate.
 
A general slowdown in the economy in the United States or unfavorable economic conditions or other developments may result in decreased consumer demand, business disruption, supply constraints, foreign currency devaluation, inflation or deflation. A slowdown in the economy or unstable economic conditions in the United States or in the countries in which we operate could have an adverse impact on our business results or financial condition. Currently we do not have any international operations.
 
Risks Relating to Our Securities
 
There has been a very limited public trading market for our securities, and the market for our securities may continue to be limited and be sporadic and highly volatile.
 
There is currently a limited public market for our common stock. Our common stock has been listed for trading on the OTC Bulletin Board (the “OTCBB”). We cannot assure you that an active market for our shares will be established or maintained in the future. Holders of our common stock may, therefore, have difficulty selling their shares, should they decide to do so. In addition, there can be no assurances that such markets will continue or that any shares, which may be purchased, may be sold without incurring a loss. Any such market price of our shares may not necessarily bear any relationship to our book value, assets, past operating results, financial condition or any other established criteria of value and may not be indicative of the market price for the shares in the future.
 
 In addition, the market price of our common stock may be volatile, which could cause the value of our common stock to decline. Securities markets experience significant price and volume fluctuations. This market volatility, as well as general economic conditions, could cause the market price of our common stock to fluctuate substantially. Many factors that are beyond our control may significantly affect the market price of our shares. These factors include: 
 
 
price and volume fluctuations in the stock markets;
 
 
changes in our revenues and earnings or other variations in operating results;
 
 
any shortfall in revenue or increase in losses from levels expected by us or securities analysts;
 
 
changes in regulatory policies or law;
 
 
operating performance of companies comparable to us; and
 
 
general economic trends and other external factors.
 
Even if an active market for our common stock is established, stockholders may have to sell their shares at prices substantially lower than the price they paid for it or might otherwise receive than if a broad public market existed.
 
 
31

 
 
Future financings could adversely affect common stock ownership interest and rights in comparison with those of other security holders.
 
Our board of directors has the power to issue additional shares of common or preferred stock without stockholder approval. If additional funds are raised through the issuance of equity or convertible debt securities, the percentage ownership of our existing stockholders will be reduced, and these newly issued securities may have rights, preferences or privileges senior to those of existing stockholders. In addition, as of March 31, 2012, we had issued and outstanding options and warrants that may be exercised into 242,029,518 shares of common stock and 9,000,000 shares of Series A Convertible Preferred Stock that may be converted into 54,000,000 shares of common stock, outstanding principal convertible notes totaling  $5,005,539 and accrued interest payable of $955,806 which together may be converted into 298,067,272 shares of common stock (subject to 4.99-9.99% beneficial ownership limitations) at a maximum conversion cap rate of $.02 per share.  The Series A votes with the common stock on an as converted basis.  Pursuant to the terms and conditions of the Company’s outstanding Series A, the conversion rate and the voting rights of the Series A will not adjust as a result of any reverse stock split.  Further, the authorized but unissued Series A will not adjust as a result of any reverse split.  As a result, in the event of a reverse split of our common stock, the voting power would be concentrated with the Series A holder.
 
Further, if we issue any additional common stock or securities convertible into common stock, such issuance will reduce the proportionate ownership and voting power of each other stockholder. In addition, such stock issuances might result in a reduction of the book value of our common stock.
 
A substantial number of our shares are available for sale in the public market, and sales of those shares could adversely affect our stock price and our ability to obtain financing.
 
Sales of a substantial number of shares of common stock into the public market, or the perception that such sales could occur, could substantially reduce our stock price in the public market for our common stock and could impair our ability to obtain capital through a subsequent financing of our securities. We have 854,047,952 shares of common stock outstanding as of March 31, 2012 of which 848,758,899 shares are held by non-affiliates.  Further, the Company has outstanding convertible notes in the face value of $5,005,539 which may be converted into 250,276,933 shares of common stock and warrants that may be exercised into 213,900,441 shares of common stock (subject to 4.99-9.99% beneficial ownership limitations).  Generally, the holders of the securities convertible or exercisable into our common stock may be able to sell the common stock issued upon conversion or exercise after a six month holding period under Rule 144 adopted under the Securities Act of 1933 (as amended, the “Securities Act”).  As such, you should expect a significant number of such shares of common stock to be sold.  Depending upon market liquidity at the time our common stock is resold by the holders thereof, such re-sales could cause the trading price of our common stock to decline.  In addition, the sale of a substantial number of shares of our common stock, an anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales.  In addition, shareholders on April 27, 2012 approved the increase of our authorized shares from one billion to five billion shares which makes more shares available for issuance. 
 
EFFECTS OF INFLATION
 
We believe that inflation has not had any material effect on our net sales and results of operations.


The consolidated financial statements for the years ended March 31, 2012 and 2011 are contained on Pages F-1 to F-56 which follows.


None.

 
Evaluation of Disclosure Controls and Procedures
 
Disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”), are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
 
 
32

 
 
We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2012. Based upon such evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were not effective as required under Rules 13a-15(e) and 15d-15(e) under the Exchange Act.
 
Management’s Report on Internal Control over Financial Reporting
 
Our management is responsible for establishing and maintaining adequate internal controls over financial reporting. Under the supervision and with the participation of our management, including our chief executive officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting using framework similar to criteria referenced in the initial steps of the Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on this evaluation, management concluded that our internal control over financial reporting was not effective as of the year ended March 31, 2012.
 
A material weakness is a significant deficiency (as defined in the Public Company Accounting Oversight Board’s Auditing Standard No. 2), or a combination of significant deficiencies, that results in reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of the Company’s internal controls over financial reporting, management determined that there were control deficiencies as of the year ended March 31, 2012 that constituted material weaknesses, as described below.
 
 
* We have noted that there may be an insufficient quantity of dedicated resources and experienced personnel involved in reviewing and designing internal controls. As a result, a material misstatement of the interim and annual financial statements could occur and not be prevented or detected on a timely basis.
 
* We do not have an audit committee or an independent audit committee financial expert. While not being legally obligated to have an audit committee or independent audit committee financial expert, it is the management’s view that to have an audit committee, comprised of independent board members, and an independent audit committee financial expert is an important entity-level control over the Company's financial statements. Currently, the Board does not have sufficient independent directors to form such an audit committee. Also, the Board of Directors does not have an independent director with sufficient financial expertise to serve as an independent financial expert.
 
* Due to the complex nature of recording derivatives and similar financial instruments, we noted a need for increased coordination and review of techniques and assumptions used in recording derivatives to ensure accounting in conformity with generally accepted accounting principles.
 
This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report is not subject to attestation by our registered public accounting firm pursuant to rules of the SEC that permit us to provide only management’s report in this annual report.
 
Remediation Efforts to Address Deficiencies in Internal Control over Financial Reporting 
 
As a result of the findings from the evaluation conducted of the effectiveness of our internal control over financing reporting as set forth above, management intends to take practical, cost-effective steps in implementing internal controls, including the following remedial measures:
 
 
* Interviewing and potentially hiring outside consultants that are experts in designing internal controls over financial reporting based on criteria established in Internal Control-Integrated Framework issued by COSO.
 
* The Company has hired an outside consultant to assist with controls over the review and application of derivatives to ensure accounting in conformity with generally accepted accounting principles.
 
 
33

 
 
 
* Board to review and make recommendations to shareholders concerning the composition of the Board of Directors, with particular focus on issues of independence. The Board of Directors to consider nominating an audit committee and audit committee financial expert, which may or may not consist of independent members as funds allow.
 
Due to inadequate financing, the Company has not hired any outside experts to design additional internal controls over financial reporting or recommended a new board director that is a financial expert.
 
A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
 
Changes in Internal Control over Financial Reporting
 
No change in the Company’s internal control over financial reporting occurred during the quarter ended March 31, 2012, that materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
 

None

PART III


The directors and executive officers as of March 31, 2012 are as follows. Our directors are elected at the annual meeting of our stockholders and serve until their successors are elected and qualified.

Name of Officer and Age
     
Position with the Company
 
Year Appointed
Roy Warren
  56  
Chairman, Chief Executive Officer and President
 
2007
Michael Edwards
  52  
Director
 
2007
H. John Buckman
  66  
Director
 
2007
Tommy Kee
  63  
Chief Financial Officer
 
2007 2010*
 
* Mr. Kee resigned as CFO in July 2009 but rejoined the Company in April 2010. 

The experience and background of the Company’s directors, executive officers and significant employees follow:

Mr. Roy Warren – Chairman, Chief Executive Officer and President since September, 2007

Mr. Warren serves as our Chairman of the Board, Chief Executive Officer and President.  As Chief Executive Officer, Mr. Warren provides overall company leadership and strategy.  Mr. Warren also serves as a director of our wholly owned subsidiary, Attitude Drink Company, Inc.  For 15 years from 1981 through 1996, Mr. Warren was in the securities brokerage industry.  During those years, Mr. Warren acted as executive officer, principal, securities broker and partner with brokerage firms in Florida, most notably Kemper Financial Companies, Alex Brown & Sons and Laffer Warren & Company.  From 1999 to 2007, Mr. Warren was Chief Executive Officer of Bravo! Brands, Inc. in Florida, a public company which was a beverage brand-development company, similar to Attitude Drinks Incorporated.  This experience in the beverage industry as well as with a public company led to the conclusion that he should serve as a director of the Company.

Mr. Michael Edwards – Director since 2007

Mr. Edwards serves on the Board of Directors.  He currently is the sole proprietor of a chain of automobile car washes in Martin County, Florida.  Prior to this, he served as Chief Revenue Officer for Bravo! Brands, Inc. for over five years in which he led the sales team force for introduction and sales of the company’s various developed beverage brands and products.  This expertise in the development and sales of beverage products led to the conclusion that he should serve as a director of the Company.  Prior to that time, he worked for 5 years in beverage marketing research for Message Factors, Inc., a Memphis, Tennessee marketing research firm.  Mr. Edwards has a BS degree from Florida State University in Management and Marketing and spent 13 years in the banking industry, leaving CitiBank to join Message Factors in 1995.
 
 
34

 
 
Mr. H. John Buckman – Director since 2007

Mr. Buckman serves on the Board of Directors.  He is a principal and majority shareholder of Buckman, Buckman and Reid, a licensed broker-dealer co-founded by Mr. Buckman in 1988.  Mr. Buckman also joined the Board of Center for Vocational Rehabilitation (CVR) in 1994 and was a member for ten years.  Presently, Mr. Buckman is President of the Board of Directors for Asian Youth Ministries in New Jersey.  His many years of broker-dealer experience, which provide valuable direction in the Company’s interactions in the securities market as well as his management and director experience, supports his role as director of the Company.
 
Mr. Tommy Kee –Chief Financial Officer since 2007

Tommy Kee joined our company in November, 2007 as Chief Financial Officer.  Mr. Kee was previously the Chief Accounting Officer of Bravo! Brands, Inc.  He graduated with an MBA from the University of Memphis and a BS degree in accounting from the University of Tennessee.  Before joining us, he served for several years as CFO for Allied Interstate, Inc. in the West Palm Beach area.  Prior to that, Mr. Kee served as CFO and Treasurer for Hearx Ltd. a West Palm Beach, Florida public company.  He also served 18 years as International Controller and Financial Director with the Holiday Inns Inc. organization in Memphis and Orlando.  Mr. Kee gave his letter of resignation as CFO, effective July 10, 2009 but rejoined the Company in April, 2010.

Section 16(a) Beneficial Ownership Reporting Compliance

Based solely on a review of the appropriate Forms 3, 4 and 5 and any amendments to such forms filed pursuant to Section 16(a) during the most recent fiscal year, we report no late filings.

Code of Ethics

On May 14, 2009, the Board of Directors approved and ratified a Code of Ethics that is applicable to all directors, officers and employees.  A copy of the Code of Ethics was attached an Exhibit 14 in the Form 10-K/A-2 that was filed for the fiscal year that ended March 31, 2009. The Code of Ethics is also available for review on our website at www.attitudedrinks.com.  Furthermore, a copy of the code is available to any person free of charge upon request by writing to our company at 10415 Riverside Drive, Suite 101, Palm Beach Gardens, Florida 33410.

Committees

Although we have a majority of independent directors due to the lack of adequate capital, we do not have a separately designated audit committee, nominating committee, compensation committee or a person designated as an audit committee member financial expert.  We do not have a separately designated audit committee or an audit committee member financial expert because the cost of identifying, interviewing, appointing, educating, and compensating such persons would outweigh the benefits to our stockholders at the present time.  If we are successful in our efforts to secure additional capital, the resources may be available to appoint additional directors, have a separately designated audit committee, nominating committee, compensation committee and a person designated as an audit committee member financial expert. All directors participate in nominations of directors, and there is no formal nomination charter or policy in regard to recommendation of directors by shareholders due to the Company’s size and operations.
 
 
35

 
 

Summary Compensation Table

The following table sets forth the compensation earned during the last two fiscal years by our executive officers as well as any unpaid compensation since the employment date with the company.  Please note that the company did not have sufficient capital to make regular compensation payments to these officers, and unpaid amounts have been accrued and reflected as expense:
 
                                     
Change in
             
                                     
Pension Value
             
                                     
Value &
             
                               
Non-equity
   
Nonqualified
   
 
       
       
Earned
         
 
   
(e)
   
Incentive
   
Deferred
   
(g)
       
 
Principal
   
Salary /
         
Stock
   
Option
   
Plan Comp.
   
Comp.
   
All Other
       
Name
Position
Year
 
Consulting $
   
Bonus $
   
Awards $
   
Awards $
      $    
Earnings $
   
Comp. $
   
Total $
 
Roy Warren(f)
 CEO
2012 (a)
  $ 162,000     $ -     $ -     $ -     $ -     $ -     $ 19,308     $ 181,308  
Roy Warren (f)
 CEO
2011 (b)
  $ 295,077     $ -     $ -     $ -     $ -     $ -     $ 19,577     $ 314,654  
                                                                     
Tommy Kee (f)
 CFO
2012 (c)
  $ 84,000     $ -     $ -     $ 2,642     $ -     $ -     $ 12,042     $ 98,684  
Tommy Kee (f)
 CFO
2011 (d)
  $ 143,500     $ -     $ -     $ -     $ -     $ -     $ 12,344     $ 155,844  
 
(a)  For the year ended March 31, 2012, Roy Warren, CEO, earned an annual base salary of $150,000.  Once the company has adequate capital, his salary will be increased back to his previous salary of $180,000.  The $162,000 amount reflects his salary of $150,000 and unpaid annual director’s fees of $12,000.

(b)  For the year ended March 31, 2011, Roy Warren, CEO, earned an annual base salary of $150,000.  His previous annual salary of $180,000 was reduced during July 2010 with the expectation to return back to this amount once adequate capital is available.  The $295,077 amount reflects his salary of $158,077, unpaid annual director’s fees of $12,000 and $125,000 for a conversion of previous years’ past due salary into 8,333,333 restricted shares of common stock.

(c)  For the year ended March 31, 2012, Tommy Kee, CFO, earned an annual base salary of $84,000. Once the company has adequate capital, his salary will be increased back to his previous salary of $150,000.  The $84,000 amount reflects his salary in which $24,100 was not paid.

(d)  For the year ended March 31, 2011, Tommy Kee, CFO, earned an annual base salary of $84,000. His previous annual salary of $150,000 was reduced during July, 2010 with the expectation to return back to this amount once adequate capital is available.  The $143,500 amount reflects his salary of $73,500 and $70,000 for a conversion of previous years’ past due salary into a total of 5,656,566 shares of common stock with 4,156,566 of the total being restricted shares.  These shares were returned back to the Company in the latter part of the 2011 calendar year.  For this return, the same number of stock options was issued at an exercise price of $.02. Out of the total earned amount for this fiscal year, he has not been paid $21,615.

(e)  This amount represents the aggregate grant date fair value that was computed in accordance with FASB Topic 718 for the grant of non-qualified stock options to the named executives.  These options were granted in December, 2012 and have an exercise price of $.02 and vest immediately with an expiration life of five (5) years.  The stock options were valued at $.000467 per stock option for Tommy Kee (5,656,566 stock options at $.000467 = $2,642).

(f)  Neither executive has an employment or a consulting agreement.  The Company intends to pay accrued but unpaid amounts either by conversions of certain past due amounts in the Company’s common stock and/or cash once the Company’s fundings and financial position will allow such payments.  Since the Company was not able to consistently make salary payments to these two named executives, the Company had to treat most of these payments as consulting fees.

(g)  All other compensation figures represent company paid medical insurance for the above named executives.

 
36

 

Outstanding Equity Awards at March 31, 2012
 
      Option Awards     Stock Awards        
                                               
Equity
 
                                                Incentive  
                                               
Plan
 
                                         
Equity
    Awards:  
                                          Incentive    
 Market
 
               
Equity
                       
Plan
   
or Payout
 
                Incentive                         Awards:    
Value of
 
               
Plan
                 
Market
   
Number
    Unearned  
               
Plan Awards:
           
Number of
   
Value of
   
of Unearned
   
Shares,
 
   
Number of
   
Number of
   
Number of
           
Shares or
   
Shares of
   
Shares, Units
   
Units or
 
   
Securities
   
Securities
   
Securities
           
Units of
   
Units of
   
or Other
   
Other Rights
 
   
Underlying
   
Underlying
   
Underlying
       
 
 
Stock That
   
Stock That
   
Rights That
   
That Have
 
   
Unexercised
   
Unexercised
   
Unexercised
   
Option
 
Option
 
Have Not
   
Have Not
   
Have Not
   
Not
 
   
Options #
   
Options #
   
Unearned
   
Exercise
 
Expiration
 
Vested
   
Vested
   
Vested
   
Vested
 
Name
 
Exercisable
   
Unexercisable
   
Options #
   
Price $
 
Date
   #      $     #     $  
Roy Warren, CEO (a)
    447,483       447,483       -     $ 1.00  
3/31/2014
    -     $ -       -     $ -  
Tommy Kee, CFO (b)
    5,725,442       5,725,442       -     $ 0.02  
12/30/2016
    -     $ -       -     $ -  
  Total
    6,172,925       6,172,925       -                 -     $ -       -          
 
(a) All 447,483 stock options were granted during March , 2009.
         
(b)  Stock optioms were granted as follows:  68,876  options during March, 2009, and 5,656,566 stock options were granted In December, 2011.
   
 
Director Compensation Table
 
     
(a)
                     
 
             
     
Fees
                     
Nonqualified
   
 
       
     
Earned or
   
 
   
 
   
Non-equity
   
Deferred
   
 
       
     
Paid In
   
Stock
   
Option
   
Incentive
   
Comp.
   
All Other
       
Name
Year
 
Cash $
   
Awards $
   
Awards $
   
Plan Comp. $
   
Earnings $
   
Comp. $
   
Total $
 
H.John Buckman (b )
2012
  $ 12,000     $ -     $ -     $ -     $ -     $ -     $ 12,000  
 
2011
  $ 12,000     $ -     $ -     $ -     $ -     $ -     $ 12,000  
Mike Edwards
2012
  $ 12,000     $ -     $ -     $ -     $ -     $ -     $ 12,000  
 
2011
  $ 12,000     $ -     $ -     $ -     $ -     $ -     $ 12,000  
 
Roy G. Warren, CEO, is the Chairman of the Board of Directors. His director compensation is reported in the Summary Compensation Table.

(a)  Each above director is compensated $1,000 per month for their roles as directors; however, no cash payments have been made for the year ended March 31, 2012.  Roy G. Warren is the only non-independent director.  The Company intends to pay these past due amounts either by issuing shares of the Company’s common stock and/or cash once the Company’s financial position will allow such payments.  Total past due director fees are $42,000 for H. John Buckman and $38,792 for Mike Edwards.

(b)  In addition to H. John Buckman being a Director, he also is an investor and debt holder of the Company whereas the Company issued him a note payable at face value of $55,000.  He also has a total of 5,500 Class A warrants at an exercise price of $1.00 with a life of five years.  He also received 11,000 shares of restricted stock that related to his note payable, 1,200 shares were issued to him in 2009 for his Director services and he received 150,000 shares of restricted stock in November 2009 for his efforts in a financing during that month (total of 162,200 restricted shares).

 
37

 


The following table sets forth the beneficial ownership of our company’s common stock as of March 31, 2012 as to:
 
      each person known to beneficially own more than 5% of our issued and outstanding common stock
      each of our directors
      each executive officer
      all directors and officers as a group
 
Except as otherwise noted, the named beneficial owners have direct ownership of the stock and have sole voting and investment power with respect to the shares shown
 
Beneficial Owners
 
Title of Class
 
Name and Address of Beneficial Owner (1)
 
Amount and Nature of Beneficial Ownership
   
Percent of Class (2)
 
Common
 
Alpha Capital Anstalt (3)
Pradafant 7
9490 Furstentums
Vaduz, Lichtenstein
    106,040,111       9.99 %
Common
 
Whalehaven Capital Fund Ltd. (3)
14 Par-La-Ville Road
3rd Floor
Hamilton, Bermuda HM08
    98,690,891       9.99 %
Common
 
Roy Warren (4)
10415 Riverside Drive
# 101
Palm Beach Gardens, Florida 33410
    59,576,291       6.52 %
Common
 
Schlomo & Rochel Rifkind (3)
Givat Shoshanna 12/3
Tzfut Israel
    58,704,749       6.43 %

(1)    Beneficial Ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities. .

(2)    Percentage calculated from base of 854,047,952 shares of common stock outstanding at March 31, 2012 plus shares subject to options, warrants or preferred stock currently exercisable or convertible within 60 days of March 31, 2012 that are deemed outstanding for computing the percentage of the person holding such option or warrant but are not deemed outstanding for computing the percentage of any other person.

(3)    This owner is contractually limited to a beneficial ownership of our equity not to exceed 9.99%.  Equity listed consists of convertible notes and/or warrants.

(4)    Equity listed consists of common stock, preferred stock and stock options to purchase common stock
 
 
38

 
 
Management Owners
Title of Class
 
Name and Address of Management Owner
 
Amount and
Nature of
Ownership (1)
   
Percent of
Class (2)
 
                 
Common
 
 
Roy Warren
10415 Riverside Dr.
Palm Beach Gardens, FL
    59,576,291 (3)     6.52
Common
 
Tommy Kee
10415 Riverside Dr.
Palm Beach Gardens, Fl.
    5,726,192 (4)  
Less than 1
%
Common
 
H. John Buckman
174 Patterson Avenue
Shrewsbury, N.J.
    167,700 (5)  
Less than 1
 
Common
 
Mike Edwards
1615 S.E. Decker Avenue
Stuart, Fl.
    1,200 (6)    
Less than 1
 
Common
 
Executive officers and directors as a group
    65,471,383       7.12 %
 
 
(1)  
Beneficial Ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities. Shares of common stock subject to options or warrants currently exercisable or convertible, or exercisable or convertible within 60 days of   March 31, 2012 are deemed outstanding for computing the percentage of the person holding such option or warrant but are not deemed outstanding for computing the percentage of any other person.

 
(2)  
Percentage calculated from base of 854,047,952 shares of common stock outstanding at March 31, 2012 plus shares subject to options, warrants or preferred stock currently exercisable or convertible within 60 days of March 31, 2012 that are deemed outstanding for computing the percentage of the person holding such option or warrant but are not deemed outstanding for computing the percentage of any other person.
 
 
(3)  
Includes 3,996 shares of our common stock owned by household family members. Remaining amount relates  to 5,124,812 shares of common stock, 447,483 non-qualified stock options and 54,000,000 shares of common stock from the potential conversion of 9,000,000 Series A Preferred Stock (conversion of 6 common shares to 1 preferred share)
 
 
(4)  
Represents 5,725,442 non-qualified stock options and 750 shares of common stock
 
 
(5)  
Includes 162,200 shares of common stock and 5,500 warrants
 
 
(6)  
Represents 1,200 shares of common stock
 
Changes in Control

None


Roy Warren’s daughter, Niki Fuller, is employed by the Company where she is in charge of all marketing functions of the Company. Her previous experience was with another similar brand development company, Bravo! Brands Inc., whereas she had worked in the marketing department.  Other than receiving compensation for her employment services and some stock options, she has no other direct or indirect material interest in the Company. She earned $30,600 and $25,330 for the fiscal years ended March 31, 2012 and March 31, 2011, respectively. She also has 26,500 stock options with an exercise price of $1.00 and an expiration date of March 31, 2014.

RPBGI LLC, our landlord, received 644,677 restricted shares of common stock back in March, 2009 for past due services. This company still owns all of these shares.

Weed & Co. LLP serves as our main outside legal counsel and holds a convertible note payable in the amount of $59,359. On May 29, 2012, they converted $50,000 of the above notes payable into 46,728,972 shares of common stock.
 
The Company previously issued aggregate notes of $100,000 ($50,000 in October 2007 and $50,000 in February 2008) to Roy Warren, the Company’s CEO, an accredited investor with whom the Company entered into subscription agreements for 10% convertible notes. Roy Warren assigned the $100,000 notes to another party. During the quarter ended September 30, 2009, 9,000,000 shares of Series A Preferred, convertible into 54,000,000 shares of common stock at the option of the holder, were granted to Roy Warren for services rendered.  We recorded a non-cash expense for $1,620,000 which is based on the then market price of $0.03 per common share times the convertible stock equivalents  (9,000,000 preferred shares x 6 = 54,000,000 common stock equivalents).  These shares vote with the common stock at a rate of 6 votes per share (54,000,000 total votes).

H. John Buckman is a board director of the company and is a debt holder of the company of a note payable at the face value of $55,000.  He also has a total of 5,500 Class A warrants at an exercise price of $1.00 with a life of three to five years, and he will be entitled to an additional 5,000 warrants with at an exercise price of $15.00 if he exercises the same number of specific Class A warrants.  He also received 11,000 shares of restricted stock that related to this note payable, 1,200 shares of restricted stock for being a Director and 150,000 shares of restricted stock for his services related to a November 2009 financing (total of 162,200 shares of restricted stock).
 
 
39

 
 
Director Independence

H. John Buckman and Mike Edwards are independent directors as defined by Rule 10A-3 of the Exchange Act under NASDAQ rules.  Roy G. Warren is not independent as he is an officer of the Company.


Audit Fees

The aggregate fees billed for the year ended March 31, 2012 for professional services rendered by the principal accountant for the review of financial statements included in our Form 10-Q’s were $89,852. We have accrued expected audit fees for the year ended March 31, 2012 in the amount of $40,000.  Total audit fees for the previous year ended March 31, 2011 were $85,897.

Audit Related Fees

None.

Tax Fees

Due to losses and limited capital, no tax returns have been prepared. However, we have accrued tax preparation fees of approximately $10, 000 for future tax preparation services.

All Other Fees

SEC review comments - $1,819.

Audit Committee Pre-Approval Policies

The Company does not have an audit committee and therefore the board considers and has approval authority over all engagements of the independent auditors.  All of the engagements resulting in the fees disclosed above for fiscal 2011-2012 were approved by the Chairman of the Board prior to the engagement.
 
 
40

 

PART IV
 
(a)  The following documents are filed as part of this Form 10-K:
 
1. Financial Statements
 
The following financial statements are included in Part II, Item 8 of this Form 10-K:
 
Consolidated Balance Sheet
Consolidated Statement of Operations
Consolidated Statement of Stockholders’ Deficit
Consolidated Statement of Cash flows
 
2.  Exhibits
 
The exhibits listed in the Exhibit Index are incorporated herein by reference and are filed as part of this Form 10-K,
 
3.  Financial Statement Schedules
 
Financial statement schedules are omitted because they are not required or are not applicable, or the required information is provided in the consolidated financial statements or notes described in Item 15(a)(1) above.
 
Exhibit No.
 
Document Description
 
Incorporated  by Reference
 
Filed Herewith
(2)(1)
 
Agreement and Plan of Merger dated September 14, 2007
 
(1)
   
(3)(1)(i)
 
Restated Certificate of Incorporation
 
(1)
   
(3)(1)(ii)
 
Certificate of Amendment to Certificate of Incorporation
 
(8)
   
(3)(1)(iii)
 
Certificate of Amendment to Certificate of Incorporation
 
(9)
   
(3)(1)(iv)
 
Certificate of Amendment to the Certificate of Incorporation
     
X
(3)(2)
 
Amended and Restated Bylaws
 
(1)
   
(4)(1)
 
Certificate of Designation of the Series A Convertible Preferred
 
(1)
   
(4)(2)
 
Form of Common Stock Certificate
 
(1)
   
(4)(3)
 
Form of Class A and B Common Stock Purchase Warrant with Schedule of other documents omitted- Exhibit B in Exhibit (10)(1)-(a)
 
(1)
   
(4)(4)
 
Form of 10% Convertible Note with Schedule of other documents omitted Exhibit A in Exhibit (10)(1) – (a)
 
(1)
   
(4)(5)
 
Form of Secured Convertible Note with Schedule of other documents omitted
 
(1)
   
(4)(6)
 
Certificate of Amendment to the certificate of Designation of the Series A Convertible Preferred Stock
 
(5)
   
(4)(7)
 
Form of Note dated January 8, 2008 –Exhibit A in Exhibit (10)(8) – (b)
 
(11)
   
(10)(1)
 
Subscription Agreement for Securities dated October 23, 2007
 
(11)
   
(10)(2)
 
2007 Stock Compensation and Incentive Plan
 
(1)
   
(10)(3)
 
Escrow Agreement dated October 23, 2007 – Exhibit C in Exhibit (10)(1) –(a)
 
(1)
   
(10)(4)
 
Security Agreement dated October 23, 2007 – Exhibit D in Exhibit (10)(1) –(a)
 
(1)
   
(10)(5)
 
Subsidiary Guaranty dated October 23, 2007 – Exhibit E in Exhibit (10)(1) – (a)
 
(1)
   
(10)(6)
 
Collateral Agent Agreement dated October 23, 2007-Exhibit F in  Exhibit (10)(1) – (a)
 
(1)
   
(10)(7)
 
Office Lease Agreement dated December 15, 2007
 
(2)
   
(10)(8)
 
Subscription Agreement for Securities dated January 8, 2008
 
(11)
   
(10)(9)
 
Funds Escrow Agreement dated January 8, 2008 – Exhibit B in Exhibit (10)(8) –(b)
 
(1)
   
(10)(10)
 
Waiver and Consent dated January 8, 2008
 
(1)
   
(10)(11)
 
Notice of Waiver of Certain Conditions effective February 15, 2008
 
(1)
   
(10)(12)
 
Notice of Waiver effective February 15, 2008
 
(1)
   
(10)(13)
 
Notice of Waiver of Conditions effective April 8, 2008
 
(1)
   
(10)(14)
 
Modification and Waiver Agreement, dated June 30, 2008
 
(11)
   
(10)(15)
 
Asset Purchase Agreement, and Secured Convertible Promissory Note, August 2008
 
(11)
   
(10)(16)
 
Sublicense Agreement, Termination Agreement, Promissory Note With Nutraceutical Discoveries, Inc. – August, 2008 and February 2010
 
(11)
   
 
 
41

 
 
Exhibit No.
 
Document Description
 
Incorporated  by Reference
 
Filed Herewith
(10)(17)
 
Form of Modification, Waiver and Consent Agreement, September 2008
 
(3)
   
(10)(18)
 
Subscription Agreement Securities September 2008
 
(11)
   
(10)(19)
 
Funds Escrow Agreement September 2008 –Exhibit C in Exhibit (10)(19) –(c)
 
(11)
   
(10)(20)
 
Form of Note, September 2008- Exhibit A in Exhibit (10)(19) –(c)
 
(3)
   
(10)(21)
 
Form of Class A and Class B Warrant, September 2008 – Exhibit B in Exhibit (10)(19) – (c)
 
(3)
   
(10)(22)
 
Manufacturing Agreement dated December 16, 2008 with O-AT-KA Milk Products Cooperative, Inc.
 
(4)
   
(10)(23)
 
Form of Note and Warrant and Modification, Waiver and Consent Agreement, December 2008
 
(11)
   
(10)(24)
 
Subscription Agreement, Form of Note and Warrant, Funds Escrow Agreement, Form of Legal Opinion, and Second Modification, Waiver And Consent Agreement, January 2009 (d)
 
(11)
   
(10)(25)
 
Amendment, Waiver and Consent Agreement, Form of Allonge No.1 to January 09 Notes, Form of Warrant, February 2009
 
(11)
   
(10)(26)
 
Subscription Agreement, Funds Escrow Agreement, Form of Note and Warrant and Legal Opinion, March 2009
 
(11)
   
(10)(27)
 
Third Modification, Waiver and Consent Agreement, Form of Allonge No. 1 to  March 09 Notes, Form of Warrant, July 2009
 
(11)
   
(10)(28)
 
Form of Note, November 2009
 
(11)
   
(10)(29)
 
Modification and Amendment Letters, Form of Warrant, January 2010
 
(11)
   
(10)(30)
 
2010 Stock Compensation and Incentive Plan
 
(7)
   
(10)(31)
 
Warrant and Allonge to March 2009 Note, dated May 13, 2010
 
(15)
   
(10)(32)
 
Promissory Note, dated June 17, 2010
 
(15)
   
(10)(33)
 
Warrants to extend short-term bridge loan June 30, 2010
 
(15)
   
(10)(34)
 
Subscription Agreement dated July 15, 2010 (Exhibits A-B (Form of Note and Warrant) filed with Form 8-K dated July 21, 2010, Exhibit C (Escrow Agreement) filed as Exhibit 10.38 to Form 10-Q as amended for quarter ended September 30, 2010 filed June 1 2011))
 
(14)
   
(10)(35)
 
Form of Convertible Promissory Note dated July 15, 2010
 
(10)
   
(10)(36)
 
Form of Class A Warrant dated July 15, 2010
 
(10)
   
(10)(37)
 
First Amendment and Consent Agreement dated July 15, 2010
 
(10)
   
(10)(38)
 
Escrow Agreement dated July 15, 2010
 
(14)
   
(10)(39)
 
Placement Agent Agreement for July 2010 financing
 
(14)
   
(10)(40)
 
Promissory Note dated December 21, 2010
 
(15)
   
(10)(41)
 
Placement Agent Agreement dated December 21, 2010 for January 2011 Financing
 
(15)
   
(10)(42)
 
Form of Bridge Loan Extension Letter and Form of Warrant dated  January 11, 2011
 
(12)
   
(10)(43)
 
Subscription Agreement dated January 21, 2011 to include cap table, all exhibits (forms of note and warrant, escrow agreement, forms of legal opinion and lockup agreements) and other schedules
 
(16)
   
(10)(44)
 
Second Amendment and Consent Agreement dated January 21, 2011
 
(16)
   
(10)(45)
 
Form of Note with Landlord dated January 26, 2011
 
(12)
   
(10)(46)
 
Subscription Agreement dated February 1, 2011 to include cap table, all exhibits (forms of note and warrant, escrow agreement, forms of legal opinion and lockup agreements) and other schedules
 
(16)
   
(10)(47)
 
Placement Agent Agreement dated March 8, 2011
 
(13)
   
(10)(48)
 
Subscription Agreement dated March 17, 2011to include cap table, all exhibits (forms of note and warrant, escrow agreement, forms of legal opinion and lockup agreements) and other schedules
 
(16)
   
(10)(49)
 
Third Amendment and Consent Agreement dated March 17, 2011
 
(16)
   
(10)(50)
 
Form of Promissory Note dated June 3, 2011
 
(18)
   
(10)(51)
 
Form of Promissory Note dated June 30, 2011
 
(18)
   
(10)(52)
 
Placement Agent Agreement dated June 22, 2011
 
(17)
   
(10)(53)
 
Form of Debt Exchange Agreement dated June 30, 2011
 
(18)
   
(10)(54)
 
Subscription Agreement dated July 15, 2011 to include cap table, all  Exhibits (forms of note and warrant, escrow agreement, form of legal opinion) and other schedules
 
(17)
   
(10)(55)
 
Form of Promissory Note dated October 7, 2011 (Alpha)
 
(19)
   
 
 
42

 
 
Exhibit No.
 
Document Description
 
Incorporated  by Reference
 
Filed Herewith
(10)(56)
 
Form of Promissory Note dated October 7, 2011 (Centaurian)
 
(19)
   
(10((57)
 
Form of Promissory Note with conversion rights November 3, 2011
 
(19)
   
(10)(58)
 
Form of Promissory Note dated December 1, 2011 (Centaurian)
 
(20)
   
(10)(59)
 
Form of Promissory Note dated December 1, 2011 (Alpha)
 
(20)
   
(10)(60)
 
Form of Note dated December 28, 2011 (Alpha)
 
(20)
   
(10)(61)
 
Cause Marketing Endorsement Partnership Agreement dated October 13, 2011
 
(20)
   
(10)(62)
 
Commission Agreement dated June 29, 2011
 
(20)
   
(10)(63)
 
Form of Approval of Grant of Stock Options at December 21, 2011
 
(20)
   
(10)(64)
 
Subscription Agreement dated February 22, 2012 to include cap table, all Exhibits (forms of note and warrant, escrow agreement, form of legal Option) and other schedules
 
(21)
   
(10)(65)
 
Fifth Amendment and Consent Agreement dated February 22, 2012
 
(21)
   
(10)(66)
 
Placement Agent Agreement dated February 6, 2012
 
(21)
   
(10)(67)
 
Extension Agreement and Form of Note dated March 31, 2012
 
(22)
   
(10)(68)
 
Personal Services Agreement
     
X
(10)(69)
 
Promissory Notes
     
X
(14)
 
Code of Ethics
 
(6)
   
(21)
 
Subsidiaries of Registrant
 
(1)
   
(31)(i)
 
Certification of Chief Executive Officer pursuant to Rule 13a-14 (a)/ 15d-14 (a), as adopted pursuant to Section 302 of the  Sarbanes-Oxley Act of 2002
     
X
(31)(ii)
 
Certification of Chief Financial Officer pursuant to Rule 13a-14 (a)/ 15d-14 (a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
X
(32)(1)
 
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to  Section 906 of the Sarbanes-Oxley Act of 2002
     
X

(1)   previously filed with the Commission on April 11, 2008 as an exhibit to Form S-1/A (SEC Accession Number 0001144204-08-021783)
(2)   previously filed with the Commission on February 14, 2008 as Exhibit 10.3 to Form 10-Q (SEC Accession Number 0001144204-08-008934)
(3)   previously filed with the Commission on November 19, 2008 as an exhibit to Form 10-Q (SEC Accession Number 0001144204-08-0063995)
(4)   previously filed with the Commission on March 5, 2009 as Exhibit 10.18 to Form 10-Q (SEC Accession Number 0001213900-09-0005)
(5)   previously filed with the Commission on November 23, 2009 as Exhibit 4.6 to Form 10-Q (SEC Accession No. 0001213900-09-003372)
(6)   previously filed with the Commission on August 14, 2009 as Exhibit 14.1 to Form 10-K (SEC Accession No. 0001213900-09-002104)
(7)   previously filed with the Commission on May 25, 2010 as Exhibit 10.1 to Form S-8 (SEC Accession No. 0001213900-10-002206)
(8)   previously filed with the Commission on July 14, 2010 as Exhibit 3(1)(ii) to Form 10-K (SEC Accession No. 0001213900-10-2857)
(9)   previously filed with the Commission on July 7, 2010 as Exhibit 3.1 to Form 8-K (SEC Accession No. 0001213900-10-002769)
(10) previously filed with the Commission on July 21, 2010 as an exhibit to the Company’s Form 8-K (SEC Accession No. 0001213900-10-002955)
(11) previously filed with the Commission on April 21, 2011 as an exhibit to Form 10-K/A (SEC Accession No. 0001213900-11-002129)
(12) previously filed with the Commission on May 9, 2011 as an exhibit to Form 8-K/A (SEC Accession No. 0001213900-11-002409)
(13) previously filed with the Commission on May 10, 2011 as an exhibit to Form 8-K/A (SEC Accession No. 0001213900-11-002431)
(14) previously filed with the Commission on June 1, 2011 as an exhibit to Form 10-Q/A (SEC Accession No.  0001213900-11-003038)
(15) previously filed with the Commission on July 6, 2011 as an exhibit to Form 10-Q/A (SEC Accession No. 0001213900-11-003542)
(16) previously filed with the Commission on July 14, 2011 as an exhibit to Form 10-K (SEC Accession No. 0001213900-11-003662)
(17) previously filed with the Commission on July 20, 2011 as an exhibit to Form 8-K (SEC Accession No. 0001313900-11-003757)
(18) previously filed with the Commission on August 22, 2011 as an exhibit to Form 10-Q (SEC Accession No. 0001213900-11-004667)
(19) previously filed with the Commission on November 21, 2011 as an exhibit to Form 10-Q (SEC Accession No. 0001213900-11-006291)
(20) previously filed with the Commission on February 21, 2012 as an exhibit to Form 10-Q (SEC Accession No. 0001213900-12-000838)
(21) previously filed with the Commission on February 24, 2012 as an exhibit to Form 8-K (SEC Accession No. 0001213900-12-000890)
(22) previously filed with the Commission on April 5, 2012 as an exhibit to Form 8-K (SEC Accession No. 0001213900-12-001638)

(a)  This exhibit is referenced in the October 23, 2007 Subscription Agreement
(b)  This exhibit is referenced in the January 8, 2008 Subscription Agreement
(c)  This exhibit is referenced in the September 29, 2008 Subscription Agreement
(d)  Schedule 9(s) for Lockup Agreement Providers, referenced in the exhibit index to the Subscription Agreement, was not included in this Subscription Agreement because this schedule was not assembled or produced although Exhibit E, Form of Lock Up Agreement, was included in the Subscription Agreement

 
43

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
       
ATTITUDE DRINKS INCORPORATED    
(Registrant)      
       
    ATTITUDE DRINKS INCORPORATED  
       
Date: July 13, 2012
By:
/s/ Roy G. Warren  
   
Roy G. Warren
 
    President and Chief Executive Officer  
 
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated,  
 
Signature
 
Title
 
       
/s/ Roy G. Warren
 
President and Chief Executive Officer
 
Roy G. Warren
     
Name
     
       
/s/ Tommy E. Kee
 
Chief Financial Officer and Principal Accounting Officer
 
Tommy E. Kee
     
Name
     

/s/ H. John Buckman
 
Director
 
H. John Buckman
     
Name
     
       
/s/ Mike Edwards
 
Director
 
Mike Edwards      
Name
     

 
44

 
 
ATTITUDE DRINKS INCORPORATED AND SUBSIDIARY

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
 
F-1

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders
Attitude Drinks Incorporated and Subsidiary
Palm Beach Gardens, Florida

We have audited the accompanying consolidated balance sheets of Attitude Drinks Incorporated and subsidiary as of March 31, 2012 and 2011, and the related consolidated statements of operations, stockholders’ deficit and cash flows for the year ended March 31, 2012 and March 31, 2011. These consolidated financial statements are the responsibility of the Company’s management.  Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.  The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  Our audits included consideration of internal controls over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal controls over financial reporting.  Accordingly, we express no such opinion.  An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.  We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Attitude Drinks Incorporated and subsidiary as of March 31, 2012 and 2011 and the results of their operations and cash flows for the years ended March 31, 2012 and March 31, 2011, in conformity with accounting principles generally accepted in the United States of America.

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern.  As shown in the financial statements and discussed in Note 2 of the accompanying financial statements, the Company has incurred significant recurring losses from operations since inception and is dependent on outside sources of financing for continuation of its operations.  These factors raise substantial doubt about the Company’s ability to continue as a going concern.

/s/ Meeks International, LLC
 
Tampa, Florida
July 9, 2012

 
F-2

 

 
   
March 31, 2012
   
March 31, 2011
 
   
 
       
ASSETS
           
             
CURRENT ASSETS:
           
  Cash and cash equivalents
  $ 132,120     $ 233,337  
  Accounts receivable less allowance for doubtful accounts of $817 and $0 for March 31, 2012 and 2011, respectively
    43,895       37,258  
  Inventories
    258,496       80,195  
  Prepaid expenses
    53,385       171,106  
     TOTAL CURRENT ASSETS
    487,896       521,896  
                 
FIXED ASSETS, NET
    24,653       27,930  
                 
OTHER ASSETS:
               
  Trademarks, net
    25,280       27,177  
  Deposits and other
    20,996       20,996  
     TOTAL OTHER ASSETS
    46,276       48,173  
                 
TOTAL ASSETS
  $ 558,825     $ 597,999  
                 
LIABILITIES AND STOCKHOLDERS' (DEFICIT)
               
                 
CURRENT LIABILITIES:
               
  Accounts payable
  $ 1,685,120     $ 1,369,354  
  Accrued liabilities
    4,165,800       3,497,215  
  Derivative liabilities
    423,262       1,468,988  
  Short-term bridge loans payable
    115,000       388,000  
  Convertible notes payable
    2,726,657       5,533,537  
  Non-convertible notes payable
    86,012       86,012  
  Deferred revenue
    7,661       18,935  
  Loans payable to related parties
    21,463       21,463  
     TOTAL CURRENT LIABILITIES
    9,230,975       12,383,504  
                 
CONVERTIBLE NOTES PAYABLE - NET OF CURRENT PORTION
    5,346,744       2,429,754  
                 
                 
STOCKHOLDERS' (DEFICIT):
               
  Series A convertible preferred stock par value $0.001 per share,
               
     20,000,000 shares authorized, 9,000,000 shares issued and outstanding
               
    at March 31, 2012 and March 31, 2011, respectively
    9,000       9,000  
  Common stock, par value $0.001, 1,000,000,000 shares authorized
               
     854,047,952 and 65,956,004 shares issued and outstanding at March
               
     31, 2012 and March 31, 2011, respectively
    854,048       65,956  
  Additional paid-in capital
    13,634,608       8,076,992  
  Deficit accumulated
    (28,516,550 )     (22,367,207 )
     TOTAL STOCKHOLDERS' (DEFICIT)
    (14,018,894 )     (14,215,259 )
                 
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT)
  $ 558,825     $ 597,999  
 
See accompanying notes to consolidated financial statements
 
 
F-3

 
 
 
   
Year
   
Year
 
   
Ended
   
Ended
 
   
March 31,
   
March 31,
 
   
2012
   
2011
 
             
REVENUES:
           
  Net revenues
  $ 376,437     $ 50,360  
  Product and shipping costs
    (318,737 )     (51,959 )
GROSS PROFIT
    57,700       (1,599 )
                 
OPERATING EXPENSES:
               
  Salaries, taxes and employee benefits
    535,690       311,471  
  Marketing and promotion
    461,272       265,358  
  Consulting fees
    82,645       40,329  
  Professional and legal fees
    228,799       260,951  
  Travel and entertainment
    47,308       (427 )
  Product development costs
    2,074       7,900  
  Stock compensation expense
    165,068       195,000  
  Other operating expenses
    374,902       468,441  
     Total Operating Expenses
    1,897,758       1,549,023  
                 
LOSS FROM OPERATIONS
    (1,840,058 )     (1,550,622 )
                 
OTHER INCOME (EXPENSE):
               
  Derivative income (expense)
    (396,512 )     2,371,504  
  Loss on extinguishment of debt
    -       (3,264 )
  Loss on asset abandonment
    (14,345 )     -  
  Interest and other financing costs
    (3,898,428 )     10,566,014  
     Total Other Income (Expense)
    (4,309,285 )     12,934,254  
                 
INCOME (LOSS) BEFORE PROVISION
               
  FOR INCOME TAXES
    (6,149,343 )     11,383,632  
                 
  Provision for income taxes
    -       -  
                 
NET INCOME (LOSS)
  $ (6,149,343 )   $ 11,383,632  
                 
Basic income (loss) per common share
  $ (0.03 )   $ 0.66  
                 
Diluted income (loss) per common share
  $ (0.03 )   $ 0.03  
                 
Weighted average common shares
               
     outstanding - basic
    225,250,685       17,302,251  
                 
Weighted average common shares
               
     outstanding - diluted
    225,250,685       355,511,621  

See accompanying notes to consolidated financial statements
 
 
F-4

 
 
 
   
Preferred
   
Common
   
Additional
   
Stock
             
   
Stock
   
Stock
   
Paid In
   
Subscription
   
Accumulated
       
   
Shares
   
Amount
   
Shares
   
Amount
   
Capital
   
Receivable
   
Deficit
   
Total
 
                                                 
Balance, March 31, 2010
    9,000,000     $ 9,000       4,306,437     $ 4,306     $ 5,959,687     $ (59,400 )   $ (33,750,839 )   $ (27,837,246 )
                                                                 
Issuance of common stock
                                                               
 for debt modification
    -       -       112,000       112       2,490       -       -       2,602  
Conversions of debt to
                                                               
  common stock
    -       -       43,758,097       43,759       1,814,674       -       -       1,858,433  
Issuance of common
                                                               
  stock for services
    -       -       15,778,935       15,779       270,220       -       -       285,999  
Finders' fees for financing
    -       -       2,046,035       2,046       29,875       -       -       31,921  
Stock subscription
                                                               
  receivable
    -       -       -       -       -       59,400       -       59,400  
Cancellation of shares
    -       -       (45,500 )     (46 )     46       -       -       -  
Net loss
    -       -       -       -       -       -       11,383,632       11,383,632  
Balance, March 31, 2011
    9,000,000     $ 9,000       65,956,004     $ 65,956     $ 8,076,992     $ -     $ (22,367,207 )   $ (14,215,259 )
                                                                 
Conversions of debt to
                                                               
  common stock
    -       -       783,777,763       783,778       5,568,698       -       -       6,352,476  
Issuance of common
                                                               
  stock for services
    -       -       (685,815 )     (686 )     (31,915 )     -       -       (32,601 )
Issuance of  stock options
    -       -       -       -       12,656       -       -       12,656  
Finders' fees for financing
    -       -       5,000,000       5,000       8,177       -       -       13,177  
Net loss
    -       -       -       -       -       -       (6,149,343 )     (6,149,343 )
Balance, March 31, 2012
    9,000,000     $ 9,000       854,047,952     $ 854,048     $ 13,634,608     $ -     $ (28,516,550 )   $ (14,018,894 )

See accompanying notes to consolidated financial statements

 
F-5

 
 
ATTITUDE DRINKS INCORPORATED AND SUBSIDIARY

 
   
Year
   
Year
 
   
Ended
   
Ended
 
   
March 31,
   
March 31,
 
   
2012
   
2011
 
             
CASH FLOWS FROM OPERATING ACTIVITIES:
           
  Net income/(loss)
  $ (6,149,343 )   $ 11,383,632  
  Adjustment to reconcile net income (loss) to net cash used in
               
    operating activities:
               
       Depreciation and amortization
    6,831       10,431  
       Compensatory stock and warrants
    165,068       195,000  
       Bad debt expense
    817       -  
       Derivative expense/(income)
    396,512       (2,371,504 )
       Fair value adjustment of convertible note
    3,169,350       (11,142,516 )
       Stock subscription receivable
    -       59,400  
       Loss on debt extinguishment
    -       3,264  
       Amortization of debt discount
    365,127       84,077  
       Loss on disposal of fixed assets
    14,345       -  
  Changes in operating assets and liabilities:
               
       Accounts receivable
    (7,454 )     (26,285 )
       Prepaid expenses and other assets
    271       (12,802 )
       Inventories
    (178,301 )     (67,482 )
       Deferred revenue
    (11,274 )     18,935  
       Accounts payable and accrued liabilities
    642,836       133,428  
  Net cash used in operating activities
    (1,585,215 )     (1,732,422 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES:
               
       Purchase of equipment
    (16,002 )     (1,865 )
       Trademarks
    -       (2,237 )
  Net cash used in investing activities
    (16,002 )     (4,102 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES:
               
       Proceeds from convertible notes payable
    1,325,000       1,955,000  
       Proceeds from short-term bridge loans payable
    400,000       125,000  
       Repayment of notes
    (225,000 )     (148,750 )
  Net cash provided by financing activities
    1,500,000       1,931,250  
                 
NET INCREASE/(DECREASE) IN CASH  AND CASH EQUIVALENTS
    (101,217 )     194,726  
                 
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
    233,337       38,611  
                 
CASH AND CASH EQUIVALENTS AT END OF PERIOD
  $ 132,120     $ 233,337  
                 
SUPPLEMENTAL CASH FLOW INFORMATION:
               
Cash paid during the period for interest
  $ 3,451     $ -  
Cash paid for taxes
  $ -     $ -  
Non-cash investing and financing activities:
               
  Payment of financing fees with issuance of new notes payable
  $ 15,000     $ 18,000  
  Payment of financing fees with common stock and warrants
  $ 146,559     $ 122,892  
  Debt modifications through issuance of common stock
  $ -     $ 2,854  
 
See  accompanying notes to consolidated financial statements

 
F-6

 


Note 1 -
Organization and Nature of Business:

Attitude Drinks Incorporated, a Delaware corporation, and subsidiary (“the Company”) is engaged in the development and sale of functional beverages, primarily in the United States.

Attitude Drinks Incorporated (“Attitude”, “We” or the “Company”) was formed in Delaware on September 11, 1988 under the name International Sportfest, Inc.  In January 1994, the Company acquired 100% of the issued and outstanding common stock of Pride Management Services PLC ("PMS").  PMS was a holding company of six subsidiaries in the United Kingdom engaged in the leasing of motor vehicles throughout the United Kingdom.  Simultaneously with the acquisition of PMS, we changed our name to Pride, Inc.  On October 1, 1999, the Company acquired all of the issued and outstanding stock of Mason Hill & Co. and changed its name to Mason Hill Holdings, Inc. During the quarter ended June 30, 2001, the operating subsidiary, Mason Hill & Co., was liquidated by the Securities Investors Protection Corporation.  As a result, the Company became a shell corporation whose principal business was to locate and consummate a merger with an ongoing business.

On September 19, 2007, the Company acquired Attitude Drink Company, Inc., a Delaware corporation (“ADCI”), under an Agreement and Plan of Merger (“Merger Agreement”) among Mason Hill Holdings, Inc. (“MHHI”), and ADCI.  Pursuant to the Merger Agreement, each share of ADCI common stock was converted into 40 shares of Company common stock resulting in the issuance of 4,000,000 shares of Company common stock.  The acquisition was accounted for as a reverse merger (recapitalization) with ADCI deemed to be the accounting acquirer, and the Company deemed to be the legal acquirer.  Accordingly, the financial information presented in the financial statements is that of ADCI as adjusted to give effect to any difference in the par value of the issuer's and the accounting acquirer's stock with an offset to capital in excess of par value. The basis of the assets, liabilities and retained earnings of ADCI, the accounting acquirer, have been carried over in the recapitalization.  On September 30, 2007, the Company changed its name to Attitude Drinks Incorporated.  Its wholly owned subsidiary, ADCI, was incorporated in Delaware on June 18, 2007.

The Company's fiscal year end is March 31.  Its plan of operation during the next twelve months is to focus on the non-alcoholic single serving beverage business, developing and marketing products in three fast growing segments: sports recovery, functional dairy and milk/juice blends.

The state of Delaware approved on April 4, 2010 the increase in our authorized shares of common stock from one hundred million (100,000,000) to one billion (1,000,000,000). On May 1, 2012, the state of Delaware approved the increase in our authorized shares of common stock from one billion (1,000,000,000) to five billion (5,000,000,000).
  
Note 2 - 
Going Concern and Management’s Plans:

As reflected in the accompanying consolidated financial statements, the Company has incurred accumulated operating losses of $28,516,550 and negative cash flows from operations and has a significant working capital deficiency in the amount of $8,743,079 at March 31, 2012. The Company has been dependent upon third party financing and will continue to depend on additional financing for at least the next twelve months.  These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

The Company plans to increase its sales, primarily by significantly increasing its sales force and partnering with new distributors as well as offering new products in the next twelve months.  The Company’s margins are expected to improve as a result of increased sales, expected economies of scales due to anticipated lower product costs based on increased volumes per production run and lower transportation costs from the expected shipment of full truck loads.  However, the Company expects to be dependent on third party financing at least through the next twelve months.  There is no assurance that further funding will be available at acceptable terms, if at all, or that the Company will be able to achieve profitability.  Ultimately, the Company’s ability to continue as a going concern is dependent upon the achievement of profitable operations. The accompanying financial statements do not reflect any adjustments that may result from the outcome of this uncertainty.

 
F-7

 
 
Note 3 - 
Significant Accounting Policies:

 (a)     Principles of Consolidation:

The Company’s consolidated financial statements include the accounts of Attitude Drinks Incorporated and its wholly-owned subsidiary, Attitude Drink Company, Inc. All material intercompany balances and transactions have been eliminated.

 (b)     Use of Estimates:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  The most significant estimate included in the Company’s financial statements is the following:
 
Estimating the fair value of the Company’s financial instruments that are required to be carried at fair value.

The Company uses all available information and appropriate techniques to develop its estimates, including the use of outside consultants. However, actual results could differ from the Company’s estimates.

(c)       Business Segment and Geographic Information:

The Company currently operates in one dominant industry segment that it has defined as the sports recovery- drink industry.  However, its next two products will enter into the functional milk category. Presently, there is no international business, although the Company may pursue the sale of its products in international markets during the next fiscal year.

(d)       Cash and Cash Equivalents:

The Company considers all highly liquid investments purchased with a remaining maturity of three months or less to be cash equivalents.

(e)       Inventories:

Inventories, which consist of finished goods and raw materials, are stated at the lower of cost on the first in, first-out method or market.  Further, the Company’s inventories are perishable.  The Company estimates for each fiscal quarter any unsalable inventory reserves based upon a specific identification basis. The finished goods on consignment represent products shipped under a “pay on scan” model whereas the revenue is deferred until the customer sells through such products to the end consumer.  The components of inventories as of March 31, 2012 and March 31, 2011 are below:
 
   
March 31, 2012
   
March 31, 2011
 
             
Finished goods
  $ 252,413     $ 66,638  
Finished goods on consignment
    6,083       13,557  
Total inventories
  $ 258,496     $ 80,195  
 
(f)       Fixed Assets:

Fixed assets are stated at cost. Depreciation is computed using the straight-line method over a period of ten years for furniture, three years for computer equipment and three years for purchased software. Maintenance, repairs and minor renewals are charged directly to expenses as incurred. Additions and betterments to property and equipment are capitalized.  When assets are disposed of, the related cost and accumulated depreciation thereon are removed from the accounts, and any resulting gain or loss is included in the statement of operations.
 
 
F-8

 
 
Note3- 
Significant Accounting Policies (continued):
 
(g)      Intangible Assets:

The Company’s intangible assets, which are recorded at cost, consist primarily of trademarks.  These assets are being amortized on a straight-line basis over fifteen years.  The following table summarizes the components of the Company’s intangible assets as of March 31, 2012 and March 31, 2011:

   
March 31, 2012
   
March 31, 2011
 
             
Trademark costs
  $ 31,570     $ 31,570  
Less accumulated depreciation
    (6,290 )     (4,393 )
Total Intangible Assets
  $ 25,280     $ 27,177  
 
Amortization expense amounted to $1,897 and $1,840 for the years ended March 31, 2012 and March 31, 2011, respectively. During the year ended March 31, 2009, we exchanged a convertible note payable (see note 6-f) for several trademarks.  These trademarks had a book value of $507,500; however we prepared an impairment analysis for the year ended March 31, 2010 as we estimated that the carrying amount of this asset may not be recoverable through the estimated undiscounted cash flows expected to result from the use of these items. As such, we determined that the full value of $507,500 should be written off.
 
(h)      Impairment of Long-Lived Assets:

Our long-lived assets consist principally of intangible assets (trademarks) and to a much lesser extent, furniture and equipment.  We evaluate the carrying value and recoverability of our long-lived assets when circumstances warrant such evaluation by applying the provisions of the FASB Accounting Standards Codification which requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected to result from the use and eventual disposition of the assets.  Whenever any such impairment exists, an impairment loss will be recognized for the amount by which the carrying value exceeds the fair value.  See the note above (g) for further explanation.

(i)       Financial Instruments:

Financial instruments, as defined in the FASB Accounting Standards Codification  consist of cash, evidence of ownership in an entity, and contracts that both (i) impose on one entity a contractual obligation to deliver cash or another financial instrument to a second entity, or to exchange other financial instruments on potentially unfavorable terms with the second entity, and (ii) conveys to that second entity a contractual right (a) to receive cash or another financial instrument from the first entity, or (b) to exchange other financial instruments on potentially favorable terms with the first entity. Accordingly, our financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, accrued liabilities, notes payable, derivative financial instruments, convertible debt and redeemable preferred stock that we have concluded is more akin to debt than equity.
 
We carry cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities at historical costs; their respective estimated fair values approximate carrying values due to their current nature.
 
Derivative financial instruments, as defined in the FASB Accounting Standards Codification, consist of financial instruments or other contracts that contain a notional amount and one or more underlying (e.g. interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial  instruments may be free-standing or embedded in other financial instruments. Further, derivative financial instruments are initially, and subsequently, measured at fair value and recorded as liabilities or, in rare instances, assets.

 
F-9

 

Note 3 - 
Significant Accounting Policies (continued):
 
(i)       Financial Instruments:

We generally do not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, we have entered into certain other financial instruments and contracts, such as debt financing arrangements, redeemable preferred stock arrangements, and freestanding warrants with features that are either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. As required by the FASB Accounting Standards Codification, these instruments are required to be carried as derivative liabilities, at fair value, in our financial statements. However, we are allowed to elect fair value measurement of the hybrid financial instruments, on a case-by-case basis, rather than bifurcate the derivative. We believe that fair value measurement of the hybrid convertible promissory notes arising from our October 23, 2007, January 8, 2008, January 27, 2009 and March 30, 2009, July 15, 2010, January 21, 2011, March 17, 2011, July 15, 2011 and February 22, 2012 financing arrangements provide a more meaningful presentation of that financial instrument.
 
(j)       Revenue Recognition:

The Company recognizes revenue in accordance with the FASB Accounting Standards Codification. Revenue is recognized when there is persuasive evidence of an arrangement, delivery has occurred or services have been rendered, the sales price is determinable, and collectability is reasonably assured.  Revenues are recognized pursuant to formal revenue arrangements with the Company’s customers, at contracted prices, when the Company’s product is delivered to their premises, and collectability is reasonably assured. The Company extends merchantability warranties to its customers on its products but otherwise does not afford its customers with rights of return. Warranty costs have been insignificant to date. However, the Company has just entered into a sales agreement with Lone Star Distribution whereby unsold product is subject to return provisions.  In determining revenue recognition for products shipped to this customer, the Company follows the guidance in ASC 605, “Revenue Recognition” (“ASC 605”).  Certain of the products shipped are under a “pay on scan” model, and revenue is deferred by the Company until such time as the customer sells through such products to the end consumer.  The amount of deferred revenue relating to pay on scan products reflected in the accompanying balance sheet as of March 31, 2012 and 2011 amounted to $7,661 and $18,935, respectively.
 
The Company’s revenue arrangements often provide for industry-standard slotting fees where the Company makes cash payments to the respective customer to obtain rights to place the Company’s products on their retail shelves for a stipulated period of time. We did not record slotting fees for the years ended March 31, 2012 and 2011, respectively. The Company also engages in other promotional discount programs in order to enhance its sales activities. The Company believes its participation in these arrangements is essential to ensuring continued volume and revenue growth in the competitive marketplace. These payments, discounts and allowances are recorded as reductions to the Company’s reported revenue and are immaterial for the year ended March 31, 2012 and 2011.
 
Shipping and Handling Costs:

Shipping and handling costs incurred to deliver products to our customers are included as a component of cost of sales.  These costs amounted to $38,300 and $9,346 for the year ended March 31, 2012 and 2011, respectively.

(k)      Income Taxes:
 
We utilize the liability method of accounting for income taxes.  Under the liability method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities and are measured using enacted tax rates and laws that will be in effect, when the differences are expected to reverse.  An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized.  We have recorded a 100% valuation allowance against net deferred tax assets due to uncertainty of their realization. The Company's open tax years are from 2008 through 2011.
 
 
F-10

 

Note 3 - 
Significant Accounting Policies (continued):

(k)       Income Taxes (continued):

There was no impact on our consolidated financial position, results of operations or cash flows for the year ended March 31, 2012 and 2011 and for the periods then ended, and we did not have any unrecognized tax benefits at March 31, 2012 and March 31, 2011.  Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.  For the year ended March 31, 2012 and 2011, we had no accrued interest or penalties related to income taxes. We currently have no federal or state tax examinations in progress.

(l)       Loss Per Common Share:

Our basic income/(loss) per common share is computed by dividing income/(loss) applicable to common stockholders by the weighted average number of common shares outstanding during the reporting period. Diluted income/(loss) per common share is computed similar to basic income/(loss) per common share except that diluted income/(loss) per common share includes dilutive common stock equivalents, using the treasury stock method, and assumes that the convertible debt instruments were converted into common stock upon issuance, if dilutive. For the year ended March 31, 2012 and 2011, respectively, potential common shares arising from the our stock warrants, stock options and convertible debt and accrued interest payable amounted to 594,096,790 shares for 2012 and 425,538,843 shares for 2011 and were not included in the computation of diluted loss per share because their effect was anti-dilutive.

(m)     Recent Accounting Pronouncements Affecting the Company:

In December 2011, the Financial Accounting Standards Board issued an Accounting Standards Update (“ASU”) that provides amendments for disclosures about offsetting assets and liabilities.  The amendments require an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. Entities are required to disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. This scope would include derivatives, sale and repurchase agreements and reverse sale and repurchase agreements, and securities borrowing and securities lending arrangements.  The amendments are effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. Disclosures required by the amendments should be provided retrospectively for all comparative periods presented. For the Company, the amendment is effective for fiscal year 2014. The Company is currently evaluating the impact these amendments may have on its disclosures.
 
In June 2011, the Financial Accounting Standards Board issued an ASU that provides amendments on the presentation of comprehensive income. The amendments require that all nonowner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In the two-statement approach, the first statement should present total net income and its components followed consecutively by a second statement that should present total other comprehensive income, the components of other comprehensive income and the total of comprehensive income. The amendments do not change the items that must be reported in other comprehensive income or when an item of other comprehensive income must be reclassified to net income. The amendments do not change the option for an entity to present components of other comprehensive income either net of related tax effects or before related tax effects, with one amount shown for the aggregate income tax expense or benefit related to the total of other comprehensive income items. In both cases, the tax effect for each component must be disclosed in the notes to the financial statements or presented in the statement in which other comprehensive income is presented. The amendments do not affect how earnings per share is calculated or presented. The amendments are effective for fiscal years and interim periods within those years, beginning after December 15, 2011 and should be applied retrospectively. For the Company, the amendment is effective for fiscal 2013. The effect of adoption will have minimum impact on the Company as the Company’s current presentation of comprehensive income follows the two-statement approach.
 
 
F-11

 
 
Note 4 - 
Fixed Assets:

The Company’s fixed assets are comprised of the following as of March 31, 2012 and 2011:
 
     
2012
   
2011
 
               
Equipment
    $ 19,669     $ 40,330  
Furniture and fixtures
    12,837       12,837  
Leasehold improvements
    3,954       3,954  
Vehicle
      13,481       -  
Purchased software
    827       1,022  
        50,768       58,143  
Less: accumulated depreciation
    (26,115 )     (30,213 )
        Total Fixed Assets   $ 24,653     $ 27,930  

Depreciation expense aggregated $4,934 and $8,571 for the year ended March 31, 2012 and 2011, respectively. We changed to a new telephone system and wrote off the old telephone system for gross assets of $23,377 less accumulated depreciation of $9,032 for a net loss of $14,345 due to abandonment.

Note 5 - 
Accrued Liabilities:
 
Accrued liabilities consist of the following as of March 31, 2012 and 2011:
 
   
2012
   
2011
 
             
Accrued payroll and related taxes
  $ 2,111,853     $ 1,989,785  
Accrued marketing program costs
    580,000       580,000  
Accrued professional fees
    70,000       67,500  
Accrued interest
    1,037,044       596,243  
Accrued board of directors' fees
    134,792       98,792  
Other expenses
    232,111       164,895  
Total Accrued Liabilities
  $ 4,165,800     $ 3,497,215  

 
F-12

 
 
Note 6 – 
Convertible Notes Payable:

Convertible debt carrying values consist of the following:
 
Original    
Fair Value Amounts
 
Issued
   
March 31,
   
March 31,
 
Face Value
   
2012
   
2011
 
 $          312,000
Convertible Note Financing, due March 31, 2014 (a)
  $ 31,201     $ 117,166  
 $          600,000
Convertible Note Financing, due March 31, 2014 (b)
    -       471,064  
 $          500,000
Convertible Note Financing, due March 31, 2014 (b)
    569,774       1,016,841  
 $          243,333
Convertible Note Financing, due March 31, 2014 (c)
    292,000       292,000  
 $            60,833
Convertible Note Financing, due March 31, 2014 (d)
    60,833       60,833  
 $            20,000
Convertible Note Financing, due March 31, 2014 (c)
    20,000       20,000  
 $          120,000
Convertible Note Financing, due March 31, 2014 (e)
    74,932       250,609  
 $              5,000
Convertible Note Financing, due March 31, 2014 (e)
    11,964       12,664  
 $              5,000
Convertible Note Financing, due March 31, 2014 (e)
    -       10,442  
 $            60,000
Convertible Note Financing, due March 31, 2014 (e)
    92,394       124,787  
 $            70,835
Convertible Note Financing, due March 31, 2014 (e)
    109,689       147,931  
 $          507,500
Convertible Note Financing, due March 31, 2014 (f)
    529,393       806,117  
 $          200,000
Convertible Note Financing, due March 31, 2014 (e)
    79,372       210,155  
 $          161,111
Convertible Note Financing, due March 31, 2014 (e)
    72,736       356,974  
 $            27,778
Convertible Note Financing, due March 31, 2014 (e)
    23,894       46,251  
 $          111,112
Convertible Note Financing, due March 31, 2014 (g)
    229,636       204,980  
 $            50,000
Convertible Note Financing, due March 31, 2014 (e)
    26,122       195,592  
 $            55,000
Convertible Note Financing, due March 31, 2014 (e)
    322,408       238,331  
 $          137,500
Convertible Note Financing, due March 31, 2014 (e)
    404,494       595,829  
 $            55,000
Convertible Note Financing, due March 31, 2014 (e)
    322,408       238,331  
 $          100,000
Convertible Note Financing, due March 31, 2014 (h)
    38,829       134,638  
 $          900,000
Convertible Note Financing, due July 15, 2012 (i)
    568,135       741,019  
 $          400,000
Convertible Note Financing, due July 15, 2012 (j)
    415,335       670,891  
 $          600,000
Convertible Note Financing, due September 17, 2012 (k)
    722,663       999,846  
 $          221,937
Convertible Note Financing, due September 17, 2012 (l)
    132,508       -  
 $          500,000
Convertible Note Financing, due January 15, 2013 (m)
    828,664       -  
 $            59,359
Convertible Note Financing, due May 5, 2012 (n)
    59,359       -  
 $       1,000,000
Convertible Note Financing due  March 31, 2014 (o)
    1,733,696       -  
 $          172,211
Convertible Note Fiancing due March 31, 2014 (p)
    300,962       -  
 
Total convertible notes payable
  $ 8,073,401     $ 7,963,291  
 
(a)
 $312,000 convertible notes payable
 
On January 8, 2008, we executed secured convertible notes in the aggregate of $520,000 with three lenders, all unrelated entities. We received a net amount of $430,000 with the $90,000 discount being treated as interest.  The loans became payable on May 7, 2008, or we had the option of compelling the holder to convert all, or a portion of the outstanding principal and accrued interest into Company common stock based on defined criteria.  On February 13, 2008, we repaid $260,000 of these loans.  To date, total conversions of $293,148 in principal face value have been converted into shares of common stock.
 
 
F-13

 
Note 6 – 
Convertible Notes Payable (continued):

(a)
 $312,000 convertible notes payable (continued)
 
We have entered into the following Modification and Waiver Agreements related to this financing:

Date
 
Terms
 
Consideration
June 2008
 
Extend maturity to July 15, 2008
 
9,750 shares of common stock
September 2008
 
Extend maturity to sooner of January 1, 2009 or closing of another funding
 
Increase principal by $52,000
January 2009
 
Extend maturity date to July 1, 2009 and add a conversion option of $0.05
 
140,000 shares of restricted stock
January 2010
 
Extend maturity date to June 30, 2010
 
Convertible notes (See Note 6(h)
July 2010    Extend maturity date to March 31, 2011    Change in conversion price to $.035
March 2011                                            Extend maturity date to March 31, 2012                                                                                     Change in conversion price to $.02
March 2012                                            Extend maturity date to March 31, 2014                                                                                      New convertible notes (See Note 6 (p)
                                                                                                                            
The addition of a conversion option and the issuance of restricted stock in January 2009 resulted in an extinguishment loss of $56,000 under the FASB Accounting Standards Codification.

The January 2010 modification resulted in an extinguishment loss of $72,441. On July 14, 2010, we extended the due date to March 31, 2011 as part of a subscription agreement for a convertible debt financing in the principal gross amount of $900,000.  On March 17, 2011, we extended the due date to March 31, 2012 as part of a subscription agreement for a convertible debt financing in the principal gross amount of $600,000. The conversion price of these notes shall be equal to eighty (80%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal market for the twenty trading days preceding a conversion date but in no event greater than $.02, subject to further reduction as described in the notes.  On March 31, 2012, we extended the due date to March 31, 2014 by issuing new convertible notes payable for 10% of the outstanding March 31, 2012 principal face value amount (see Note 6 (p)).

We chose to value the entire hybrid instrument at fair value. We estimate the fair value of the hybrid contract as a common stock equivalent, enhanced by the forward elements (coupon, puts, and calls), because that technique embodies all of the assumptions (including credit risk, interest risk, stock price volatility and conversion behavior estimates) that are necessary to fair value complex, hybrid contracts.
 
(b)
$1,200,000 convertible notes payable
 
On October 23, 2007, we entered into a Subscription agreement with a group of accredited investors.  Under this agreement, we agreed to sell up to $1,200,000 of our securities consisting of 10% convertible notes, shares of common stock and Class A and Class B common stock purchase warrants.  The original subscription agreement required that we have an effective registration statement in order for the second closing date to occur. On February 15, 2008, we obtained a Waiver of Certain Conditions that allowed us to waive the requirement for the Registration Statement to become effective prior to the occurrence of the Second closing.
 
The indexed shares and closing dates for the three tranches of the $1,200,000 financing are as follows:
 
         
Shares
             
         
Indexed
   
Series A
   
Series B
 
Financing  
Closing date
 
to Note
   
Warrants
   
Warrants
 
$
 600,000 Face Value Convertible Note Financing
 
October 23, 2007
 
Converted
      958,805       140,910  
$
 $500,000 Face Value Convertible Note Financing
 
February 15, 2008
    117,895,560       757,304       75,758  
$
 $100,000 Face Value Convertible Note Financing
 
June 26, 2008
 
Converted
      151,502       15,152  
 
     Total
        117,895,560       1,867,611       231,820  
 
 
F-14

 
 
Note 6 – 
Convertible Notes Payable (continued):

(b)
$1,200,000 convertible notes payable (continued)

The convertible promissory notes were initially convertible into common shares based on a fixed conversion price of $6.60, and are subject to full-ratchet anti-dilution protection if we sell shares or share-indexed financing instruments at less than those prices. The conversion features were not afforded the exemption as conventional convertible, and the notes require liability classification under the FASB Accounting Standards Codification. We chose to value the entire hybrid instruments at fair value. We estimate the fair value of the hybrid contract as a common stock equivalent, enhanced by the forward elements (coupon, puts, and calls), because that technique embodies all of the assumptions (including credit risk, interest risk, stock price volatility and conversion behavior estimates) that are necessary to fair value complex, hybrid contracts. The warrants issued in this financing arrangement did not meet the conditions for equity classification and are also required to be carried as a derivative liability, at fair value.  We estimate the fair value of the warrants on the inception dates, and subsequently, using the Black-Scholes valuation technique, adjusted for dilution, because that technique embodies all of the assumptions (including volatility, expected terms, dilution and risk free rates) that are necessary to fair value freestanding warrants.  See also Note 9 –Derivative Liabilities.

The warrants and the convertible notes contain full-ratchet protection so the exercise price of the warrants and the conversion price of the notes were reduced to $3.30 when the Company issued additional convertible instruments with this conversion rate on December 18, 2008.  On January 27, 2009, we entered into a modification of the agreement which reduced the maturity date from October 23, 2009 to July 1, 2009 and changed from a periodic debt payment schedule to full payment of principal and interest on July 1, 2009.  In exchange for this modification, we issued 62,500 shares of restricted stock, and we agreed to reduce the conversion price of the notes and related warrants to $1.00.  This modification resulted in a loss on extinguishment of $379,183. The conversion price was reduced again to $.494 when the Company issued additional convertible instruments with a lower conversion rate in November 2009.  On January 10, 2010, we entered into a modification of the agreement with certain note holders, which extended the maturity date to June 30, 2010.  In exchange for this modification, we issued convertible promissory notes in the amount of $100,000 (See Note 6(h)).  Additionally, we agreed to (i) issue additional warrants to purchase 1,635,792 shares of common stock and (ii) reduce the price of certain warrants to $0.20.  This modification resulted in an extinguishment loss of $395,249.  On January 28, 2010, certain warrants were re-priced to $0.16, and the expiration dates were extended to July 15, 2015.  On February 11, 2010, the warrants which were re-priced to $0.20 on January 10, 2010 were re-priced to $0.16, and the expiration dates were extended to July 15, 2015.

On July 14, 2010, we extended the due date to March 31, 2011 as part of a subscription agreement for a convertible debt financing in the principal gross amount of $900,000.  The conversion price for the convertible debt was changed to $.035.  In addition, $221,608 of the outstanding balance plus $27,460 in accrued interest payable was assigned to new debt holders. On March 17, 2011, we extended the due date to March 31, 2012 as part of a subscription agreement for a convertible debt financing in the principal gross amount of $600,000.  The conversion price for the convertible debt was changed to $0.02 as well as the exercise price of all associated warrants to $.02. The conversion price of these notes shall be equal to eighty (80%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal market for the twenty trading days preceding a conversion date but in no event greater than $.02, subject to further reduction as described in the notes.  On March 31, 2012, we extended the due date to March 31, 2014 by issuing new convertible notes payable for 10% of the outstanding March 31, 2012 principal face value amount (see Note 6 (p)). To date, a total of $543,850 of the principal balance and $177,981 in accrued interest have been converted into shares of common stock, and a total of $301,608 of the principal balance was sold to other accredited investors, resulting in the outstanding principal amount of $354,542 at March 31, 2012.
 
Information and significant assumptions embodied in our valuations (including ranges for certain assumptions during the subject periods that instruments were outstanding) as of March 31, 2012 and March 31, 2011 for this financing are illustrated in the following tables:
 
 
F-15

 

Note6– 
Convertible Notes Payable (continued):

(b)
$1,200,000 convertible notes payable (continued)
 
The original principal amounts of $600,000 from October, 2007 and $100,000 from June, 2008 out of the original total of $1,200,000 financing have been fully converted into shares of common stock and/or sold to other accredited investors.
 
$500,000 Convertible Promissory Note Financing
 
 
         
 
       
  (Initial Closing)
 
Hybrid Note
   
Warrants
 
     
March
       March      
March
     
March
 
      31, 2012       31, 2011       31, 2012       31, 2011  
Estimated fair value of underlying common share
  $ 0.003     $ 0.020     $ 0.0048     $ 0.0305  
Conversion or strike price
  $ 0.003     $ 0.0154     $ 0.02     $ 0.02  
Volatility (based upon Peer Group)
    -       -       120.00 %     130.00 %
Equivalent term (years)
    -       -       3.29       4.29  
Risk-free rate
    -       -       0.62 %     1.94 %
Credit-risk adjusted yield
    7.19 %     7.30 %     -       -  
Dividends
    -       -       -       -  
 
(c)
$243,333 convertible notes payable
 
On September 29, 2008, for cash proceeds for $192,500, net of issuance costs of $7,500, we issued $243,333 face value convertible notes, due March 29, 2009, plus warrants to purchase (i) 28,384 shares of our common stock at an exercise price of $10.00 and (ii) additional warrants to purchase 28,384 shares of our common stock at an exercise price of $15.00, representing an aggregate 56,768 shares.  The notes are convertible, only at the Company’s option, into Common Stock at $3.30 and are subject to full-ratchet anti-dilution protection if we sell shares or share-indexed financing instruments at less than that price. The notice of conversion must be given to the Holder on the first day following the twenty consecutive trading days during which the stock price is greater than $100.00 per share each trading day and the daily trading volume is greater than 100,000 shares.  The Holder of the note does not have an option to convert the instrument. The note is secured by a security interest in all the tangible and intangible assets of the Company. According to the original terms of the note, fifty percent of the interest was due on December 28, 2008 and fifty percent due and payable on March 29, 2009; however, the Company modified the agreement on January 27, 2009 to require full payment of principal and interest on July 1, 2009 in exchange for a reduction of the conversion price of the note and exercise price of the warrants to $1.00.  On January 27, 2009, the warrants were redeemed in exchange for a convertible note in the amount of $70,834. The exchange resulted in an extinguishment loss of $82,484.  See Note 6(e).  On January 10, 2010, we entered into a modification of the agreement with certain note holders, which extended the maturity date to June 30, 2010.  In exchange for this modification, we issued convertible promissory notes in the amount of $100,000 (See Note (h).  This modification resulted in an extinguishment loss of $113,768. On July 14, 2010, we extended the due date to March 31, 2011 as part of the subscription agreement for a convertible debt financing in the principal gross amount of $900,000. On March 17, 2011, we extended the due date to March 31, 2012 as part of a subscription agreement for a convertible debt financing in the principal gross amount of $600,000.  The conversion price for the convertible debt was changed to $0.02 as well as the exercise price of all associated warrants to $.02. The conversion price of these notes shall be equal to eighty (80%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal market for the twenty trading days preceding a conversion date but in no event greater than $.02, subject to further reduction as described in the notes.  On March 31, 2012, we extended the due date to March 31, 2014 by issuing new convertible notes payable for 10% of the outstanding March 31, 2012 principal face value amount (see Note 6 (p)).The original face principal amount of $243,333 is still outstanding as no conversions have occurred.
 
In originally evaluating the financing transaction, we concluded that the conversion feature was not clearly and closely related to the debt instrument since the risks are those of an equity security; however, we determined that the conversion feature met the paragraph 11(a) exemption and did not require liability classification under the FASB Accounting Standards Codification.  Since the embedded conversion feature did not require liability classification, we were required to consider if the contract embodied a beneficial conversion feature (“BCF”).  The conversion option is contingent on a future stock price so under the guidance of The FASB Accounting Standards Codification, the beneficial conversion feature was calculated at inception but will not be recognized until the contingency is resolved.  The aggregate BCF at its intrinsic value amounted to $192,739. This amount gives effect to (i)
 
 
F-16

 
 
Note 6 – 
Convertible Notes Payable (continued):

(c)
$243,333 convertible notes payable (continued)
 
the trading market price on the contract date and (ii) the effective conversion price after allocation of proceeds to the warrants. Notwithstanding, BCF was limited to the value ascribed to the note (using the relative fair value approach).
 
We also evaluated the warrants to determine if they required liability or equity accounting. The warrants issued in conjunction with the financing are redeemable for cash upon the occurrence of acquisition, merger or sale of substantially all assets of the Company in an all cash transaction; therefore, the FASB Accounting Standards Codification requires that they be recorded as derivative liabilities on our balance sheet and marked to fair value each reporting period.

The warrants and the convertible note contain full-ratchet protection so the exercise price of the warrants and the conversion price of the notes were reduced to $3.30 when the Company issued additional convertible instruments with a lower conversion rate on December 18, 2008.  The conversion price was reduced again to $.494 when the Company issued additional convertible instruments with a lower conversion rate in November 2009. The conversion price and exercise price were reduced again to $.035 as part of the July, 2010 financing of $900,000 and again to $.02 as part of the March, 2011 financing of $600,000.

In connection with the note, we issued a note payable in the amount of $20,000 under the same terms as the $243,333 note as consideration for finders’ fees.  The finders’ fee note did not include warrants.

(d)
$60,833 convertible notes payable
 
On December 18, 2008, we entered into a financing arrangement that provided for the issuance of $60,833 face value convertible note for a purchase price of $50,000, due March 29, 2009, plus warrants to purchase (i) 7,084 shares of our common stock at an exercise price of $10.00 and (ii) additional warrants to purchase 7,084 shares of our common stock at an exercise price of $15.00, representing an aggregate 14,168 shares.  The note was initially convertible into common shares, only at the Company’s option, a conversion price of $3.30 and is subject to full-ratchet anti-dilution protection if we sell shares or share-indexed financing instruments at less than that price. The notice of conversion must be given to the Holder on the first day following the twenty consecutive trading days during which the stock price is greater than $100.00 per share each trading day and the daily trading volume is greater than 100,000 shares.  The Holder of the note does not have an option to convert the instrument. The note is secured by a security interest in all the tangible and intangible assets of the Company.  According to the original terms of the note, fifty percent of the note was due on December 28, 2008 and fifty percent due and payable on March 29, 2009 and if the note was not paid by its maturity date; a default rate of 15% applied. The note was considered in default as of December 28, 2008 due to non-payment of the required principle payment, therefore, it is recorded at face value and default interest of 15% is being accrued. We modified the note agreement on January 27, 2009 to require full payment of principal and interest on July 1, 2009 in exchange for a reduction of the conversion price of the note and exercise price of the warrants to $1.00.  On January 27, 2009, the warrants were redeemed in exchange for a convertible note in the amount of $70,834. The exchange resulted in an extinguishment loss of $82,484. See Note 6(e).   The conversion price was reduced again to $.494 when the Company issued additional convertible instruments with a lower conversion rate in November 2009.  On January 10, 2010, we entered into a modification of the agreement with certain note holders, which extended the maturity date to June 30, 2010.  In exchange for this modification, we issued convertible promissory notes in the amount of $100,000 (See Note 6(h)).  This modification resulted in an extinguishment loss of $26,282. On July 14, 2010, we extended the due date to March 31, 2011 as part of a subscription agreement for a convertible debt financing in the principal gross amount of $900,000 in which the conversion price for the notes payable and exercise price of the warrants were reduced to $0.035.  Later on March 17, 2011, we extended the due date to March 31, 2012 as part of a subscription agreement for a convertible debt financing in the principal gross amount of $600,000 which the conversion price for the notes payable and exercise price for the warrants was reduced to $0.02. The conversion price of these notes shall be equal to eighty (80%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal market for the twenty trading days preceding a conversion date but in no event greater than $.02, subject to further reduction as described in the notes.  On March 31, 2012, we extended the due date to March 31, 2014 by issuing new convertible notes payable for 10% of the outstanding March 31, 2012 principal face value amount (see Note 6 (p)). The original principal amount of $60,833 is still outstanding as there have been no conversions.
 
In originally evaluating the financing transaction, we concluded that the conversion feature was not clearly and closely related to the debt instrument; however, it did meet the paragraph 11(a) exemption and did not require liability classification. We considered if the contract embodied a beneficial conversion feature (“BCF”) however there was no beneficial conversion feature present, since the effective conversion price was greater than the market value of the stock.
 
 
F-17

 
 
 
Note 6 – 
Convertible Notes Payable (continued):

(d)
$60,833 convertible notes payable (continued)

We also evaluated the warrants to determine if they required liability or equity accounting. The warrants issued in conjunction with the financing are redeemable for cash upon the occurrence of acquisition, merger or sale of substantially all assets of the Company in an all cash transaction; therefore, the FASB Accounting Standards Codification requires that they be recorded as derivative liabilities on our balance sheet and marked to fair value each reporting period.

(e)
$947,224 convertible notes payable
 
On January 27, 2009 , March 30, 2009, and July 15, 2009,  we entered into Subscription agreements with a group of accredited investors that provided for the sale of an aggregate $892,224 face value secured convertible notes and warrants to purchase an aggregate 1,183,473 shares of our common stock.  The notes and warrants are based on a fixed conversion price of $1.00 and are subject to full-ratchet anti-dilution protection if we sell shares or share-indexed financing instruments at less than those prices.  The conversion price was reduced to $.494 when the Company issued additional convertible instruments with a lower conversion rate in November 2009.  On January 10, 2010, we entered into a modification of the agreement with certain note holders, which extended the maturity date to June 30, 2010.  In exchange for this modification, we issued convertible promissory notes in the amount of $50,000.  Additionally, we agreed to reduce the price of certain warrants to $0.20.  This modification resulted in an extinguishment loss of $309,740.   On January 28, 2010, certain warrants were re-priced to $0.16, and the expiration dates were extended to July 15, 2015.  On February 11, 2010, the warrants which were re-priced to $0.20 on January 10, 2010 were re-priced to $0.16, and the expiration dates were extended to July 15, 2015.  On May 13, 2010, we executed an allonge to the March, 2009 secured convertible notes payable for $55,000 as well as issued 114,583 warrants at an exercise price of $0.16.  On July 14, 2010, we extended the due date to March 31, 2011 as part of a subscription agreement for a convertible debt financing in the principal gross amount of $900,000.  As part of this extension, the conversion price of the convertible notes payable and the exercise price of the applicable warrants were changed to $.035.   On March 17, 2011, we extended the due date to March 31, 2012 as part of a subscription agreement for a convertible debt financing in the principal gross amount of $600,000.  As part of this extension, the conversion price of the convertible notes payable and the exercise price of the applicable warrants were changed to $.02. The conversion price of these notes shall be equal to eighty (80%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal market for the twenty trading days preceding a conversion date but in no event greater than $.02, subject to further reduction as described in the notes.  On March 31, 2012, we extended the due date to March 31, 2014 by issuing new convertible notes payable for 10% of the outstanding March 31, 2012 principal face value amount (see Note 6 (p)).  To date, $336,535 of the principal balance and $85,266 of accrued interest were converted into shares of common stock, resulting in the outstanding principal balance of $610,689.
 
The following table provides the details of each of the financings:

   
Outstanding
         
Shares
   
Shares
 
   
Outstanding
               
Original
 
Face Balance at
         
indexed
   
indexed
 
Face Value
 
3/31/2012
 
Closing date
 
 Maturity Date
 
to note
   
to warrants
 
 $        130,000
  $ 65,000  
January 27, 2009
 
March 31, 2014
    21,666,667       120,000  
             70,835
    70,835  
January 27, 2009
 
March 31, 2014
    23,611,333       -  
             60,000
    60,000  
February 17, 2009
 
March 31, 2014
    20,000,000       60,000  
           200,000
    100,000  
March 30, 2009
 
March 31, 2014
    33,333,333       416,667  
           161,111
    80,556  
July 15, 2009
 
March 31, 2014
    26,852,000       335,649  
             27,778
    27,778  
October 1, 2009
 
March 31, 2014
    9,259,333       -  
             50,000
    25,000  
January 28, 2010
 
March 31, 2014
    8,333,333       104,167  
             55,000
    55,000  
February 19, 2010
 
March 31, 2014
    18,333,333       104,167  
           137,500
    71,520  
March 26, 2010
 
March 31, 2014
    23,839,940       286,459  
             55,000
    55,000  
May 13, 2010
 
March 31, 2014
    18,333,333       114,584  
 $        947,224
  $ 610,689             203,562,605       1,541,693  
 
 
F-18

 
 
Note 6 – 
Convertible Notes Payable (continued):

(e)
$947,224 convertible notes payable (continued)

(1)   
The $130,000 convertible notes payable includes two $5,000 face value convertible notes issued as payment for finder’s fees.
(2)   
The $70,835 convertible notes payable was issued in exchange for the redemption of 56,767 warrants shares issued in connection with the September 29, 2008 convertible note financing and 14,167 warrant shares issued in connection with the December 18, 2008 convertible note financing.

We received the following proceeds from the financing transactions:
 
           
Debt
       
           
Discount &
   
Net
 
     
Gross Proceeds
   
Finance Costs
   
Proceeds
 
                     
$
130,000 Face Value Convertible Note Financing
  $ 120,000     $ 23,750     $ 96,250  
$
60,000 Face Value Convertible Note Financing
    60,000       10,000       50,000  
$
200,000 Face Value Convertible Note Financing
    200,000       41,900       158,100  
$
161,111 Face Value Convertible Note Financing
    161,111       16,111       145,000  
$
27,778 Face Value Convertible Note Financing
    27,778       -       27,778  
$
50,000 Face Value Convertible Note Financing
    50,000       10,000       40,000  
$
55,000 Face Value Convertible Note Financing
    55,000       -       55,000  
$
137,500 Face Value Convertible Note Financing
    137,500       13,100       124,400  
$
55,000 Face Value Convertible Note Financing
    55,000       5,000       50,000  
 
Total
  $ 866,389     $ 119,861     $ 746,528  

The holder has the option to redeem the convertible notes for cash in the event of defaults and certain other contingent events, including events related to the common stock into which the instrument was convertible, registration and listing (and maintenance thereof) of our common stock and filing of reports with the Securities and Exchange Commission (the “Default Put”). The conversion feature was not afforded the exemption as conventional convertible and the notes require liability classification under the FASB Accounting Standards Codification.  We chose to value the entire hybrid instrument at fair value. We estimate the fair value of the hybrid contract as a common stock equivalent, enhanced by the forward elements (coupon, puts, and calls), because that technique embodies all of the assumptions (including credit risk, interest risk, stock price volatility and conversion behavior estimates) that are necessary to fair value complex, hybrid contracts.
 
We also evaluated the warrants to determine if they required liability or equity accounting. The warrants issued in conjunction with the financing are redeemable for cash upon the occurrence of acquisition, merger or sale of substantially all assets of the Company in an all cash transaction; therefore, the FASB Accounting Standards Codification requires that they be recorded as derivative liabilities on our balance sheet and marked to fair value each reporting period.

Information and significant assumptions embodied in our valuations (including ranges for certain assumptions during the subject periods that instruments were outstanding) as of March 31, 2012 and March 31, 2011 for this financing are illustrated in the following tables:
 
 
F-19

 
 
Note 6 – 
Convertible Notes Payable (continued):

(e)
$947,224 convertible notes payable (continued)
 
$130,000 Convertible Promissory Note Financing
 
 
         
 
       
  (Initial Closing)
 
Hybrid Note
   
Warrants
 
   
March
   
March
   
March
   
March
 
     31, 2012      31, 2011      31, 2012      31, 2011  
Estimated fair value of underlying common share
  $ 0.0012     $ 0.02     $ 0.003     $ 0.02  
Conversion or strike price
  $ 0.003     $ 0.0154     $ 0.02     $ 0.02  
Volatility (based upon Peer Group)
    -       -       120.00 %     130.00 %
Equivalent term (years)
    -       -       3.29       4.29  
Risk-free rate
    -       -       0.62 %     1.938 %
Credit-risk adjusted yield
    7.37 %     7.3 %     -       -  
Dividends
    -       -       -       -  
 
$60,000 Convertible Promissory Note Financing
 
 
         
 
       
  (Initial Closing)
 
Hybrid Note
   
Warrants
 
   
March
   
March
   
March
   
March
 
     31, 2012      31, 2011      31, 2012      31, 2011  
Estimated fair value of underlying common share
  $ 0.0012     $ 0.02     $ 0.003     $ 0.02  
Conversion or strike price
  $ 0.003     $ 0.0154     $ 0.02     $ 0.02  
Volatility (based upon Peer Group)
    -       -       120.00 %     130.00 %
Equivalent term (years)
    -       -       3.29       4.29  
Risk-free rate
    -       -       0.62 %     1.938 %
Credit-risk adjusted yield
    7.37 %     7.3 %     -       -  
Dividends
    -       -       -       -  
 
$200,000 Convertible Promissory Note Financing
 
 
         
 
       
  (Initial Closing)
 
Hybrid Note
   
Warrants
 
   
March
   
March
   
March
   
March
 
     31, 2012      31, 2011      31, 2012      31, 2011  
Estimated fair value of underlying common share
  $ 0.0012     $ 0.02     $ 0.003     $ 0.02  
Conversion or strike price
  $ 0.003     $ 0.0154     $ 0.02     $ 0.02  
Volatility (based upon Peer Group)
    -       -       120.00 %     130.00 %
Equivalent term (years)
    -       -       3.29       4.29  
Risk-free rate
    -       -       0.62 %     1.938 %
Credit-risk adjusted yield
    7.37 %     7.3 %     -       -  
Dividends
    -       -       -       -  
 
 
F-20

 
 
Note 6 – 
Convertible Notes Payable (continued):

(e)
$947,224 convertible notes payable (continued)
 
$161,111 Convertible Promissory Note Financing
 
 
         
 
       
  (Initial Closing)
 
Hybrid Note
   
Warrants
 
   
March
   
March
   
March
   
March
 
     31, 2012      31, 2011      31, 2012      31, 2011  
Estimated fair value of underlying common share
  $ 0.0012     $ 0.02     $ 0.003     $ 0.02  
Conversion or strike price
  $ 0.003     $ 0.0154     $ 0.02     $ 0.02  
Volatility (based upon Peer Group)
    -       -       120.00 %     130.00 %
Equivalent term (years)
    -       -       3.29       4.29  
Risk-free rate
    -       -       0.62 %     1.938 %
Credit-risk adjusted yield
    7.37 %     7.3 %     -       -  
Dividends
    -       -       -       -  

$27,778 Convertible Promissory Note Financing
 
 
         
 
       
  (Initial Closing)
 
Hybrid Note
   
Warrants
 
   
March
   
March
   
March
   
March
 
     31, 2012      31, 2011      31, 2012      31, 2011  
Estimated fair value of underlying common share
  $ 0.0012     $ 0.02     $ 0.003     $ 0.02  
Conversion or strike price
  $ 0.003     $ 0.0154     $ 0.02     $ 0.02  
Volatility (based upon Peer Group)
    -       -       120.00 %     130.00 %
Equivalent term (years)
    -       -       3.29       4.29  
Risk-free rate
    -       -       0.62 %     1.938 %
Credit-risk adjusted yield
    7.37 %     7.3 %     -       -  
Dividends
    -       -       -       -  
 
$50,000, $55,000, $137,500 and $55,000 Convertible
 
 
         
 
       
   Promissory Note Financings
 
Hybrid Note
   
Warrants
 
   
March
   
March
   
March
   
March
 
     31, 2012      31, 2011      31, 2012      31, 2011  
Estimated fair value of underlying common share
  $ 0.0012     $ 0.02     $ 0.00     $ 0.02  
Conversion or strike price
  $ 0.003     $ 0.0154     $ 0.02     $ 0.02  
Volatility (based upon Peer Group)
    -       -       120.00 %     130.00 %
Equivalent term (years)
    -       -       3.29       4.29  
Risk-free rate
    -       -       0.62 %     1.938 %
Credit-risk adjusted yield
    7.37 %     7.3 %     -       -  
Dividends
    -       -       -       -  
 
(f)
$507,500 convertible note payble:
 
On August 8, 2008, the Company executed a secured convertible promissory note in the aggregate amount of $507,500 with one lender, an unrelated entity.  The note was payable on August 7, 2009 with interest on the outstanding principal to accrue at 10%.  This note was entered into pursuant to the terms of a Secured Promissory Note and Security Agreement, Asset Purchase Agreement and Registration Rights Agreement to purchase certain trademarks, notably “Slammers” and “Blenders”, from a company that previously acquired such trademarks through a foreclosure sale of certain assets of Bravo! Brands, Inc.  The holder
 
 
F-21

 
 
Note 6 – 
Convertible Notes Payable (continued):

(f)
$507,500 convertible notes payable
 
of this note payable had the right to convert all or any portion of the then aggregate outstanding principal amount together with interest at the fixed conversion price of $20.00.  In November 2009, the note was settled with the issuance of new notes of equal face value, which are convertible into shares of common stock at a conversion price equal to the lesser of $1.00 or 80% of the average of the three lowest closing bid prices for the Company’s common stock for the twenty trading days preceding the date of conversion. The notes are subject to full-ratchet anti-dilution protection if we sell shares or share-indexed financing instruments at less than those prices.  On January 10, 2009, we entered into a modification of the agreement with certain note holders, which extended the maturity date to June 30, 2010.  In exchange for this modification, we issued convertible promissory notes in the amount of $50,000.  Additionally, we agreed to reduce the price of certain warrants to $0.20.  This modification resulted in an extinguishment loss of $206,356.  On July 14, 2010, we extended the due date to March 31, 2011 as part of a subscription agreement for a convertible debt financing in the principal gross amount of $900,000 in which the conversion price for the notes payable was changed to $.035. In addition, $203,882 of the outstanding balance plus $46,327 in accrued interest payable were assigned to new debt holders.  On March 17, 2011, we extended the due date to March 31, 2012 as part of a subscription agreement for a convertible debt financing in the principal gross amount of $600,000 in which the conversion price for the notes payable was changed to $.02. The conversion price of these notes shall be equal to eighty (80%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal market for the twenty trading days preceding a conversion date but in no event greater than $.02, subject to further reduction as described in the notes.  On March 31, 2012, we extended the due date to March 31, 2014 by issuing new convertible notes payable for 10% of the outstanding March 31, 2012 principal face value amount (see Note 6 (p)).  After the sale of $253,750 to other accredited investors, the current outstanding balance at March 31, 2012 is $253,750.
 
The conversion feature was not afforded the exemption as conventional convertible and the notes require liability classification under the FASB Accounting Standards Codification. We chose to value the entire hybrid instruments at fair value. We estimate the fair value of the hybrid contract as a common stock equivalent, enhanced by the forward elements (coupon, puts, and calls), because that technique embodies all of the assumptions (including credit risk, interest risk, stock price volatility and conversion behavior estimates) that are necessary to fair value complex, hybrid contracts.
 
(g)
$111,112 convertible note payable

In November 2009, the Company issued a convertible note with a face value of $111,112 and 150,000 shares of common stock in exchange for marketable securities with a fair market value on the date of the transaction of $76,000.  The note is convertible into common stock at a fixed conversion price of $1.00 per share subject to full-ratchet anti-dilution protection if we sell shares or share-indexed financing instruments at less than those prices.  On January 10, 2009, we entered into a modification of the agreement with certain note holders, which extended the maturity date to June 30, 2010.  In exchange for this modification, we issued convertible promissory notes in the amount of $50,000.  Additionally, we agreed to reduce the price of certain warrants to $0.20.  This modification resulted in an extinguishment loss of $47,520.  On July 14, 2010, we extended the due date to March 31, 2011 as part of a subscription agreement for a convertible debt financing in the principal gross amount of $900,000 in which the conversion price of the notes payable and the exercise price of the applicable warrants were changed to $.035.  On March 17, 2011, we extended the due date to March 31, 2012 as part of a subscription agreement for a convertible debt financing in the principal gross amount of $600,000.  As part of this extension, the conversion price of the convertible notes payable and the exercise price of the applicable warrants were changed to $.02. The conversion price of these notes shall be equal to eighty (80%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal market for the twenty trading days preceding a conversion date but in no event greater than $.02, subject to further reduction as described in the notes.  On March 31, 2012, we extended the due date to March 31, 2014 by issuing new convertible notes payable for 10% of the outstanding March 31, 2012 principal face value amount (see Note 6 (p)). The full original amount of $111,112 is still outstanding.
 
We chose to value the entire hybrid instrument at fair value. We estimate the fair value of the hybrid contract as a common stock equivalent, enhanced by the forward elements (coupon, puts, and calls), because that technique embodies all of the assumptions (including credit risk, interest risk, stock price volatility and conversion behavior estimates) that are necessary to fair value complex, hybrid contracts.

(h)
$100,000 convertible notes payable

As consideration for the modification agreement we entered into with certain investors on January 10, 2010, we agreed to issue two convertible promissory notes in the aggregate amount of $100,000.  The notes are based on a fixed conversion price of $1.00 and are subject to full-ratchet anti-dilution protection if we sell shares or share-indexed financing instruments at less than those
 
 
F-22

 
 
Note 6 –  
Convertible Notes Payable (continued):

(h)
$100,000 convertible notes payable (continued)
 
prices. As part of the agreement from the July, 2010 financing for $900,000, the maturity date was extended to March 31, 2011, and the conversion price of the notes payable was changed to $.035.  As part of the agreement from the March, 2011 financing for $600,000, the maturity date was extended to March 31, 2012, and the conversion price of the notes payable was changed to $.02. The conversion price of these notes shall be equal to eighty (80%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal market for the twenty trading days preceding a conversion date but in no event greater than $.02, subject to further reduction as described in the notes.  On March 31, 2012, we extended the due date to March 31, 2014 by issuing new convertible notes payable for 10% of the outstanding March 31, 2012 principal face value amount (see Note 6 (p)).  To date, $50,000 of the principal balance and $13,450 of accrued interest were converted into shares of common stock, resulting in an outstanding balance at March 31, 2012 of $50,000.
 
The holder has the option to redeem the convertible notes for cash in the event of defaults and certain other contingent events, including events related to the common stock into which the instrument was convertible, registration and listing (and maintenance thereof) of our common stock and filing of reports with the Securities and Exchange Commission (the “Default Put”). The conversion feature was not afforded the exemption as conventional convertible and the notes require liability classification under the FASB Accounting Standards Codification.  We chose to value the entire hybrid instrument at fair value. We estimate the fair value of the hybrid contract as a common stock equivalent, enhanced by the forward elements (coupon, puts, and calls), because that technique embodies all of the assumptions (including credit risk, interest risk, stock price volatility and conversion behavior estimates) that are necessary to fair value complex, hybrid contracts.
 
Information and significant assumptions embodied in our valuations (including ranges for certain assumptions during the subject periods that instruments were outstanding) as of March 31, 2012 and March 31, 2011 for this financing is illustrated in the following table:

$100,000 Convertible Promissory Note Financing
 
Hybrid Note
 
     
March
     
March
 
      31, 2012       31, 2011  
Estimated fair value of underlying common share
  $ 0.003     $ 0.02  
Conversion or strike price
  $ 0.003     $ 0.0154  
Volatility (based upon Peer Group)
    -       -  
Equivalent term (years)
    -       -  
Risk-free rate
    -       -  
Credit-risk adjusted yield
    7.19 %     7.30 %
Dividends
    -       -  
 
(i) 
$900,000 convertible notes payable
 
On July 15, 2010, we entered into a Subscription Agreement with a group of accredited investors.  Under this agreement, we agreed to sell up to $900,000 of our securities consisting of 10% convertible notes with a maturity date of July 15, 2012 and 65,999,999 Class A stock purchase warrants at an exercise price of $.035 with an expiration date of July 14, 2015.
 
The conversion price for the convertible notes payable per share shall be equal to seventy-five percent (75%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal Market for the ten trading days preceding a conversion date but in no event greater than $.08. On February 22, 2012, we entered into a Fifth Amendment and Consent Agreement as part of the February, 2012 financing in which the above $.08 conversion price was changed to $.02 as well as the exercise price of the warrants was changed from $.035 to $.02. These notes payable and warrants are subject to full ratchet anti-dilution protection if we sell shares or share-indexed financing instruments at less than those prices.  The conversion features were not afforded the exemption as conventional convertible, and the notes require liability classification under the FASB Accounting Standards Codification.  We chose to value the entire hybrid instruments at fair value.  The warrants issued in this financing arrangement did not meet the conditions for equity classification and are also required to be carried as a derivative liability, at fair value.  We estimate the fair value of the warrants on the inception dates, and subsequently, using the Black-Sholes
 
 
F-23

 
 
Note 6– 
 Convertible Notes Payable (continued):

(i)
$900,000 convertible notes payable (continued)
 
Merton valuation technique, adjusted for dilution, because that technique embodies all of the assumptions (including volatility, expected terms, dilution and risk free rates) that are necessary to fair value freestanding warrants.  See also Note 8 – Derivative Liabilities. At inception, we allocated $156,000 as the valuation cost of the warrants (debt discount) against the gross proceeds of the $900,000 financing using the relative fair value method. We recorded a total debt discount of $171,600 (above $156,000 plus $15,600 for warrants issued to placement agent) in which we recorded $145,978 to capture the accretion of the debt discount from inception. To date, $75,000 was converted into shares of common stock, resulting in an outstanding balance of $825,000 at March 31, 2012.
 
Total financing costs paid from this financing amounted to $164,500 as well as a payment of $39,024 for other past due professional fees, resulting in a net amount of $696,476 to be paid to us at $150,000 per month until the total amount is paid in the following months.  As such, we reported a stock subscription amount of $246,476 for the period ended September 30, 2010.  That amount has since been paid from October through November, 2010.  In addition, we recorded $15,600 in non-cash deferred financing fees for the issuance of 6,000,000 warrants as a finder’s fee as part of the total issued 65,999,999 Class A warrants.  In addition, we paid other financing fees associated with this financing in the amount of $11,500, resulting in a total of $191,600.
 
As noted throughout Note 6, certain debts were assigned to new debt holders.  A total of $413,358 in convertible notes payable and $86,642 in accrued interest payable for a total of $500,000 was assigned to new debt holders as part of the July, 2010 financing.  Out of the total $500,000 balance, a total of $173,576 in these assigned notes payable were converted into common shares of stock from inception through the year ended March 31, 2011.These $500,000 assigned notes have the same conversion price terms as the $900,000 new notes payable.
 
Information and significant assumptions embodied in our valuations (including ranges for certain assumptions during the subject periods that instruments were outstanding) as of March 31, 2012 and March 31, 2011 for this financing is illustrated in the following table:
 
$900,000 Convertible Promissory Note Financing
 
 
         
 
       
  (Initial Closing)
 
Hybrid Note
   
Warrants
 
     
March
     
March
     
March
     
March
 
      31, 2012       31, 2011       31, 2012       31, 2011  
Estimated fair value of underlying common share
  $ 0.003     $ 0.02     $ 0.003     $ 0.02  
Conversion or strike price
  $ 0.00222     $ 0.0154     $ 0.02     $ 0.02  
Volatility (based upon Peer Group)
    -       -       120.00 %     115.00 %
Equivalent term (years)
    -       -       3.29       4.54  
Risk-free rate
    -       -       0.62 %     1.801 %
      7.37 %     7.30 %     -       -  
Dividends
    -       -       -       -  
 
(j) 
$400,000 convertible notes payable
 
On January 21, 2011, we entered into a Subscription Agreement with a group of accredited investors.  Under this agreement, we agreed to sell up to $400,000 of our securities consisting of 10% convertible notes with a maturity date of July 15, 2012 and 20,460,357 Class A stock purchase warrants at an exercise price of $.035 with an expiration date of January 20, 2016. The conversion price for the convertible notes payable per share shall be equal to seventy-five percent (75%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal Market for the ten trading days preceding a conversion date but in no event greater than $.08.  On February 22, 2012, we entered into a Fifth Amendment and Consent Agreement as part of the February, 2012 financing in which the above $.08 conversion price was changed to $.02 as well as the exercise price of the warrants was changed from $.035 to $.02. These notes payable and warrants are subject to full
 
 
F-24

 
 
Note 6 – 
Convertible Notes Payable (continued):

(i)
$400,000 convertible notes payable (continued)
 
ratchet anti-dilution protection if we sell shares or share-indexed financing instruments at less than those prices.  The conversion features were not afforded the exemption as conventional convertible, and the notes require liability classification under the FASB Accounting Standards Codification.  We chose to value the entire hybrid instruments at fair value.  The warrants issued in this financing arrangement did not meet the conditions for equity classification and are also required to be carried as a derivative liability, at fair value.  We estimate the fair value of the warrants on the inception dates, and subsequently, using the Black-Sholes Merton valuation technique, adjusted for dilution, because that technique embodies all of the assumptions (including volatility, expected terms, dilution and risk free rates) that are necessary to fair value freestanding warrants.  See also Note 9 – Derivative Liabilities. At inception, we allocated $136,123 as the valuation cost of the warrants (debt discount) against the gross proceeds of the $400,000 financing using the relative fair value method. We recorded $108,646 to capture the accretion of the debt discount since inception.  Total conversions of the principal amount to date amounted to $177,505 which were converted into shares of common stock, resulting in the current outstanding balance of $222,495 at March 31, 2012.
 
Total financing costs paid from this financing amounted to $70,000  as well as the payment of $102,500 of a previous promissory note resulted  in a net amount of $227,500 to be paid to us.  Out of this total $227,500, an amount of $128,500 was paid in the first January, 2011 closing with the remaining amount of $99,000 being paid in the second February, 2011 closing.  In addition, we recorded $31,921 in non-cash deferred financing fees for the issuance of 2,046,035 restricted shares of common stock as a finder’s fee.
 
Information and significant assumptions embodied in our valuations (including ranges for certain assumptions during the subject periods that instruments were outstanding) as of March 31, 2012 and March 31, 2011 for this financing is illustrated in the following table:
 
 
 
Hybrid Note
   
Warrants
 
     
March
     
March
     
March
     
March
 
      31, 2012       31, 2011       31, 2012       31, 2011  
Estimated fair value of underlying common share
  $ 0.003     $ 0.02     $ 0.003     $ 0.02  
Conversion or strike price
  $ 0.00222     $ 0.015     $ 0.02     $ 0.02  
Volatility (based upon Peer Group)
    -       -       120.00 %     130.00 %
Equivalent term (years)
    -       -       3.81       4.81  
Risk-free rate
    -       -       0.76 %     2.2 %
Credit-risk adjusted yield
    7.37 %     7.3 %     -       -  
Dividends
    -       -       -       -  
 
(k)           $600,000 convertible notes payable
 
On March 17, 2011, we entered into a Subscription Agreement with a group of accredited investors.  Under this agreement, we agreed to sell up to $600,000 of our securities consisting of 10% convertible notes with a maturity date of September 17, 2012 and 43,708,610 Class A stock purchase warrants (includes 3,973,510 warrants as a finder’s fee) at an exercise price of $.02 with an expiration date of March 16, 2016. The conversion price for the convertible notes payable per share shall be equal to seventy-five percent (75%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal Market for the ten trading days preceding a conversion date but in no event greater than $.02. These notes payable and warrants are subject to full ratchet anti-dilution protection if we sell shares or share-indexed financing instruments at less than those prices.  The conversion features were not afforded the exemption as conventional convertible, and the notes require liability classification under the FASB Accounting Standards Codification.  We chose to value the entire hybrid instruments at fair value.  The warrants issued in this financing arrangement did not meet the conditions for equity classification and are also required to be carried as a derivative liability, at fair value.  We estimate the fair value of the warrants on the inception dates, and subsequently, using the Black-Sholes Merton valuation technique, adjusted for dilution, because that technique embodies all of the assumptions (including volatility, expected terms, dilution and risk free rates) that are necessary to fair value freestanding warrants.  See also
 
 
F-25

 
 
Note 6 – 
Convertible Notes Payable (continued):

(k)
$600,000 convertible notes payable (continued)
 
Note 9 – Derivative Liabilities. At inception, we allocated $223,802 as the valuation cost of the warrants (debt discount) against the gross proceeds of the $400,000 financing using the relative fair value method. We recorded $155,832 to capture the accretion of the debt discount through March 31, 2012.  Total conversions of the principal amount to date amounted to $332,887 which were converted into shares of common stock, resulting in an outstanding principal balance of $267,113 at March 31, 2012.
 
Total financing costs paid from this financing amounted to $90,000 resulted in a net amount of $510,000 to be paid to us.   In addition, we recorded $75,371 in non-cash deferred financing fees for the issuance of 3,973,510 warrants to purchase common stock as a finder’s fee as well as issued a convertible note for $18,000 for a 3% non-accountable allowance placement agent fee as this note contained the same conversion rights as the above convertible notes.  This particular note has been fully converted into shares of common stock.
 
Information and significant assumptions embodied in our valuations (including ranges for certain assumptions during the subject periods that instruments were outstanding) as of March 31, 2012 and March 31, 2011 for this financing is illustrated in the following table:
 
$600,000 Convertible Promissory Note Financing
 
 
         
 
       
  (Initial Closing)
 
Hybrid Note
   
Warrants
 
     
March
     
March
     
March
     
March
 
      31, 2012       31, 2011       31, 2012       31, 2011  
Estimated fair value of underlying common share
  $ 0.003     $ 0.02     $ 0.003     $ 0.02  
Conversion or strike price
  $ 0.00222     $ 0.015     $ 0.02     $ 0.02  
Volatility (based upon Peer Group)
    -       -       120.00 %     130.00 %
Equivalent term (years)
    -       -       3.96       4.96  
Risk-free rate
    -       -       0.80 %     2.280 %
Credit-risk adjusted yield
    7.19 %     7.3 %     -       -  
Dividends
    -       -       -       -  

(l)           $221,937 convertible notes payable
 
On May 23, 2011, the holder of the original April 2, 2008 short term bridge loan with principal balance of $120,000 and of the original May 19, 2008 short term bridge loan with principal balance of $33,000 entered into an agreement to transfer the original notes and personal guarantee of Roy Warren, CEO, to another debt holder (Jody Eisenman) who already is an existing debt holder and accredited investor.   On June 30, 2011, the new debt holder entered into a Debt Exchange Agreement with the Company to transfer these two short term bridge loans dated April 2, 2008 with principal balance of $120,000 plus interest of $53,951 and the second short term bridge loan dated May 19, 2008 with principal balance of $33,000 plus interest of $14,986 for a grand total of $221,937 into a new long term convertible note with an interest rate of 10% and a maturity date of September 17, 2012.  This new note covers all previous commitments through June 30, 2011. As consideration for this exchange, the Company cancelled the personal guarantee of Roy Warren, CEO, and issued a warrant to purchase 20,000,000 shares of the Company’s common stock at an exercise price of $.02 with a life of five years.  This convertible note and warrants are subject to the same rights as all other convertible notes and associated warrants as the conversion price for the convertible notes payable per share shall be equal to seventy-five percent (75%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal Market for the ten trading days preceding a conversion date but in no event greater than $.02. The conversion features were not afforded the exemption as conventional convertible, and the notes require liability classification under the FASB Accounting Standards Codification.  We chose to value the entire hybrid instruments at fair value.  The warrants issued in this financing arrangement did not meet the conditions for equity classification and are also required to be carried as a derivative liability, at fair value.  We estimate the fair value of the warrants on the inception dates, and subsequently, using the Black-Sholes Merton valuation technique, adjusted for dilution, because that technique embodies all of the assumptions (including volatility, expected terms, dilution and risk free rates) that are necessary to fair value freestanding warrants.  See also Note 9.
 
 
F-26

 
 
Note 6 – 
Convertible Notes Payable (continued):

(l)
$221,937 convertible notes payable (continued)
 
Derivative Liabilities. Through this exchange, all original notes and guarantee and all obligations related thereunder were cancelled and terminated.  We recorded $1,940 to capture the accretion of the debt discount through March 31, 2012. Total conversions of the principal amount to date amounted to $134,349 leaving a remaining outstanding principal face amount of $87,588.
 
Information and significant assumptions embodied in our valuations (including ranges for certain assumptions during the subject periods that instruments were outstanding) as of March 31, 2012 for this financing is illustrated in the following table:

$221,937 Convertible Promissory Note Financing
 
Hybrid Note
   
Warrants
 
     
March
     
March
     
March
     
March
 
      31, 2012       31, 2011       31, 2012       31, 2011  
Estimated fair value of underlying common share
  $ 0.003     $ -     $ 0.003     $ -  
Conversion or strike price
  $ 0.003     $ -     $ 0.02     $ -  
Volatility (based upon Peer Group)
    --       --       120.00 %     --  
Equivalent term (years)
    --       --       4.25       --  
Risk-free rate
    --       --       0.88 %     --  
Credit-risk adjusted yield
    7.19 %     --       --       --  
Dividends
    --       --       --       --  
 
(m)           $500,000 convertible notes payable
 
On July 15, 2011, we entered into a Subscription Agreement with a group of accredited investors.  Under this agreement, we agreed to sell up to $1,000,000 of our securities consisting of 10% convertible notes with a maturity date of January 15, 2013 in which we did sell $500,000.  In addition, we did issue a convertible note under the same terms as the $500,000 convertible notes for a 3% finder’s fee in the amount of $15,000.  We issued 27,500,000 Class A stock purchase warrants (includes 2,500,000 warrants as a finder’s fee) at an exercise price of $.02 with an expiration date of July 14, 2016.  The conversion price for the convertible notes payable per share shall be equal to seventy-five percent (75%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal Market for the ten trading days preceding a conversion date but in no event greater than $.02. These notes payable and warrants are subject to full ratchet anti-dilution protection if we sell shares or share-indexed financing instruments at less than those prices.  The conversion features were not afforded the exemption as conventional convertible, and the notes require liability classification under the FASB Accounting Standards Codification.  We chose to value the entire hybrid instruments at fair value.  The warrants issued in this financing arrangement did not meet the conditions for equity classification and are also required to be carried as a derivative liability, at fair value.  We estimate the fair value of the warrants on the inception dates, and subsequently, using the Black-Sholes Merton valuation technique, adjusted for dilution, because that technique embodies all of the assumptions (including volatility, expected terms, dilution and risk free rates) that are necessary to fair value freestanding warrants.  See also Note 8 – Derivative Liabilities. At inception, we allocated $70,454 as the valuation cost of the warrants (debt discount) against the gross proceeds of the $500,000 financing using the relative fair value method. We recorded $33,662 to capture the accretion of the debt discount through March 31, 2012. There have been no conversions of this debt.

Total financing costs paid from this financing amounted to $95,000 resulting in a net amount of $405,000 to be paid to us.

Information and significant assumptions embodied in our valuations (including ranges for certain assumptions during the subject periods that instruments were outstanding) as of March 31, 2012 and March 31, 2011 for this financing is illustrated in the following table:
 
 
F-27

 
 
Note 6 – 
Convertible Notes Payable (continued):

(m)
$500,000 convertible notes payable (continued)

$500,000 Convertible Promissory Note Financing
 
Hybrid Note
   
Warrants
 
     
March
      March      
March
     
March
 
      31, 2012       31, 2011       31, 2012       31, 2011  
Estimated fair value of underlying common share
  $ 0.003     $ -     $ 0.003     $ -  
Conversion or strike price
  $ 0.00222     $ -     $ 0.02     $ -  
Volatility (based upon Peer Group)
    --       --       110.00 %     --  
Equivalent term (years)
    --       --       4.29       --  
Risk-free rate
    --       --       0.89 %     --  
Credit-risk adjusted yield
    7.19 %     --       --       --  
Dividends
    --       --       --       --  
 
(n)           $59,359 convertible notes payable
 
On November 3, 2011, we entered into a promissory note with conversion rights with outside legal counsel in the principal sum of $59,359, payable on or before May 5, 2012.  This note shall bear interest at the rate of five percent (5%) simple interest per annum until paid in full. At the option of the holder at the due date, all or any portion of the unpaid accrued interest and/or unpaid principal amount of this note shall be converted into newly issued shares of the Company’s common stock at the lesser of a conversion price per share equal to (1) the closing price reported on the primary trading market on the day prior to the conversion date or (2) the lowest conversion price for other convertible debt or securities issued by the Company with the ability to be converted or exercised on the Due Date. The conversion price in no event will be such an amount to trigger any conversion or exercise price reset or anti-dilution rights in existing convertible notes or other convertible securities on the Due Date. The holder may not convert any amount of the note into a number of shares of common stock which would result in beneficial ownership by the holder and its affiliates of more than 4.99% of the outstanding shares of common stock on such conversion date. The holder is not limited to aggregate conversions of 4.99%.  There have been no conversions of this debt.
 
(o)           $1,000,000 convertible notes payable

On February 22, 2012, we entered into a Subscription Agreement with a group of accredited investors.  Under this agreement, we agreed to sell up to $1,000,000 of our securities consisting of 10% convertible notes with a maturity date of March 31, 2014 in which we did sell $1,000,000.  We issued 50,000,000 Class A stock purchase warrants at an exercise price of $.02 with an expiration date of February 21, 2017.  The conversion price for the convertible notes payable per share shall be equal to seventy-five percent (75%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal Market for the ten trading days preceding a conversion date but in no event greater than $.02. These notes payable and warrants are subject to full ratchet anti-dilution protection if we sell shares or share-indexed financing instruments at less than those prices.  The conversion features were not afforded the exemption as conventional convertible, and the notes require liability classification under the FASB Accounting Standards Codification.  We chose to value the entire hybrid instruments at fair value.  The warrants issued in this financing arrangement did not meet the conditions for equity classification and are also required to be carried as a derivative liability, at fair value.  We estimate the fair value of the warrants on the inception dates, and subsequently, using the Black-Sholes Merton valuation technique, adjusted for dilution, because that technique embodies all of the assumptions (including volatility, expected terms, dilution and risk free rates) that are necessary to fair value freestanding warrants.  See also Note 8 – Derivative Liabilities. At inception, we allocated $44,735 as the valuation cost of the warrants (debt discount) against the gross proceeds of the $1,000,000 financing using the relative fair value method. We recorded $3,148 to capture the accretion of the debt discount through March 31, 2012. There have been no conversions of this debt.

Total financing costs paid from this financing amounted to $160,000. In addition, we applied three previous bridge loans for a total of $175,000 into this new financing, paid $103,451 for two other previous  bridge loans including interest, resulting in a net amount of $561,549 to be paid to us.
 
Information and significant assumptions embodied in our valuations (including ranges for certain assumptions during the subject periods that instruments were outstanding) as of March 31, 2012 and March 31, 2011 for this financing is illustrated in the following table:
 
 
F-28

 
 
Note 6 – 
Convertible Notes Payable (continued):

(o)
$1,000,000 convertible notes payable (continued)
 
$1,000,000 Convertible Promissory Note Financing
 
Hybrid Note
   
Warrants
 
     
March
     
March
     
March
     
March
 
      31, 2012       31, 2011       31, 2012       31, 2011  
Estimated fair value of underlying common share
  $ 0.003     $ -     $ 0.003     $ -  
Conversion or strike price
  $ 0.00222     $ -     $ 0.02     $ -  
Volatility (based upon Peer Group)
    --       --       110.00 %     --  
Equivalent term (years)
    --       --       4.9       --  
Risk-free rate
    --       --       1.06 %     --  
Credit-risk adjusted yield
    7.19 %     --       --       --  
Dividends
    --       --       --       --  

(p)           $172,211 convertible notes payable

On March 31, 2012, we entered into an Extension Agreement with note holders who have existing convertible notes in the total outstanding amount of $172,211 with a due date of March 31, 2012 to extend the maturity date of these notes to March 31, 2014.  As consideration of the extension of the maturity date of these notes, we issued to each note holder a new convertible note with an interest rate of twelve percent (12%) in the principal amount representing ten percent (10%) of the principal amount owed to each note holder.  The conversion price for the convertible notes payable per share shall be equal to seventy-five percent (75%) of the average of the three lowest closing bid prices for the common stock as reported by Bloomberg L.P. for the principal Market for the ten trading days preceding a conversion date but in no event greater than $.02. These notes payable are subject to full ratchet anti-dilution protection if we sell shares or share-indexed financing instruments at less than those prices.  The conversion features were not afforded the exemption as conventional convertible, and the notes require liability classification under the FASB Accounting Standards Codification.  We chose to value the entire hybrid instruments at fair value.  There have been no conversions of this debt.
 
Information and significant assumptions embodied in our valuations (including ranges for certain assumptions during the subject periods that instruments were outstanding) as of March 31, 2012 for this financing is illustrated in the following table:
 
$172,211 Convertible Promissory Note Financing
 
Hybrid Note
 
     
March
     
March
 
      31, 2012       31, 2011  
Estimated fair value of underlying common share
  $ 0.003     $ -  
Conversion or strike price
  $ 0.00222     $ -  
Volatility (based upon Peer Group)
    --       --  
Equivalent term (years)
    --       --  
Risk-free rate
    --       --  
Credit-risk adjusted yield
    7.19 %     --  
Dividends
    --       --  
 
Note 7 – 
Short Term Bridge Loans:

April 2, 2008 financing:
 
(a) On June 30, 2011, another accredited investor entered into a Debt Exchange Agreement with the original holder of this short-term bridge loan with principal balance of $120,000 plus accrued interest of $53,951 along with the May 19, 2008 bridge loan with principal balance of $33,000 plus accrued interest of $14,986 (see below in the May 19, 2008 financing section) for a total of $221,937 (see Note 6 (l)). The new debt holder desired to exchange the two original bridge loans into the issuance of a long term convertible note with a maturity date of September 17, 2012 and an interest rate of 10%.  As part of this agreement, the Company
 
 
F-29

 

Note 7 – 
Short Term Bridge Loans: (continued)
 
April 9, 2008 financing (continued) :
 
issued the new debt holder a warrant to purchase 20,000,000 shares of the Company’s common stock at an exercise price of $.02 per share with a life of five years and cancelled the personal guarantee of Roy Warren, CEO, for these two original loans.  Both the note and warrant have similar rights as all other convertible notes and associated warrants.  The Company is no longer in default of these previous two bridge loans.
 
April 9, 2008 financing
 
(b) On May 6, 2011, the holder of this bridge loan and the Company agreed to convert the original $120,000 principal amount of the short-term bridge loan into six million (6,000,000) shares of restricted common stock.  The bridge loan is now considered paid and no longer outstanding, and the personal guarantee of Roy Warren, CEO, is cancelled.
 
April 14, 2008 financing:
 
(c)  On April 14, 2008, the Company entered into a financing arrangement that provided for the issuance of a $60,000 face value short-term bridge loan note payable due July 15, 2008 plus warrants to purchase (i) 5,000 shares of our common stock and (ii) additional warrants to purchase 5,000 shares of our common stock, representing an aggregate 10,000 shares which all warrants have expired and are cancelled.  We determined that the warrants issued in this financing arrangement meet the conditions for equity classification so we allocated the proceeds of the debt between the debt and the detachable warrants based on the relative fair value of the debt security and the warrants in accordance with the FASB Accounting Standards Codification.
 
We entered into the following Modification and Waiver Agreements related to the April 14, 2008 financing:
 
Date
 
Terms
 
Consideration
June 2008
 
Extend maturity to July 19, 2008
 
Warrants indexed to 2,500 shares of common stock
September 2008
 
Extend maturity to December 15, 2008
 
6,000 shares of restricted stock
January 2009
 
Extend maturity date to April 30, 2009
 
1) Warrants indexed to 6,000 shares of common stock
2) 6,000 shares of restricted stock
 
The modifications resulted in a loss on extinguishment of $171,622 in accordance with the Financial Accounting Standards Codification.
 
On December 15, 2008, we were in default on the notes for non-payment of the required principal payment.  The remedy for event of default was acceleration of principal and interest so they were recorded at face value.  As of March 31, 2012, this April 14, 2008 note was considered in default for non-payment. The Company is negotiating with the debt holder to extend the due date of the note. It was determined that the extension warrants required liability accounting and are being recorded at fair value with changes in fair value being recorded in derivative (income) expense. The exercise dates for all warrants other than 6,000 warrants granted on January 27, 2009 have expired. The exercise price of the 6,000 warrants was reduced again to $1.00 when the Company issued additional convertible instruments with a lower conversion rate on January 27, 2009.  
 
May 19, 2008 financing:
 
(d) On June 30, 2011, another accredited investor entered into a Debt Exchange Agreement with the original holder of this short-term bridge loan with principal balance of $33,000 plus accrued interest of $14,986 along with the April 2, 2008 bridge loan with principal balance of $120,000 plus accrued interest of $53,951 (see above in the April 2, 2008 financing section) for a total of $221,937 (see Note 6 (l)). The new debt holder exchanged the two original bridge loans for a long term convertible note with a maturity date of September 17, 2012 and an interest rate of 10%.  As part of this agreement, the Company issued the new debt holder a warrant to purchase 20,000,000 shares of the Company’s common stock at an exercise price of $.02 per share with a life
 
 
F-30

 

Note 7 – 
Short Term Bridge Loans: (continued)
 
May 19, 2008 financing (continued) :

of five years and cancelled the personal guarantee of Roy Warren, CEO, for these two original loans.  Both the note and warrant have the same rights as all other convertible notes and associated warrants.  The Company is no longer in default of these previous two bridge loans.
 
August 5, 2008 financing:
 
(e) On August 5, 2008, the Company entered into a financing arrangement that provided for the issuance of a $55,000 face value short term bridge loan, due September 5, 2008, plus warrants to purchase (i) 5,000 shares of our common stock at an exercise price of $10.00 and (ii) additional warrants to purchase 5,000 shares of our common stock at an exercise price of $15.00, representing an aggregate 10,000 shares as the exercise dates for these warrants have now expired.  The due date of the loan was extended to December 15, 2008 with 5,500 restricted shares of common stock issued as consideration. On December 15, 2008, we were in default on the notes for non-payment of the required principal payment. Remedies for an event of default are acceleration of principal and interest.  There were no incremental penalties for the event of default; however, the notes were recorded at face value.
 
We also evaluated the warrants to determine if they required liability or equity accounting. The warrants issued in conjunction with the financing are redeemable for cash upon the occurrence of acquisition, merger or sale of substantially all assets of the Company in an all cash transaction; therefore, the FASB Accounting Standards Codification requires that they be recorded as derivative liabilities on our balance sheet and marked to fair value each reporting period. We allocated the proceeds of the debt to the warrants, and the remaining portion was allocated to the debt instrument. The fair value of the warrants using the Black-Scholes pricing model was $62,700 and since the fair value of the warrants exceeded the proceeds from the financing, we recorded a day-one derivative loss of $12,700.
 
On January 15, 2009, we extended the term on the note from December 15, 2008 to April 30, 2009, and we issued investor warrants to purchase 5,500 shares of our common stock and 5,500 shares of restricted common stock as consideration for the extension.   We recorded a loss on extinguishment of $2,112 in accordance with the FASB Accounting Standards Codification. As of March 31, 2012, this note was considered in default for non-payment.  The Company is negotiating with the debt holder to extend the due date of the note.
 
The exercise price of the warrants was reduced to $3.30 when the Company issued additional convertible instruments with a lower conversion rate on December 18, 2008.  The exercise price of the warrants was reduced again to $1.00 when the Company issued additional convertible instruments with a lower conversion rate on January 27, 2009.  
 
Information and significant assumptions as of March 31, 2012 and March 31, 2011 for warrants which are required to be recorded at fair value each reporting period:
 
   
January 27, 2009
 
   
Extension Warrants
 
     
March
     
March
 
      31, 2012       31, 2011  
Estimated fair value of underlying common share
  $ 0.0015     $ 0.02  
Conversion or strike price
  $ 1.00     $ 1.00  
Volatility (based upon Peer Group)
    115.00 %     145.00 %
Equivalent term (years)
    1.83       2.83  
Risk-free rate
    0.33 %     1.20 %
Dividends
    --       --  
 
 
F-31

 
 
Note 8 – 
Notes Payable (non-convertible):

For the period ended March 31, 2011, we paid $23,750 as part of a promissory note in the total principal amount of $34,000 as a final settlement amount for a previous license agreement. The remaining amount due of $10,250 was required to be settled through monthly payments of $4,250 through December, 2010.  Although we did not make all payments for the year ended March 31, 2012, we anticipate making those payments in 2012.
 
On January 26, 2011, we entered into a promissory note with our landlord (Pishon Partners, LLC) in the principal amount of $75,762.  This amount is due June 30, 2011 together with interest of 10% computed on the basis of the actual number of days elapsed over a 360-day year on the unpaid balance.  The default rate shall be a per annum interest rate equal to the maximum amount permitted by applicable law.   Although we have not paid this note yet, we anticipate making a payment pending a future financing.
 
On June 3, 2011 and June 30, 2011, we entered into two promissory notes of $100,000 and $25,000, respectively.  These notes were subject to an interest rate of ten percent (10%) and are due the sooner of (i) July 3, 2011 for the $100,000 note and July 30, 2011 for the $25,000 note or (ii) from the proceeds of the next funding by the Company.  These notes were paid in July 2010 for the total full amount of $125,000 from proceeds of the July 2011 financing.
 
On October 7, 2011, we entered into two promissory notes of $75,000 each for a total of $150,000 with two accredited investors.  These notes were subject to an interest rate of ten percent (10%) and are due the sooner of (i) January 30, 2012 or (ii) from the process of the next funding by the Company.  One of the $75,000 notes was paid through the proceeds of the February, 2012 financing, and the other $75,000 note was transferred as a new convertible note for the same amount in the February, 2012 financing.
 
On December 1, 2011, we entered into two promissory note of $25,000 each for a total of $50,000 with two accredited investors.  We received the second $25,000 on December 20, 2011.  These notes were subject to an interest rate of ten percent (10%) and are due the sooner of (i) January 30, 2012 or (ii) from the proceeds of the next funding by the Company. One of the $25,000 notes was paid through the proceeds of the February, 2012 financing, and the other $25,000 note was transferred as a new convertible note for  the same amount  in the February, 2012 financing.
 
On December 28, 2011, we entered into a note in the principal amount of $100,000, purchase price of $75,000 with an accredited investor.  The note is due on the second anniversary date of December 28, 2013. The Company’s CEO, Roy Warren, signed a personal guarantee for this payment.  This note was transferred as a convertible note as part of the February, 2012 financing.
 
 
F-32

 
 
Note 9 – 
Derivative Liabilities:

The following table summarizes the components of derivative liabilities as of March 31, 2012 and 2011:

 
Financing arrangement giving rise to
 
March
   
March
 
 
derivated financial instruments
   31, 2012      31, 2011  
$ 600,000  
Face Value Convertible Note Financing
  $ 3,913     $ 22,250  
$ 500,000  
Face Value Convertible Note Financing
    2,964       16,855  
$ 100,000  
Face Value Convertible Note Financing
    593       3,372  
$ 120,000  
Face Value Short Term Bridge Loan Financing
    12       113  
$ 120,000  
Face Value Short Term Bridge Loan Financing
    12       113  
$ 60,000  
Face Value Short Term Bridge Loan Financing
    6       56  
$ 33,000  
Face Value Short Term Bridge Loan Financing
    3       31  
$ 55,000  
Face Value Short Term Bridge Loan Financing
    -       6  
$ 120,000  
Face Value Convertible Note Financing
    241       1,427  
$ 60,000  
Face Value Convertible Note Financing
    121       714  
$ 200,000  
Face Value Convertible Note Financing
    837       4,956  
$ 161,111  
Face Value Convertible Note Financing
    674       3,992  
$ 50,000  
Face Value Convertible Note Financing
    209       1,239  
$ 55,000  
Face Value Convertible Note Financing
    209       1,239  
$ 137,500  
Face Value Convertible Note Financing
    575       3,407  
$ 55,000  
Face Value Convertible Note Financing
    230       1,363  
$ 900,000  
Face Value Convertible Note Financing
    113,810       673,958  
$ 400,000  
$Face Value Convertible Note Financing
    31,102       188,173  
$ 600,000  
Face Value Convertible Note Financing
    89,678       545,724  
$ 221,937  
Face Value Convertible Note Financing
    44,502       -  
$ 500,000  
Face Value Convertible Note Financing
    57,528       -  
$ 1,000,000  
Face Value Convertible Note Financing
    76,043       -  
                       
     
Total derivative liabilities
  $ 423,262     $ 1,468,988  
                       
 
We estimate fair values of derivative financial instruments using various techniques (and combinations thereof) that are considered to be consistent with the objective measuring fair values. In selecting the appropriate technique, we consider, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex derivative instruments, such as free-standing warrants, we generally use the Black-Scholes-Merton option valuation technique because it embodies all of the requisite assumptions (including trading volatility, estimated terms, dilution and risk free rates) necessary to fair value these instruments. For complex hybrid instruments, such as convertible promissory notes that include embedded conversion options, puts and redemption features embedded in, we generally use techniques that embody all of the requisite assumptions (including credit risk, interest-rate risk, dilution and exercise/conversion behaviors) that are necessary to fair value these more complex instruments. For forward contracts that contingently require net-cash settlement as the principal means of settlement, we project and discount future cash flows applying probability-weightage to multiple possible outcomes. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the trading market price of our common stock, which has a high-historical volatility. Since derivative financial instruments are initially and subsequently carried at fair values, our income will reflect the volatility in these estimate and assumption changes.
 
Note 10 – 
Transactions with Related Parties:

In connection with the reverse merger (see Note 1), we assumed $47,963 in advances payable to the officers of MHHI in which we paid $1,500 in January, 2009 and issued 25,000 shares of common at $1.00 per share or $25,000, resulting in an outstanding balance of $21,463 that is due.   These advances are non-interest bearing and payable upon demand.
 
 
F-33

 

In addition, the Company previously issued aggregate notes of $100,000 to Roy Warren, the Company’s CEO, an accredited investor with whom the Company entered into subscription agreements for 10% convertible notes (see Note 6b).  However Roy Warren assigned the $100,000 notes to another party. During the quarter ended September 30, 2009, 9,000,000 shares of Series A Preferred, convertible into 54,000,000 shares of common stock at the option of the holder, were granted to Roy Warren (see Note 11).

H. John Buckman is a board director of the company and is a debt holder of the company whereas the company issued him a note payable at the face value of $55,000.  He also has a total of 10,500 Class A warrants at an exercise price of $1.00 with a life of three to five years, and he will be entitled to an additional 5,000 warrants with at an exercise price of $15.00 if he exercises the same number of specific Class A warrants.  He also received 11,000 shares of restricted stock that related to this note payable, 1,200 shares of restricted stock for being a Director and 150,000 shares of restricted stock for his services related to a November, 2009 financing (total of 162,200 shares of restricted stock).

RPBGI LLC, our landlord, received 644,677 restricted shares of common stock back in March, 2009 for past due services. This company still owns all of these shares.

Weed & Co. LLP serves as our main outside legal counsel and holds a convertible note payable in the amount of $59,359.  On May 29, 2012, they converted $50,000 of the above note payable into 46,728,972 shares of common stock.
 
Note 11
Stockholders’ Deficit
 
(a) Series A Preferred Stock:
 
The Company’s articles of incorporation authorize the issuance of 20,000,000 shares of preferred stock which the Company has designated as Series A Preferred (“Series A”), $.001 par value.  Each share of Series A is convertible into six shares of the Company’s common stock for a period of five years from the date of issue.  The conversion basis is not adjusted for any stock split or combination of the common stock.  The Company must at all times have sufficient common shares reserved to effect the conversion of all outstanding Series A Preferred. The holders of the Series A Preferred shall be entitled to receive common stock dividends when, as, if and in the amount declared by the directors of the Company to be in cash or in market value of the Company’s common stock.  The Company is restricted from paying dividends or making distributions on its common stock without the approval of a majority of the Series A holders. The Series A shall be senior to the Common Stock and any other series or class of the Company’s Preferred Stock.  The Series A has liquidation rights in the event of any liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary, the holders of the Series A then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its shareholders, before any payment or declaration and setting apart for payment of any amount shall be made in respect of any outstanding capital stock  of the Company, an amount equal to $.001 per share,  The Company, at the option of its directors, may at any time or from time to time redeem the whole or any part of the outstanding Series A. Upon redemption, the Company shall pay for each share redeemed the amount of $2.00 per share, payable in cash, plus a premium to compensate the original purchaser(s) for the investment risk and cost of capital equal to the greater of (a) $2.00 per shares, or (b) an amount per share equal to fifty percent (50%) of the market capitalization of the Company on the date of notice of such redemption divided by 2,000,000.  We have evaluated our Series A Preferred Stock and determined these shares required equity classification because the number of shares convertible into common stock is fixed and reserved.  Redemption of these preferred shares cannot be effected because of the Company’s stockholders’ deficit.
 
 
F-34

 
 
Note 11
Stockholders’ Deficit (continued):

(a) Series A Preferred Stock (continued):

During the quarter ended September 30, 2009, 9,000,000 shares of Series A Preferred were granted to Roy Warren.  We recorded a non-cash expense for $1,620,000 which is based on the then market price of $0.03 per common share times the convertible stock equivalents (9,000,000 preferred shares x 6 = 54,000,000 common stock equivalents). These shares have specific voting power in that Roy Warren has voting rights for the 54,000,000 common stock equivalents.  The Board of Directors on September 4, 2009 approved an amendment whereas Section 2(A) of the Certificate of Designation is hereby declared in its entirety, and the following shall be substituted in lieu thereof-Rights, Powers and Preferences:    The Series A shall have the voting powers, preferences and relative, participating, optional and other special rights, qualifications, limitations and restrictions as follows:  Designation and Amount – Out of the Twenty Million (20,000,000) shares of the $0.001 par value authorized preferred stock, all Twenty Million (20,000,000) shares shall be designated as shares of “Series A.”
 
(b) Common Stock Warrants
 
As of March 31, 2012, the Company had the following outstanding warrants:
 
         
Expiration
   
Warrants
     
Exericse
 
Issued Class A Warrants
   
Grant Date
 
Date
   
Granted
     
Price
 
                           
October, 2007 Convertible Notes Financing
   
10/23/2007
 
7/15/2015
   
         908,806
    $
        0.02
 
October, 2007 Due Diligence
   
10/23/2007
 
10/22/2012
   
           50,000
    $
0.02
 
January, 2008 Investment Banker Agreement
   
1/1/2008
 
12/31/2012
   
             6,250
    $
10.00
 
February, 2008 Convertible Note Financing
   
2/15/2008
 
7/15/2015
   
         757,304
    $
0.02
 
April, 2008 Supply Agreement
   
4/16/2008
 
4/15/2013
   
             5,000
    $
15.00
 
Aprl, 2008 Finder's Fees
   
4/14/2008
 
4/13/2013
   
             3,125
    $
10.00
 
May, 2008 Finder's Fees
   
5/19/2008
 
5/18/2013
   
             1,875
    $
10.00
 
June, 2008 Convertible Note Financing
   
6/26/2008
 
6/25/2013
   
         151,502
    $
0.02
 
January, 2009 Convertible Note Financing
   
1/27/2009
 
7/15/2015
   
         120,000
    $
0.02
 
January, 2009 Debt Extensions
   
1/27/2009
 
1/26/2014
   
           26,800
    $
1.00
 
February, 2009 Convertible Note Financing
   
1/27/2009
 
1/26/2014
   
           60,000
    $
0.02
 
March, 2009 Convertible Note Financing
   
3/30/2009
 
7/15/2015
   
         416,666
    $
0.02
 
July, 2009 Convertible Note Financing
   
7/15/2009
 
7/15/2015
   
         335,648
    $
0.02
 
January, 2010 Convertible Note Financing
   
1/28/2010
 
7/15/2015
   
         104,166
    $
0.02
 
February, 2010 Convertible Note Financing
   
2/19/2010
 
7/15/2015
   
         104,167
    $
0.02
 
March, 2010 Convertible Note Financing
   
3/26/2010
 
7/15/2015
   
         286,458
    $
0.02
 
May, 2010 Convertible Note Financing
   
5/13/2010
 
7/15/2015
   
         114,583
    $
0.02
 
July, 2010 Convertible Notes Financinbg
   
7/15/2010
 
7/14/2015
   
    56,666,666
    $
0.02
 
September, 2010 Debt Extension
   
9/9/2010
 
9/9/2013
   
           51,000
    $
0.05
 
January, 2011 Debt Extension
   
1/11/2011
 
1/10/2014
   
           12,000
    $
0.05
 
January, 2011 Financing
   
1/21/2011
 
1/20/2016
   
    14,578,005
    $
0.02
 
March, 2011 Financing
   
3/17/2011
 
3/16/2016
   
    37,423,842
    $
0.02
 
March, 2011 Financing Finder's Fees
   
3/17/2011
 
3/16/2016
   
      3,973,510
    $
0.02
 
June, 2011 Debt Exchange Agreement
   
6/30/2011
 
6/29/2016
   
    20,000,000
    $
0.02
 
July, 2011 Financing
   
7/15/2011
 
7/14/2016
   
    25,000,000
    $
0.02
 
July, 2011 Financing Finder's Fees
   
7/15/2011
 
7/14/2016
   
      2,500,000
    $
0.02
 
February, 2012 Financing
   
2/22/2012
 
2/21/2017
   
    50,000,000
    $
0.02
 
                           
Total issued Class A warrants
             
  213,657,373
         
                           
 
 
F-35

 
 
Note 11 – 
Stockholders’ Deficit (continued):

(b) Common Stock Warrants (continued)
 
Unissued Class B warrants (a):
     
       
October, 2007 Convertible Notes Financing
    140,910  
January, 2008 Investment Banker Agreement
    6,250  
February, 2008 Convertible Notes Financing
    75,756  
April, 2008 Finder's Fees
    3,125  
May, 2008 Finder's Fees
    1,875  
June, 2008 Convert8ible Note Financing
    15,152  
         
  Total unissued Class B Warrants
    243,068  
         
  Total Warrants
    213,900,441  
         
 
(a) When certain Class A warrants are exercised, holders of these warrants will receive an equal number of Class B warrants with an exercise price of $15.00.
 
         
Average
 
   
Shares
   
Price
 
             
Activity for our common stock warrants is presented below:
           
             
Total warrants outstanding March 31, 2010
    3,704,840     $ 1.60  
                 
New warrants granted
    130,283,548       0.02  
Additional warrants due to modification letters to extend due dates
    8,995       0.05  
Cashless exercise of warrants
    (17,526,942 )     (0.02 )
                 
Total warrants outstanding March 31, 2011
    116,470,441       0.06  
                 
New warrants granted
    97,500,000       0.02  
Warrants that expired
    (70,000 )     -  
                 
Total warrants outstanding March 31, 2012
    213,900,441     $ 0.04  
 
Cashless exercises of 17,526,942 warrants were made for the fiscal year ended March 31, 2011. No warrants were exercised for the fiscal year ended March 31, 2012.
 
 
F-36

 
 
Note 11 –
Stockholders’ Deficit (continued):
 
(c) Common Stock:

At March 31, 2012, we had issued and outstanding 854,047,952 shares of common stock of which 5,125,562 shares are owned by our two officers.  Holders of shares of common stock are entitled to one vote for each share on all matters to be voted on by the shareholders.  Holders of common stock have no cumulative voting rights.  In the event of liquidation, dissolution or winding down of the Company, the holders of shares of common stock are entitled to share, pro rata, all assets remaining after payment in full of all liabilities.  Holders of common stock have no preemptive rights to purchase our common stock.  There are no conversion rights or redemption or sinking fund provisions with respect to the common stock.  All of the outstanding shares of common stock are validly issued, fully paid and non-assessable.
 
Common Stock Issued for the Year Ended March 31, 2012:

On April 1, 2011, we issued a total of 351,000 shares of common stock pursuant to two conversions of October, 2007 convertible notes (later assigned to new debt holders in July, 2010)  for $4,065 and $1,200 (total of $5,265) at a conversion price of $.015.
 
On April 6, 2011, we issued 260,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $3,822 at a conversion price of $.0147.
 
On April 14, 2011, we issued 89,660 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,816 at a conversion price of $.02025.
 
On May 2, 2011, we issued 1,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $12 at a conversion price of $.01225.
 
On May 5, 2011, certain employees converted a total $327,248 of past due salaries into 22,261,770 shares of common stock at a conversion price of $.0147.
 
On May 5, 2011, we issued 2,000,000 shares of common stock to an investor relations firm for services rendered at a conversion price of $.0157 valued at $31,400.
 
On May 6, 2011, we issued 6,000,000 shares of common stock for the conversion of the original April 9, 2008 short-term bridge loan with principal balance of $120,000 at a conversion price of $.02.
 
Also on May 6, 2011, we issued 2,952,958 shares of common stock pursuant to a conversion of certain March 2009 convertible notes for $37,001 at a conversion price of $.01253.
 
On May 12, 2011, we issued 100,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,150 at a conversion price of $.0115.
 
On May 13, 2011, we issued 86,136 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $991 at a conversion price of $.0115.
 
On May 17, 2011, we issued 67,500 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $768 at a conversion price of $.011375.
 
On May 18, 2011, we issued 70,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $718 at a conversion price of $.01025.
 
On May 23, 2011, we issued 211,200 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,785 at a conversion price of $.0085.
 
On May 25, 2011, we issued 321,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $2,688 at a conversion price of $.008375.
 
On June 1, 2011, we issued 192,800 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,591 at a conversion price of $.00825.
 
 
F-37

 
 
Note 11 –
Stockholders’ Deficit (continued):
 
(c) Common Stock (continued):

On June 7, 2011, we issued 139,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $938 at a conversion price of $.00675.

On June 13, 2011, we issued 175,700 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,120 at a conversion price of $.006375.
 
On June 14, 2011, we issued 207,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,320 at a conversion price of $.006375.
 
On June 15, 2011, we issued 156,600 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $979 at a conversion price of $.00625.
 
On June 20, 2011, we issued 400,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $2,500 at a conversion price of $.00625.
 
On June 22, 2011, we issued 400,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $2,560 at a conversion price of $.0064.
 
On June 30, 2011, we issued 500,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $3,213 at a conversion price of $.006425.
 
On July 20, 2011, we issued 3,079,286 shares of common stock pursuant to a conversion of certain March, 2009 convertible notes for $21,555 at a conversion price of $.007.
 
On July 21, 2011, we issued 1,500,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $10,688 at a conversion price of $.007125.
 
On July 25, 2011, we issued 5,000,000 shares of common stock pursuant to a conversion of January, 2008 convertible notes for $33,484 and another $1,356 for the original October, 2007 convertible notes for a total of $34,840 at a conversion price of $.006968.
 
On July 27, 2011, we issued 500,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $3,188 at a conversion price of $.006375.
 
On August 3, 2011, we issued 500,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $3,188 at a conversion price of $.00436.
 
On August 11, 2011, we issued 5,376,344 shares of common stock pursuant to a conversion of certain March, 2009 convertible notes for $25,000 at a conversion price of $.00465.
 
On August 11, 2011, we issued 200,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $872 at a conversion price of $.00436.
 
On August 31, 2011, we issued 3,000,000 shares of restricted common stock to outside legal counsel for past due services at a conversion price of $.002 with a recorded value of $6,000.
 
On September 1, 2011, we issued 1,338,678 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $2,470 at a conversion price of $.001845.
 
On September 13, 2011, we issued 4,513,899 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $5,530 at a conversion price of $.001225.
 
On September 27, 2011, we issued 2,800,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $2,800 at a conversion price of $.001.
 
 
F-38

 
 
Note 11 –
Stockholders’ Deficit (continued):
 
(c) Common Stock (continued):

On October 4, 2011, we issued 6,000,263 shares of common stock pursuant to a conversion of accrued interest associated with February, 2008 convertible notes in the amount of $5,712 at a conversion price of $.000952.

On October 12, 2011, we issued 701,064 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $526 at a conversion price of $.00075.

On November 1, 2011, we issued 1,295,609 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $1,095 at a conversion price of $.000845.
 
On November 3, 2011, we issued 9,300,000 shares of common stock pursuant to conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for two conversions totaling $8,580 at a conversion price of $.000923.
 
On November 3, 2011, we issued 5,517,402 shares of common stock pursuant to conversion of January, 2011 convertible notes for three conversions totaling $5,091 at a conversion price of $.000923.
 
On November 8, 2011, we issued 5,437,815 shares of common stock pursuant to conversion of January, 2011 convertible notes for three conversions totaling $5,955 at a conversion price of $.001095.
 
On November 8, 2011, we issued 4,000,000 shares of common stock pursuant to a conversion of October, 2007 convertible notes for $4,672 at a conversion price of $.001168.
 
On November 8, 2011, we issued 6,900,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $7,556 at a conversion price of $.001095.
 
On November 10, 2011, we issued 5,600,000 shares of common stock pursuant to conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for two conversions totaling $6,748 at a conversion price of $.001205.
 
On November 10, 2011, we issued 2,440,987 shares of common stock pursuant to conversion of January, 2011 convertible notes for three conversions totaling $2,941 at a conversion price of $.001205.
 
On November 14, 2011, we issued 6,000,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $8,070 at a conversion price of $.001345.
 
On November 17, 2011, we issued 1,400,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $2,275 at a conversion price of $.001625.
 
On November 17, 2011, we issued 586,373 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $953 at a conversion price of $.001625.
 
On November 23, 2011, we issued 2,304,694 shares of common stock pursuant to conversion of January, 2011 convertible notes for two conversions totaling $3,914 at a conversion price of $.001518.
 
On November 23, 2011, we issued 2,000,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $3,035 at a conversion price of $.001518.
 
On November 28, 2011, we issued 3,309,051 shares of common stock pursuant to conversion of March, 2011 convertible notes for two conversions totaling $4,194 at a conversion price of $.001268.
 
On November 29, 2011, we issued 9,000,000 shares of common stock pursuant to a conversion of October, 2007 convertible notes for $11,880 at a conversion price of $.00132.
 
On December 7, 2011, we issued 3,748,592 shares of common stock pursuant to conversion of March, 2011 convertible notes for two conversions totaling $3,490 plus $1,205 for one of the conversions at a conversion price of $.001253 to $.001268.
 
 
F-39

 
 
Note 11 –
Stockholders’ Deficit (continued):

(c) Common Stock (continued):

On December 7, 2011, we issued 501,236 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $628 at a conversion price range of $.001253.
 
On December 20, 2011, we issued 703,619 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $825 at a conversion price of $.001173.
 
On December 20, 2011, we issued 5,000,000 shares of common stock pursuant to conversion of March, 2011 convertible notes for two conversions totaling $5,863 at a conversion price of $.001173.
 
On December 30, 2011, company employees returned 27,918,336 shares of common stock previously granted to them earlier in the year for past due services in exchange for a similar number of employee stock options at an exercise price of $.02. These shares were cancelled and reduced the total outstanding number of common shares.
 
On December 31, 2011, we issued 3,134,422 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $2,701 at a conversion price of $.000863.
 
On January 10, 2012, we issued 7,000,000 shares of common stock pursuant to a conversion of October, 2011 convertible notes for $6,300 at a conversion price of $.0009.
 
On January 10, 2012, we issued 7,000,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $5,933 at a conversion price of $.000848.
 
On January 10, 2012, we issued 1,142,700 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $968 at a conversion price of $.000848.
 
On January 10, 2012, we issued 4,000,000 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $3,390 at a conversion price of $.000848.
 
On January 12, 2012, we issued 8,928,571 shares of common stock pursuant to a conversion of accrued interest from March, 2009 convertible notes for $8,000 at a conversion price of $.000896.
 
On January 20, 2012, we issued 2,000,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $1,630 at a conversion price of $.000815.
 
On January 20, 2012, we issued 4,541,178 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $3,701 at a conversion price of $.000815.
 
On January 20, 2012, we issued 4,000,000 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $3,260 at a conversion price of $.000815.
 
On January 23, 2012, we issued 1,355,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $1,104 at a conversion price of $.000815.
 
On January 23, 2012 and January 25, 2012, we issued 11,500,000 shares of common stock pursuant to  conversion of October, 2007 convertible notes for two conversions totaling $9,994 at a conversion price of $.000869.
 
On January 25, 2012, we issued 11,150,000 shares of common stock pursuant to a conversion of $9,689 accrued interest for March, 2009 convertible notes at a conversion price of $.000869.
 
On January 25, 2012 and January 26, 2012, we issued 12,000,000 shares of common stock pursuant to  conversion of March, 2011 convertible notes for four conversions totaling $9,780 at a conversion price of $.000815.
 
On January 25, 2012 and January 26, 2012, we issued 7,000,000 shares of common stock pursuant to  conversion of July, 2010 convertible notes for two conversions totaling $5,705 at a conversion price of $.000815.
 
 
F-40

 

Note 11 –
Stockholders’ Deficit (continued):
 
(c) Common Stock (continued):

On January 25, 2012, we issued 11,000,000 shares of common stock pursuant to a conversion of January, 2008 convertible notes for $9,559 at a conversion price of $.000869.
 
On January 25, 2012, we issued 3,000,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $2,445 at a conversion price of $.000815.
 
On January 25, 2012, we issued 3,500,000 shares of common stock pursuant to conversion of January, 2011 convertible notes for two conversions totaling $2,853 at a conversion price of $.000815.
 
On January 26, 2012, we issued 4,000,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $3,260 at a conversion price of $.000815.
 
On January 26, 2012, we issued 4,000,000 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $3,260 at a conversion price of $.000815.
 
On January 26, 2012, we issued 10,000,000 shares of common stock pursuant to conversion of January, 2011 convertible notes for three conversions totaling $2,935 at a conversion price of $.000815.
 
On January 27, 2012, we issued 2,410,414 shares of common stock pursuant to a conversion of accrued interest for March, 2009 convertible notes for $2,095 at a conversion price of $.000869.
 
On January 27, 2012, we issued 12,267,120 shares of common stock pursuant to conversion of January, 2011 convertible notes for three conversions totaling $9,998 at a conversion price of $.000815.
 
On January 27, 2012, we issued 13,000,000 shares of common stock pursuant to conversion of March, 2011 convertible notes for two conversions totaling $10,595 at a conversion price of $.000815.
 
On January 27, 2012, we issued 2,800,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $2,282 at a conversion price of $.000815.
 
On January 27, 2012, we issued 8,000,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $6,520 at a conversion price of $.000815.
 
On January 27, 2012, we issued 3,000,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $2,445 at a conversion price of $.000815.
 
On January 27, 2012, we issued 8,000,000 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $4,075 at a conversion price of $.000815.
 
On January 27, 2012, we issued 16,000,000 shares of common stock pursuant to conversion of October, 2007 convertible notes for two conversions totaling $13,904 at a conversion price of $.000869.
 
On January 27, 2012, we issued 11,507,479 shares of common stock pursuant to a conversion of accrued interest for the January, 2009 convertible notes for $10,000 at a conversion price of $.000869.
 
On January 30, 2012, we issued 7,000,000 shares of common stock pursuant to a conversion of October, 2007 convertible notes for $2,083 at a conversion price of $.000869.
 
On January 30, 2012, we issued 3,000,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $2,445 at a conversion price of $.000815.
 
On January 30, 2012 and January 31, 2012, we issued 21,000,000 shares of common stock pursuant to conversion of March, 2011 convertible notes for four conversions totaling $17,115 at a conversion price of $.000815.
 
 
F-41

 
 
Note 11 –
Stockholders’ Deficit (continued):
  
(c) Common Stock (continued):

On January 30, 2012, we issued 3,000,000 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $2,445 at a conversion price of $.001087.
 
On January 31, 2012, we issued 2,000,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $1,630 at a conversion price of $.000815.
 
On February 2, 2012, we issued 2,442,666 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $2,601 at a conversion price of $.001065.
 
On February 2, 2012, we issued 3,000,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $3,195 at a conversion price of $.001065.
 
On February 2, 2012, we issued 8,000,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $2,601 at a conversion price of $.001065.
 
On February 3, 2012, we issued 8,000,000 shares of common stock pursuant to conversion of January, 2011 convertible notes for three conversions totaling $13,261 at a conversion price of $.0010658.
 
On February 3, 2012, we issued 5,427,772 shares of common stock pursuant to conversion of March, 2011 convertible notes for two conversions totaling $13,565 at a conversion price of $.002315.
 
On February 6, 2012, we issued 5,743,130 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $18,234 at a conversion price of $.003175.
 
On February 8, 2012, we issued 1,000,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $3,175 at a conversion price of $.003175.
 
On February 9, 2012, we issued 1,500,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $4,763 at a conversion price of $.003175.
 
On February 9, 2012, we issued 6,000,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $19,050 at a conversion price of $.003175.
 
On February 9, 2012, we issued 6,500,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $20,638 at a conversion price of $.003175.
 
On February 10, 2012, we issued 3,359,033 shares of common stock pursuant to a conversion of January 2008 convertible notes for $2,919 at a conversion price of $.000869.
 
On February 13, 2012, we issued 4,000,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $12,820 at a conversion price of $.003205.
 
On February 13, 2012, we issued 5,000,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $16.025 at a conversion price of $.003205.
 
On February 13, 2012, we issued 1,000,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $3,205 at a conversion price of $.003205.
 
On February 13, 2012, we issued 533,550 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $1,710 at a conversion price of $.003205.
 
On February 14, 2012, we issued 4,7000,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $15,064 at a conversion price of $.003205.
 
 
F-42

 
 
Note 11 –
Stockholders’ Deficit (continued):
 
(c) Common Stock (continued):

On February 15, 2012, we issued 12,500,000 shares of common stock pursuant to a conversion of January, 2009 convertible notes for $12,500 at a conversion price of $.001.
 
On February 14, 2012, we issued 12,000,000 shares of common stock pursuant to a conversion of October 2007 convertible notes for $10,428 at a conversion price of $.000869.
 
On February 16, 2012, we issued 1,600,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $10,428 at a conversion price of $.002923.
 
On February 17, 2012, we issued 3,000,000 shares of common stock pursuant to two conversions of March, 2011 convertible notes totaling $8,768 at a conversion price of $.002923.
 
On February 17, 2012, we issued 1,000,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $2,923 at a conversion price of $.002923.
 
On February 17, 2012, we issued 5,000,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $10,428 at a conversion price of $.002923.
 
On February 21, 2012, we issued 13,000,000 shares of common stock pursuant to a conversion of October 2007 convertible notes for $30,576at a conversion price of $.002352.
 
On February 21, 2012, we issued 12,755,102 shares of common stock pursuant to a conversion of January, 2009 convertible notes for $30,000 at a conversion price of $.002352.
 
On February 21, 2012, we issued 8,939,822 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $26,131 at a conversion price of $.002923.
 
On February 21, 2012, we issued 9,600,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $28,061 at a conversion price of $.002923.
 
 On February 21, 2012, we issued 5,460,178 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $9,873 and accrued interest for $6,087 at a conversion price of $.002923.
 
On February 22, 2012, we issued 3,000,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $9,000 at a conversion price of $.003.
 
On February 22, 2012, we issued 1,813,317 shares of common stock pursuant to two conversions of March, 2011 convertible notes totaling 5,440 at a conversion price of $.003.
 
On February 22, 2012, we issued 3,000,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for 1,939 and accrued interest for $7,061 at a conversion price of $.003.
 
On February 22, 2012, we issued 5,000,000 shares of common stock as a finder’s fee for the February, 2012 financing. This amount represents 10% of the total 50,000,000 warrants that were issued in connection with this financing. We recorded $13,177 in financing fees expense for these shares.
 
On February 23, 2012, we issued 14,000,000 shares of common stock pursuant to a conversion of October, 2007 convertible notes for $43,400 at a conversion price of $.0031.
 
On February 24, 2012, we issued 13,797,419 shares of common stock pursuant to a conversion of January, 2009 convertible notes for $22,500 and accrued interest for 20,272 at a conversion price of $.0031.
 
On February 27, 2012, we issued 13,054,175 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $39,554 at a conversion price of $.00303.
 
 
F-43

 

Note 11 –
Stockholders’ Deficit (continued):
 
(c) Common Stock (continued):

On February 28, 2012, we issued 1,458,139 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $4,418 at a conversion price of $.00303.
 
On February 28, 2012, we issued 9,000,000 shares of common stock pursuant to a conversion of July 2010 convertible notes for $27,270 at a conversion price of $.00303.
 
On February 29, 2012, we issued 1,005,600 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $3,017 at a conversion price of $.003.
 
On March 1, 2012, we issued 5,000,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $15,700 at a conversion price of $.00314.
 
On March 1, 2012, we issued 5,000,000 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $15,700 at a conversion price of $.00314.
 
On March 1, 2012, we issued 1,000,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $3,140 at a conversion price of $.00314.
 
On March 2, 2012, we issued 18,000,000 shares of common stock pursuant to a conversion of October, 2007 convertible notes for $56,106 at a conversion price of $.003117.
 
On March 2, 2012, we issued 1,500,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $5,070 at a conversion price of $.00338.
 
On March 2, 2012, we issued 6,000,000 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $20,280 at a conversion price of $.00338.
 
On March 2, 2012, we issued 7,000,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $23,660 at a conversion price of $.00338.
 
On March 2, 2012, we issued 20,476,742 shares of common stock pursuant to a conversion of December, 2009 convertible notes for $50,000 and accrued interest for $13,450 at a conversion price of $.0031.
 
On March 6, 2012, we issued 7,000,000 shares of common stock pursuant to a conversion of October, 2007 convertible notes for $22,176 at a conversion price of $.003168.
 
On March 6, 2012, we issued 3,419,737 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $11,559 at a conversion price of $.00338.
 
On March 6, 2012, we issued 1,857,263 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $3,462 and accrued interest for $2,816 at a conversion price of $.00338.
 
On March 12, 2012, we issued 35,000,000 shares of common stock pursuant to a conversion of October, 2007 convertible notes for $3,125 and $105,970 accrued interest at a conversion price of $.003117.
 
On March 13, 2012, we issued 3,000,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $9,510 at a conversion price of $.00317.
 
On March 13, 2012, we issued 706,463 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $2,239 at a conversion price of $.00317.
 
On March 13, 2012, we issued 7,000,000 shares of common stock pursuant to two conversions of July, 2010 convertible notes totaling $22,190 at a conversion price of $.00317.
 
 
F-44

 
 
Note 11 –
Stockholders’ Deficit (continued):
 
(c) Common Stock (continued):

On March 16, 2012, we issued 4,856,750 shares of common stock pursuant to two conversions of January. 2011 convertible notes totaling $14,085 at a conversion price of $.0029.
 
On March 19, 2012, we issued 25,862,069 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $75,000 at a conversion price of $.0029.
 
On March 21, 2012, we issued 6,500,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $18,850 at a conversion price of $.0029.
 
On March 21, 2012, we issued 1,652,480 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $4,792 at a conversion price of $.0029.
 
On March 21, 2012, we issued 7,000,000 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $20,300 at a conversion price of $.0029.
 
On March 23, 2012, we issued 10,000,000 shares of common stock pursuant to a conversion of February, 2008 convertible notes for $28,850at a conversion price of $.002885.
 
On March 27, 2012, we issued 2,500,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $5,793 at a conversion price of $.002317.
 
On March 27, 2012, we issued 600,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $1,390 at a conversion price of $.002317.
 
On March 27, 2012, we issued 3,000,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $6,951 at a conversion price of $.002317.
 
On March 28, 2012, we issued 3,523,979 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $7,823 at a conversion price of $.00222.
 
On March 29, 2012, we issued 1,400,000 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $1,609 and accrued interest for $1,499 at a conversion price of $.00222.
 
Common Stock Issued for the Year Ended March 31, 2011:

On April 5, 2010, we issued 64,813 shares of common stock pursuant to a conversion of August, 2008 convertible notes of $10,000 and accrued interest payable of $370 at a conversion price of $0.16.
 
On April 6, 2010, we issued 125,000 shares of common stock pursuant to a conversion of October, 2007 convertible notes of $20,000 at a conversion price of $0.16.
 
On April 12, 2010, we issued 155,423 shares of common stock pursuant to a conversion of $24,868 in convertible notes payable at a conversion price of $0.16.
 
On April 29, 2010, we issued 5,000 shares of common stock pursuant to a conversion of January, 2008 convertible notes of $800 at a conversion price of $0.16.
 
On May 4, 2010, we issued 100,000 shares of common stock pursuant to a conversion of January, 2008 convertible notes of $16,000 at a conversion price of $0.16.
 
On May 14, 2010, we issued 100,000 shares of common stock pursuant to a conversion of October, 2007 convertible notes of $16,000 at a conversion price of $.16.
 
On June 2, 2010, the Board of Directors approved the issuance of 138,889 (valued at $25,000) and 150,000 (valued at $30,000) for a total of 288,889 shares for payment of past due services.  These shares were issued from the Company’s 2010 Stock
 
 
F-45

 

Note 11 –
Stockholders’ Deficit (continued):

(c) Common Stock (continued):

Compensation Plan which was registered on a Form S-8 registration statement filed and declared effective on May 25, 2010.
 
On June 30, 2010, we issued 12,000 shares of common stock for the extension of the due date for certain April, 2008 short term notes payable to December 31, 2010.
 
On July 21, 2010, we issued 8,333,333 shares of common stock to Roy Warren, CEO, for payment of past due salary for $125,000 at a conversion price of $.015.
 
On July 28, 2010, we issued 40,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $880 at a conversion price of $.022.
 
On August 5, 2010, we issued 500,000 shares of common stock pursuant to a conversion of June, 2008 convertible notes for $20,000 at a conversion price of $.04.
 
On August 9, 2010, we issued 25,550 shares of common stock pursuant to a conversion of October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $956 at a conversion price of $.0374.
 
On August 23, 2010, we issued 50,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,725 at a conversion price of $.0345.
 
On September 20, 2010, we issued 12,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $360 at a conversion price of $.04.
 
On September 28, 2010, we issued 25,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $681 at a conversion price of $.02725.
 
On October 11, 2010, we issued 614,672 shares of common stock pursuant to a conversion of $14,852 in accrued interest payable
for certain March, 2009 convertible notes payable.
 
On October 14, 2010, we issued 30,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $675 at a conversion price of $.0225.
 
On October 28, 2010, we issued 20,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $375 at a conversion price of $.01875.
 
On October 28, 2010, we issued 30,375 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $570 at a conversion price of $.01875.
 
On October 29, 2010, we issued 30,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $563 at a conversion price of $.01875.
 
On November 11, 2010, we issued 11,800 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $221 at a conversion price of $.01875.
 
On December 1, 2010, we issued 10,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $165 at a conversion price of $.01675.
 
On December 23, 2010, we issued 20,000 shares of common stock pursuant to a conversion of original October, 007 convertible notes (later assigned to a new debt holder in July, 2010) for $225 at a conversion price of $.01125.
 
On January 3, 2011, we issued 50,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $563 at a conversion price of $.01125.
 
On January 4, 2011, we issued 40,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $451 at a conversion price of $.01125.
 
 
F-46

 
 
Note 11 –
Stockholders’ Deficit (continued):
 
(c) Common Stock (continued):

On January 5, 2011, we issued 30,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $345 at a conversion price of $.0115.
 
On January 6, 2011, we issued 38,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $447 at a conversion price of $.01175.
 
On January 7, 2011, we issued 440,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $5,280 at a conversion price of $.012.
 
On January 9, 2011, we issued 60,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $720 at a conversion price of $.012.
 
On January 10, 2011, we issued 1,290,789 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $15,659 at a conversion price of $.01213.
 
On January 10, 2011, we issued 742,534 shares of common stock pursuant to a conversion of convertible notes for $1,963 and $6,948 of accrued interest as part of the March, 2009 convertible notes at a conversion price of $.012.
 
On January 10, 2011, we issued 1,466,666 shares of common stock pursuant to a conversion of convertible notes for $17,835 as part of the June, 2008 convertible notes at a conversion price of $.01216.
 
On January 11, 2011, we issued 1,496,586 shares of common stock pursuant to a conversion of convertible notes for $17,939 as part of the March, 2009 convertible notes at a conversion price of $.012.
 
On January 11, 2011, we issued 212,500 shares of common stock pursuant to a conversion of original October, 2007 convertible
notes (later assigned to a new debt holder in July, 2010) for $2,630 at a conversion price of $.012375.
 
On January 12, 2011, we issued 317,500 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $4,247 at a conversion price of $.013375.
 
On January 12, 2011, we issued 1,000,000 shares of common stock pursuant to a conversion of January, 2008 convertible notes of $12,000 at a conversion price of $.012.
 
On January 13, 2011, we issued 1,000,000 shares of common stock pursuant to a conversion of January, 2008 convertible notes of $12,000 at a conversion price of $.012.
 
On January 13, 2011, we issued 180,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $2,700 at a conversion price of $.015.
 
On January 18, 2011, we issued 113,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,960 at a conversion price of $.01742.
 
On January 19, 2011, we issued 574,293 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $10,007 at a conversion price of $.017425.
 
On January 19, 2011, we issued 1,466,666 shares of common stock pursuant to a conversion of convertible notes for $11,665 and accrued interest payable for $5,788 as part of the June, 2008 convertible notes at a conversion price of $.01232.
 
On January 19, 2011, we issued 476,190 shares of common stock pursuant to a conversion of convertible notes for $5,714 as part of the January, 2008 convertible notes at a conversion price of $.012.
 
On January 20, 2011, we issued 200,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $3,660 at a conversion price of $.0183.
 
 
F-47

 

Note 11 –
Stockholders’ Deficit (continued):
 
(c) Common Stock (continued):

On January 21, 2011, we issued 100,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,955 at a conversion price of $.01955.
 
On January 24, 2011, we issued 50,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,050 at a conversion price of $.021.
 
On January 24 2011, we issued 1,124,613 shares of common stock pursuant to a conversion of convertible notes for $14,545 as part of the March, 2009 convertible notes at a conversion price of $.012933.
 
On January 25, 2011, we issued 22,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $451 at a conversion price of $.0205.
 
On January 28, 2011, we issued 500,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $10,125 at a conversion price of $.02025.
 
On January 31, 2011, we issued 83,100 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,683 at a conversion price of $.02025.
 
On February 1, 2011, we issued 1,000,000 shares of common stock pursuant to a conversion of January, 2008 convertible notes of $19,390 at a conversion price of $.01939.
 
On February 1, 2011, we issued 500,000 shares of common stock pursuant to a conversion as part of the January, 2008 notes for $9,290 at a conversion price of $.01858.
 
On February 1, 2011, we issued 438,980 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $8,890 at a conversion price of $.02025.

On February 2 and 3, 2011 collectively, we issued 272,500 shares of common stock pursuant to a conversion of original 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $5,519 at a conversion price of $.02025.
 
On February 2, 2011, we issued 1,345,243 shares of common stock pursuant to a conversion as part of the March, 2009 notes for $25,000 at a conversion price of $.018584.
 
On February 2, 2011, we issued 50,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,013 at a conversion price of $.02025.
 
On February 3, 2011, we issued 160,500 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $3,250 at a conversion price of $.02025.
 
On February 4, 2011, we issued 161,415 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $3,269 at a conversion price of $.02025.
 
On February 10, 2011, we issued 84,393 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,597 at a conversion price of $.01892.
 
On February 14, 2011, we issued 51,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $874 at a conversion price of $.01713.
 
On February 17, 2011, we issued 105,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,628 at a conversion price of $.0155.
 
On February 18, 2011, we issued 335,003 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $5,026 at a conversion price of $.015.
 
 
F-48

 

Note 11 –
Stockholders’ Deficit (continued):
 
(c) Common Stock (continued):

On February 18, 2011, we issued 1,625,000 shares of common stock pursuant to a conversion of original March, 2009 convertible notes for $26,000 at a conversion price of $.016.
 
On February 22, 2011, we issued 209,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $3,109 at a conversion price of $.014875.
 
On February 23, 2011, we issued 1,431,522 shares of common stock pursuant to a conversion of original March, 2009 convertible notes for $14,534 and accrued interest for $7,798 at a conversion price of $.0156.
 
On February 24, 2011, we issued 3,000,000 freely tradable shares of common stock from the Company’s 2/24/11 Form S-8 and 4,156,566 restricted shares for payment of past due payroll and professional services.
 
On February 23, 2011, we issued 100,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,463 at a conversion price of $.014625.
 
On February 24, 2011, we issued 90,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,294 at a conversion price of $.014375.
 
On February 25, 2011, we issued 81,200 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,167 at a conversion price of $.014375.
 
On February 28, 2011, we issued 80,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,120 at a conversion price of $.014.
 
On March 4, 2011, we issued 100,000 restricted shares of common stock to extend the due date to March 31, 2011 for a certain April, 2008 short-term bridge.
 
On March 2, 2011, we issued 54,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $749 at a conversion price of $.013875.
 
On March 3, 2011, we issued 200,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $2,750 at a conversion price of $.01375.
 
On March 4, 2011, we issued 39,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $531 at a conversion price of $.013625.
 
On March 7, 2011, we issued 1,485,253 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $19,754 at a conversion price of $.0133.
 
On March 7, 2011, we issued 2,046,035 restricted shares of common stock as a placement fee for the January, 2011 convertible note financing at a recorded cost of $31,921.
 
On March 7, 2011, we issued 1,692,047 shares of common stock pursuant to a conversion of original March, 2009 convertible notes for $24,000 at a conversion price of $.014184.
 
On March 7, 2011, we issued 3,523,510 shares of common stock pursuant to a conversion of original January, 2008 convertible notes for $50,000 at a conversion price of $.014184.
 
On March 8, 2011, we issued 592,500 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $7,880 at a conversion price of $.0133.
 
On March 10, 2011, we issued 2,185,561 shares of common stock pursuant to a conversion of original March, 2009 convertible notes for $31,000 at a conversion price of $.014184.
 
 
F-49

 
 
Note 11 –
Stockholders’ Deficit (continued):
 
(c) Common Stock (continued):

On March 11, 2011, we issued 555,392 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $7.386 at a conversion price of $.0133.
 
On March 14, 2011, we issued 120,357 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,616 at a conversion price of $.013425.
 
On March 15, 2011, we issued 130,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,745 at a conversion price of $.013425.
 
On March 15, 2011, we issued 2,326,565 shares of common stock pursuant to a conversion of original March, 2009 convertible notes for $33,000 at a conversion price of $.014184.
 
On March 16, 2011, we issued 219,600 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $2,948 at a conversion price of $.013425.
 
On March 17, 2011, we issued 80,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $1,204 at a conversion price of $.01505.
 
From March 18, 2011 through March 21, 2011, a total of 17,526,942 Class A warrants were exercised via a cashless exercise option into 6,363,287 at a non cash expense of $75,371.
 
On March 23, 2011, we issued 259.000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $4,144 at a conversion price of $.016.
 
On March 24, 2011, we issued 180,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $2,745 at a conversion price of $.01525.
 
On March 25, 2011, we issued 56,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $840 at a conversion price of $.015.
 
On March 28, 2011, we issued 174,000 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $2,610 at a conversion price of $.015.

On March 29, 2011, we issued 183,100 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $2,747 at a conversion price of $.015.
 
On March 30, 2011, we issued 224,100 shares of common stock pursuant to a conversion of original October, 2007 convertible notes (later assigned to a new debt holder in July, 2010) for $3,362 at a conversion price of $.015.
 
(d) Compensation and Incentive Plan:

On October 31, 2007, management approved the Company’s 2007 Stock Compensation and Incentive Plan and reserved 50,000 shares of the Company’s common stock for future issuance under the Plan to employees, directors and other persons associated with Attitude.  These shares were included in a Form S-8 that was filed with the Securities Exchange Commission on May 16, 2008 to register the underlying shares. We have issued 49,877 shares from this plan leaving an available 124 shares to be issued in the future.

On August 1, 2008, we issued 17,500 Non-Qualified Stock Options to Nutraceutical Discoveries at the exercise price of $13.00 per option for a licensing agreement to use certain intellectual property and “Innutria®” formulation.  These options are immediately vested and will expire in five (5) years on July 31, 2013. Due to the immediate vesting, we recognized the full cost of $163,240 in August, 2008 by using the Black-Scholes-Merton (BSM) option-pricing formula.  See table below for additional information that was used in this computation.
 
 
F-50

 

Note 11 –
Stockholders’ Deficit (continued):

(d) Compensation and Incentive Plan (continued):

Although our Board of Directors approved the creation of the March, 2009 Stock Option, Compensation and Incentive Plan in which 1,000,000 shares of our $.001 par value common stock will be reserved for future issuance under this plan, the plan was not filed with the Securities Exchange Commission. As such, any issuance will be subject to restrictions and Rule 144 holding periods. During March 30, 2009, we issued 884,569 non-qualified stock options at the exercise price of $1.00 to employees and certain consultants.  The stock options vest immediately and will expire in five (5) years on March 31, 2014. No other employee stock options have been granted prior to this transaction. We recorded the full compensation cost of $159,348 for these employee stock options in March, 2009.  None of these stock options have been exercised.
 
On March 10, 2010, our Board of Directors approved the issuance of 50,000 stock options to our Scientific Advisory Board at an exercise price of $0.60 that will expire in five (5) years on March 11, 2015.  We recorded the full compensation cost of $41,100 for these options in March, 2010.  None of these stock options have been exercised.  In addition and on the same date, we issued 75,000 stock options as a retainer for future services from our outside legal counsel at an exercise price of $1.00 in which the options will expire in five (5) years on March 11, 2015.  We recorded the full compensation cost of $57,450 for these options in March, 2010.  None of these options have been exercised.

On May 25, 2010, a registration that covers the offering of an aggregated 3,750,000 shares of the Company’s common stock was approved by the Company’s Board of Directors.  As such, the 2010 Stock Compensation and Incentive Plan was created for employees, directors, consultants and other persons associated with the Company in which awards of common stock and/or non-qualified stock options may be granted.  During the fiscal year ended March 31, 2011, we issued 3,288,889 shares of common stock for a total of $161,000 for past due professional services and payroll in which 1,500,000 shares were returned back to the plan,  leaving an available 1,961,111 shares to be issued in the future

On December 21, 2011, the Company’s Board of Directors approved the issuance of 27,102,009 non-qualified stock options to certain employees for the return of previously issued shares of common stock that were issued for payment of past due expenses to be effective at December 31, 2011.  The stock options have an exercise price of $.02, full vesting rights and a life of five years.  The Board of Directors intends to approve a registration to cover an offering to include these stock options once the increase in authorized shares has been approved, (increase approved May 1, 2012).  We recognized the full compensation expense of $12,656 at December 31, 2011 by using the Black-Scholes valuation model (27,102,009 x $.000467).

As required by the FASB Accounting Standards Codification, we would normally estimate forfeitures of employee stock option and recognize the compensation cost over the requisite service period for the entire award in accordance with the provisions.   As all stock options were fully vested, no estimate of forfeitures was required, and compensation cost is fully recognized at the time of grant and full vesting.  We estimated the fair value of these stock options on the date of grant using a Black-Scholes-Merton (BSM) option-pricing formula, applying the following assumptions:
 
Year Ended   3/31/09
 
   
17,500 options
   
884,569 options
 
Expected Term (in years)                        
   
3.33
     
5
 
Risk-free rate                                            
   
3.23
%
   
1.72
%
Volatility (based on peer group)              
   
107
%
   
78.02
%
Dividends                                                                               
   
-
     
-
 
 
Year Ended   3/31/10
 
   
50,000 options
   
75,000 options
 
Expected Term (in years)                        
   
5
     
5
 
Risk-free rate                                            
   
2.42
%
   
2.42
%
Volatility (based on peer group)              
   
103
%
   
103
%
Dividends                                                                               
   
-
     
-
 
 
 
F-51

 
 
Note 11 –
Stockholders’ Deficit (continued):

(d) Compensation and Incentive Plan (continued):

Year Ended   3/31/12
 
   
27,102,009
 options
 
Expected Term (in years)                        
   
5
 
Risk-free rate                                            
   
.83
%
Volatility (based on peer group)              
   
115
%
Dividends                                                                               
   
-
 

Expected Term:  The expected term represents the period over which the share-based awards are expected to be outstanding.

Risk-Free Interest Rate:  We based the risk-free interest rate used in its assumptions on the implied yield currently available on U.S. Treasury zero-coupon issues with a remaining term equivalent to the stock option award’s expected term.

Expected Volatility: Due to a limited trading history of our common stock, the volatility factor used in our
assumptions is based on weighted average “peer group” historical stock prices of three different companies that are similar in nature to our company over the most recent period commensurate with the expected term of the stock option award.

Expected Dividend Yield:  We do not intend to pay dividends on our common stock for the foreseeable future.  Accordingly, we used a dividend yield of zero in our assumptions.

A summary of option activity under these stock option plans for the year ended March 31, 2012 is presented below:
 
               
Weighted-Average
       
         
Weighted-
   
Remaining
       
         
Average
   
Contractual
   
Aggregate
 
         
Exercise
   
Term
   
Intrinsic
 
Options
 
Shares
   
Price
   
(in years)
   
Value
 
                         
                         
Outstanding at 3/31/10
    1,027,068     $ 1.20       4.11       -  
Granted
    -       -                  
Exercised
    -       -                  
Forfeited
    -       -                  
Expired
    -       -                  
                                 
Outstanding at 3/31/11
    1,027,068     $ 1.20       3.11       -  
Granted
    27,102,009     $ 0.02                  
Exercised
    -       -                  
Forfeited
    -       -                  
Expired
    -       -                  
                                 
Outstanding at 3/31/12
    28,129,077     $ 0.06       4.66       -  
 
Note that all of the stock options are outstanding, fully vested and exercisable for the year ended March 31, 2012.  As such, all compensation expense for the above options has been recognized, and there is no unrecognized compensation expense to be recorded in the future.
 
 
F-52

 
 
Note 12 – 
Income Taxes:
 
The Company has recorded no income tax benefit for its taxable losses during the period ending March 31, 2012 because there is no certainty that the Company will realize those benefits. The components of the Company's deferred tax assets and liabilities as of  March 31, 2012 and 2011 are as follows:
 
   
2012
   
2011
 
Net operating loss carryforwards
  $ 4,805,496     $ 4,012,749  
Compensatory stock and warrants
    56,123       66,300  
Accrued expenses that are deductible in future periods
    26,630       26,820  
Depreciation method differences
    1,623       96  
      4,889,872       4,105,965  
Valuation allowances
    (4,889,872 )     (4,105,965 )
                 
Net deferred tax assets
  $ -     $ -  
 
As of March 31, 2012 the Company has a net tax operating loss of $14,134,000 that will be available to offset future taxable income, if any. The use of net operating loss carryforwards to reduce future income tax liabilities is subject to limitations, and these amounts will begin to expire in 2028.
 
The following table illustrates the reconciliation of the tax benefit at the federal statutory rate to the Company's effective rate for the period ending March 31, 2012 and 2011:
 
   
2012
   
2011
 
Benefit at federal statutory rate
    -34.00 %     -34.00 %
Benefit at state rate, net of federal deficit
    2.31 %     -1.03 %
Fair value adjustment of convertible debt
    51.54 %     97.88 %
Non-deductible derivative loss
    6.45 %     20.83 %
Loss on extinguishment of debt
    0.00 %     -0.03 %
Non-deductible travel expenses
    0.07 %     -0.02 %
Benefit at the Company's effective rate
    -26.37 %     -83.63 %
Less valuation allowance effective tax rate
    0.00 %     0.00 %
 
Note 13 – 
Commitments and Contingencies:
 
Lease of office

In December 2007, the Company entered into a five year agreement for office space in Palm Beach Gardens, Florida with a commencement date of June 1, 2008.  The minimum starting monthly base rent was $7,415 and currently is $8,340 per month.  The lease provides for annual 4% increases throughout its term.
 
Future minimum rental payments for the new office lease, based on the current adjusted minimum monthly amount of $8,020 and excluding variable common area maintenance charges, as of March 31, 2012, are as follows:
 
Years ending March 31,
 
Amount
 
         
2013
  $
103,422
 
2014
   
17,348
 
         
   
$
120,770
 

Rental expense, which also includes maintenance and parking fees, for the period ended March 31, 2012 was $130,587.  We plan to enter into a first amendment of the lease  in late July 2012 to reduce the size of the premises by 2,750 square feet to from 5,561 square feet to 2,811 square feet.

 
F-53

 

Note 13 – 
Commitments and Contingencies (continued):

Production and Supply Agreements

On December 16, 2008, we signed a manufacturing agreement with O-AT-KA Milk Products Cooperative, Inc. for the production of future new products that are in the development stage.  The manufacturer shall manufacture, package and ship such products.  All products shall be purchased F.O.B., the facility by the company.  

Litigation

On May 18, 2009, F&M Merchant Group, LLC commenced a lawsuit in the state of Texas to recover the balance owed by us under a Sales Agent Agreement entered by the parties on November 1, 2008.  This agreement requires us to pay $5,000 per month and a 5% commission on all net sales. On September 3, 2009, a final judgment by default was approved by the district court in Denton County, Texas for a total sum of $22,347.  This claim has been recorded on the Company’s records.   Due to the lack of adequate capital financing, we have not been able to make any payments.  We expect to resolve this matter as soon as practical.

On June 5, 2009, Tuttle Motor Sports, Inc. commenced a lawsuit in the state of Florida to recover the balance owed by us under a Letter of Agreement to sponsor a Top Fuel Dragster for the 2008 NHRA racing season in the amount of $803,750. Out of this total amount, only $300,000 is required to be paid in cash with the remainder to be paid in shares of common stock. This amount had already been recorded in our records.  During May, 2010, Tuttle Motor Sports, Inc. dismissed the lawsuit without prejudice.  Prior to that time, the parties went through mediation but were unable to settle.  The likelihood of an unfavorable outcome cannot be evaluated as another lawsuit possibly could be filed against the Company.

On August 21, 2009, CH Fulfillment Services, LLC commenced a lawsuit in the state of Alabama to recover past due amounts owed by us under a contract to provide shipping and fulfillment services.  The claim is for $2,106 plus interest and legal costs.  This amount was already recorded on our records as well as projected interest costs of $682 and estimated court costs of $307 for a total of $3,095. This amount was recorded on our records.  A process of garnishment by the district court in Mobile County, Alabama was approved on September 25, 2009 for the total amount of $3,095.  On October 26, 2009, the same court authorized a garnishment process to pay $657 which was done as part payment of the total due amount. Current outstanding balance due is $2,438.  No other payments have been paid.

On April 20, 2012, Arena Advertising and Sports Marketing Inc commenced a lawsuit in the state of Florida to recover past due amounts owed by us in the amount of $15,000 plus interest since January 16, 2012.  The $15,000 was already recorded in our records.  We expect to resolve this matter as soon as practical.

Note 14 – 
Subsequent Events
 
On April 3, 2012, we issued 6,000,000 shares of common stock pursuant to two conversions of January, 2011 convertible notes totaling $10,443 and $2,877 accrued interest at a conversion price of $.00222.
 
On April 4, 2012, we issued 663,800 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $1,444 at a conversion price of $.002175.
 
On April 5, 2012, we issued 62,332 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $132 at a conversion price of $.002123.
 
On April 5, 2012, we issued 2,843,146 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $873 and accrued interest for $5,163 at a conversion price of $.002123.
 
On April 10, 2012, we issued 23,809,524 shares of common stock pursuant to a conversion of July, 2010 convertible notes for $50,000 at a conversion price of $.0021.
 
On April 10, 2012, we issued 3,225,000 shares of common stock pursuant to a conversion of January, 2011 convertible notes for $6,702 at a conversion price of $.002078.
 
On April 10, 2012, we issued 3,225,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $6,702 at a conversion price of $.002078.
 
 
F-54

 
 
Note 14 – 
Subsequent Events (continued)
 
On April 11, 2012, we issued 3,250,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $6,347 at a conversion price of $.001953.
 
On April 16, 2012, we issued 1,900,000 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $3,178 at a conversion price of $.0016725.
 
On April 26, 2012, we issued 5,800,000 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $7.076 at a conversion price of $.00122.
 
On April 27, 2012, we held a Special Meeti8ng of Stockholders for increasing the authorized shares from one billion to five billion common shares.  The shareholders voted in favor by 52.6% of the voting power to approve the increase to five billion authorized shares.
 
On May 1, 2012, the State of Delaware filed the Certificate of Amendment to Certificate of Incorporation to increase the authorized shares of the common stock from one billion (1,000,000,000) to five billion (5,000,000,000) shares.
 
On May 15, 2012, we issued 2,000,000 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $2,536 at a conversion price of $.001268.
 
On May 17, 2012, we issued 6,500,000 shares of common stock pursuant to a conversion of accrued interest for July, 2010 convertible notes for $8,242 at a conversion price of $.001268.
 
On May 17, 2012, we issued 60,000,000 shares of common stock pursuant to a conversion of February, 2008 convertible notes for $76,140 at a conversion price of $.001269.
 
On May 17, 2012, we issued 44,970,414 shares of common stock pursuant to a conversion of accrued interest for July, 2010 convertible notes for $57,000 at a conversion price of $.0012675.
 
On May 25, 2012, we issued 3,000,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $3,285 at a conversion price of $.001095.
 
On May 29, 2012, we issued 46,728,972 shares of common stock pursuant to a conversion of November, 2011convertible notes for $50,000 at a conversion price of $.00107.
 
On May 31, 2012, we issued 2,500,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $2,588 at a conversion price of $.001035.
 
On May 25, 2012, we issued 3,000,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $3,285 at a conversion price of $.001095.
 
On June 4, 2012, we issued 363,056 shares of common stock pursuant to a cashless exercise of 1,000,000 warrants from the March, 2011 financing.
 
On June 5, 2012, we issued 5,100,000 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $4,549 and accrued interest of $806 at a conversion price of $.00105.
 
On June 11, 2012, we issued 4,900,000 shares of common stock pursuant to a conversion of June, 2011 convertible notes for $5,145 at a conversion price of $.00105.
 
On June 19, 2012, we issued 40,000,000 shares of common stock pursuant to a conversion of February, 2008 convertible notes for $40,000 at a conversion price of $.001.
 
On June 23, 2012, we issued 6,900,000 shares of common stock pursuant to a conversion of July, 2011 note of accrued interest for $8,211 at a conversion price of $.00119.
 
 
F-55

 
 
Note 14 – 
Subsequent Events (continued)
 
On June 25, 2012, we issued 5,000,000 shares of common stock pursuant to a conversion of March, 2011 convertible notes for $4,000 at a conversion price of $.001067.
 
On June 14 2012, we entered into two promissory notes for $100,000 and $40,000, respectively, with two current accredited investors.  These notes are subject to an interest rate of ten percent (10%) and are due the sooner of (i) October 14, 2012 or (ii) from the proceeds of the next funding.  We received the $100,000 payment on June 27, 2012 and the $40,000 payment on July 9, 2012.
 
On June 26, 2012, we entered into a promissory note of $110,000 with a current accredited investor.  We agreed to pay a finder’s fee of $10,000 as we received the net payment of $100,000 on June 28, 2012.  The note is subject to an interest rate of ten percent (10%) and is due the sooner of (i) October 14, 2012 or (ii) from the proceeds of the next funding.
 
 
 
F-56